methotrexate has been researched along with cyclosporine in 1093 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 307 (28.09) | 18.2507 |
| 2000's | 371 (33.94) | 29.6817 |
| 2010's | 331 (30.28) | 24.3611 |
| 2020's | 84 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Jadhav, A; Kerns, E; Nguyen, K; Shah, P; Sun, H; Xu, X; Yan, Z; Yu, KR | 1 |
| Kabir, M; Kerns, E; Neyra, J; Nguyen, K; Nguyễn, ÐT; Shah, P; Siramshetty, VB; Southall, N; Williams, J; Xu, X; Yu, KR | 1 |
| Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
| Belinsky, MG; Chen, ZS; Kruh, GD; Rea, PA; Zeng, H | 1 |
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Belinsky, MG; Chen, ZS; Hopper-Borge, E; Kotova, E; Kruh, GD; Shchaveleva, I | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Fent, K; Popovic, M; Smital, T; Zaja, R | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Ahirrao, P; Bakhle, D; Bhankhede, T; Bhonde, M; Bokan, S; Budhe, S; Dadke, D; Daler, J; Deshmukh, G; George, SK; Gholve, M; Gundu, J; Gupta, R; Ingawale, S; Irlapatti, NR; Jachak, S; Kalia, A; Kamalakannan, P; Kamboj, RK; Kanoje, V; Karche, V; Khedkar, NR; Kizhakinagath, PA; Kuldharan, S; Kumar, H; Kumar, S; Mallurwar, S; Mehta, M; Modi, D; Naik, K; Narasimham, L; Nemade, HN; Nemmani, KVS; Nigade, P; Padiya, KJ; Palle, VP; Pandey, D; Pareek, H; Patil, A; Patil, V; Pawar, S; Phukan, S; Shah, C; Shaikh, Z; Shankar, R; Sharma, N; Sharma, S; Shinde, V; Sindkhedkar, M; Singh, M; Sinha, N; Tamane, K; Venugopal, S; Vishwase, G; Wagh, A; Yeshodharan, R | 1 |
| Ringdén, O | 2 |
| Boström, L; Forsgren, M; Ringdén, O | 1 |
| Calabrese, LH; Chou, SM; Sayers, ME | 1 |
| Kersey, JH; Ringdén, O | 1 |
| Hammer, JH; Nielsen, HJ | 1 |
| Masaoka, T | 1 |
| Apperley, J; Barrett, AJ; Cullis, JO; Hows, JM; Hughes, TP; Kelly, S; Mackinnon, S; Marks, DI; Schwarer, AP; Szydlo, R | 1 |
| Anasetti, C; Appelbaum, FR; Bowden, RA; Deeg, HJ; Doney, K; Longton, G; Nash, RA; Pepe, MS; Pettinger, M; Storb, R | 1 |
| Dawson, T; Findeisen, JM; Ryan, PF; Scheinkestel, CD | 1 |
| Beelen, DW; Brandt, H; Graeven, U; Haralambie, E; Linzenmeier, G; Mahmoud, HK; Müller, KD; Quabeck, K; Sayer, HG; Schaefer, UW | 1 |
| Cámara, R; Fernández-Villalta, MJ; Ferro, T; Figuera, A; Kassack, JJ; Lamana, M; López, J; Serrano, F; Steegmann, JL; Vázquez, L | 1 |
| Korstanje, MJ | 1 |
| Blaise, D; Bordigoni, P; Esperou-Bourdeau, H; Gluckman, E; Kuentz, M; Michel, G; Milpied, N; Rubie, H; Thuret, I; Vernant, JP | 1 |
| Wigley, FM | 1 |
| Belaiche, J; Delwaide, J; Gast, P; Louis, E | 1 |
| Bessell, EM; Hunter, AE; Russell, NH | 1 |
| Jaffe, IA | 1 |
| Yocum, DE | 3 |
| Dahllöf, G; Heimdahl, A; Lönnquist, B; Mattsson, T; Ringdén, O | 1 |
| Brown, R; Stevens, M; Tiedemann, K; Vowels, M | 1 |
| Klaesson, S; Ljungman, P; Lönnqvist, B; Persson, U; Ringdén, O; Sundberg, B | 1 |
| Goldman, JM | 1 |
| Calhoun, L; Champlin, RE; Gajewski, JL; Ho, WG; Hunt, LA; Landaw, EM; Lyddane, NR; O'Rourke, S; Petz, LD; Schiller, GJ | 1 |
| Anasetti, C; Appelbaum, FR; Deeg, HJ; Martin, P; Pepe, M; Sanders, JE; Singer, J; Stewart, P; Storb, R; Sullivan, KM | 1 |
| Brooks, P | 1 |
| Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Cliff, RA; Deeg, HJ; Doney, K; Hansen, J; Pepe, M; Storb, R | 1 |
| Nielsen, HJ | 1 |
| Bacigalupo, A; Biggs, JC; Camitta, BM; Champlin, RE; Gale, RP; Gluckman, E; Gordon-Smith, EC; Horowitz, MM; Hows, JM; Marmont, AM | 1 |
| Andersson, BS; Brunner, LJ; Deisseroth, AB; Dimopoulos, MA; Huan, SD; Spencer, V; Spitzer, G; Wallerstein, RO; Woo, SY; Yau, JC | 1 |
| Hidaka, S; Hiraoka, A; Kobayashi, M; Matsunashi, T; Nakamura, H; Tejima, H; Tominaga, N; Yoshida, H; Yoshida, S; Yoshimura, M | 1 |
| Speck, B | 1 |
| Athreya, BH; Cassidy, JT | 1 |
| Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S | 1 |
| Bender-Götze, C; Dopfer, R; Ebell, W; Ehninger, G; Friedrich, W; Gadner, H; Henze, G; Klingebiel, T; Peters, C; Riehm, H | 1 |
| Banquerigo, ML; Brahn, E; Peacock, DJ | 1 |
| Bourdeau-Esperou, H; Cosset, JM; Devergie, A; Gluckman, E; Socie, G; Traineau, R | 1 |
| González, T; Hernández-Beriaín, JA; Rodríguez-Lozano, B | 1 |
| Malleson, P | 1 |
| Hoch, S; Huppert, A; Schlesinger, N | 1 |
| Steinberg, AD | 1 |
| Birnbaum, AH; Rosh, JR | 1 |
| Kamel, OW; van de Rijn, M | 1 |
| Storb, R; Thomas, ED | 1 |
| Brugger, S; Greinix, HT; Höcker, P; Kalhs, P; Keil, F; Knöbl, P; Kyrle, PA; Linkesch, W; Schneider, B; Schwarzinger, I | 1 |
| Lewis, HM | 1 |
| Grigg, AP; Lickliter, JD; Roberts, AW | 1 |
| Arseniev, L; Bähre, O; Battmer, K; Berenson, RJ; Casper, J; Diedrich, H; Jacobs, R; Kadar, JG; Kühl, J; Link, H; Poliwoda, H; Schubert, J | 1 |
| Devine, SM; Dix, SP; Geller, RB; Wingard, JR | 1 |
| Dohy, H; Kakishita, E; Kanamaru, A; Kasai, M; Katoh, S; Kodera, Y; Moriyama, Y; Saitoh, H; Shibata, A; Takemoto, Y | 1 |
| Baruchel, A; Devergie, A; Esperou Bourdeau, H; Hirsch, I; Moussalem, M; Parquet, N; Ribaud, P; Schaison, G; Socie, G; Traineau, R | 1 |
| Hill, JM; Tattersfield, AE | 1 |
| Chan, GL; Vijayanagar, RR; Weinstein, SS | 1 |
| Arnold, R; Bunjes, D; Duncker, C; Hampl, W; Heimpel, H; Hertenstein, B; Koszinowski, U; Mertens, T; Wiesneth, M | 1 |
| Brandt, SA; Edwards, JR; Goodman, S; Greer, JP; Leelasiri, A; Stein, RS; Wolff, SN | 1 |
| Carreras, E; Rovira, M; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
| Dagis, AC; Molina, A; Nademanee, A; O'Donnell, M; Parker, P; Schmidt, GM; Smith, EP; Snyder, DS; Stein, A; Stepan, DE | 1 |
| Korelitz, BI | 1 |
| Carrier, M; Ferraro, P; Pelletier, GB; Pelletier, LC; White, M | 1 |
| Betker, R; Hoffknecht, M; Horstmann, M; Kabisch, H; Krüger, W; Stockschläder, M; Zander, A | 1 |
| Arnold, R; Bunjes, D; Duncker, C; Heimpel, H; Heit, W; Hertenstein, B; Novotny, J; Stefanic, M; Wiesneth, M | 1 |
| Ash, RC; Auerbach, AD; Bortin, MM; Butturini, A; Camitta, BM; Champlin, RE; Friedrich, W; Gale, RP; Gluckman, E; Good, RA; Gordon-Smith, EC; Harris, RE; Horowitz, MM; Klein, JP; Ortega, JJ; Pasquini, R; Ramsay, NK; Sobocinski, KA; Speck, B; Vowels, MR; Zhang, MJ | 1 |
| De Witte, T; Dompeling, EC; Schattenberg, A; Swaak, AJ; Vreugdenhil, G | 1 |
| Conn, DL; Valente, RM | 1 |
| Favre, H; Huang, YP; Lemoine, R; Miescher, PA | 1 |
| Blaise, D; Leblond, V; Maraninchi, D; Marit, G; Michallet, M; Olive, D | 1 |
| Andersen, WK; Feingold, DS | 1 |
| Bartoli, E; Boiocchi, M; Carbone, A; Casatta, L; De Vita, S; Dolcetti, R; Ferraccioli, GF | 1 |
| Panizzon, R | 1 |
| Baker, P; Gluck, O; Kraag, G; McKendry, R; Pincus, T; Stein, M; Tesser, J; Tugwell, P; Wells, G; Yocum, D | 1 |
| Breedveld, FC | 1 |
| Sherlock, S | 1 |
| Berson, M; Callens, A; Lorette, G; Machet, L; Pourcelot, L; Vaillant, L | 1 |
| Bellazzi, R; Quaglini, S | 1 |
| Bensen, W; Gent, M; Grace, E; Ludwin, D; Roberts, RM; Ross, H; Tugwell, P | 1 |
| Moss, RB | 1 |
| Braidley, PC; Wallwork, J; White, DJ | 1 |
| Boogaerts, MA; Van Acker, KL; Van Hove, LM | 1 |
| Stark, ME; Tremaine, WJ | 1 |
| Goddard, CJ; Warnes, TW | 1 |
| Jones, G; Sambrook, PN | 1 |
| Chan, TK; Chiu, EK; Yuen, P | 1 |
| Attal, M; Brousset, P; Dastugue, N; Demur, C; Duchayne, E; Rigal-Huguet, F; Robert, A; Rubie, H | 1 |
| Abla, O; Arcese, W; Boni, L; Di Bartolomeo, P; Dini, G; Iori, AP; Locatelli, F; Polchi, P; Rossetti, F; Uderzo, C | 1 |
| Renz, H | 1 |
| van Hogezand, RA | 1 |
| Aschan, J; Lönnqvist, B; Lungman, P; Markling, L; Remberger, M; Ringdén, O | 1 |
| Andström, E; Aschan, J; Ljungman, P; Lönnqvist, B; Remberger, M; Ringdén, O | 1 |
| Jones, AR; Poon, MC; Ruether, BA; Russell, JA; Woodman, RC | 1 |
| Catovsky, D; Horton, C; Mehta, J; Milan, S; Powles, R; Tait, D; Treleaven, J | 1 |
| Favre, H; Lemoine, R; Miescher, PA | 1 |
| Lauharanta, J | 1 |
| Hasan, RI; Karusseit, VO; Mieny, CJ; Van den Bogaerde, JB; White, DJ | 1 |
| Hasan, RI; Sriwatanawangosa, V; Wallwork, J; White, DJ | 1 |
| Boström, L; Hägglund, H; Nilsson, B; Remberger, M; Ringdén, O | 1 |
| Andström, E; Aschan, J; Ljungman, P; Remberger, M; Ringdén, O | 1 |
| Aschan, J; Ljungman, P; Lönnqvist, B; Markling, L; Remberger, M; Ringden, O | 1 |
| Bruno, M; Cosseddu, D; Linari, F; Manganaro, M; Pellerito, R; Ravarino, N; Torchio, B; Urbano, D | 1 |
| Sigidin, IaA; Usova, SB | 1 |
| Clancy, J; Kovacs, EJ; Malinowska, K; Piccinini, LA; Pizarro, TT; Robinson, JA | 2 |
| Longmire, AW; Minton, TA; Morrow, JD; Pincus, T; Roberts, LJ; Stein, CM | 1 |
| Hale, G; Waldmann, H | 1 |
| Lynch, JP; McCune, WJ; Vallance, DK | 1 |
| Aschan, J; Ringdén, O | 1 |
| Ito, H; Kimura, Y; Nakamura, H; Nomura, N; Otaka, M; Sakai, N; Shirota, T; Suzuki, A; Toyama, K; Uchida, H | 1 |
| Chandanayingyong, D; Issaragrisil, S; Piankijagum, A; Suvatte, V; Visuthisakchai, S | 1 |
| Amylon, MD; Chao, NJ; Long, GD; Nademanee, AP; Negrin, RS; O'Donnell, MR; Parker, PM; Smith, EP; Snyder, DS; Stein, AS | 1 |
| Hirose, M; Kuroda, Y; Ninomiya, T; Okamoto, Y; Sano, T; Takahashi, Y; Ushiroguchi, Y; Watanabe, T | 1 |
| Coloni, L; De Sabbata, G; Mazzanti, G; Paladini, G | 1 |
| Andreani, M; Lucarelli, G; Manna, M; Nesci, S; Tonucci, P | 1 |
| Furst, DE | 1 |
| Berkman, E; Comenzo, R; Erban, JK; Fogaren, T; Hirsch, CA; Miller, KB; Rabson, A; Schenkein, DP | 1 |
| Egeler, M; Filipovich, AH; Jyonouchi, H; Loechelt, BJ; Shapiro, RS | 1 |
| De Marzio, P; Giordano, M; Morelli, S; Priori, R; Sgreccia, A; Valesini, G | 1 |
| Cooley, MA; Donnellan, M; Farrell, C; Fussell, ST | 1 |
| Fox, DA; McCune, WJ | 1 |
| Anasetti, C; Appelbaum, F; Bensinger, W; Buckner, CD; Clift, R; Deeg, HJ; Doney, K; Hansen, J; Leisenring, W; Storb, R | 1 |
| Fitzsimmons, WE; Ghalie, R; Kaizer, H; Manson, S; Weinstein, A | 1 |
| Fujita, H; Hashimoto, Y; Hataoka, K; Kanamori, H; Maeda, K; Ohtsuka, M; Okamoto, R; Tamura, T; Tanabe, J; Yamazaki, E | 1 |
| Angelucci, E; Baronciani, D; Erer, B; Galimberti, M; Gaziev, D; Giardini, C; Lucarelli, G; Polchi, P; Rapa, S; Ripalti, M | 1 |
| Aresu, G; Barca, L; Frongia, T; Pascalis, L; Pia, G | 1 |
| Bloom, EJ; Schwinghammer, TL | 1 |
| Connolly, KM; Noel, LS; Smith-Oliver, T; Stimpson, SS; Yarnall, DP | 1 |
| Akashi, K; Eto, T; Gondo, H; Harada, M; Hayashi, S; Nagafuji, K; Takamatsu, Y; Taniguchi, S; Teshima, T; Yamasaki, K | 1 |
| Arcese, W; Bandini, G; Bosi, A; Carreras, E; Frassoni, F; Gahrton, G; Gratwohl, A; Hermans, J; Niederwieser, D; Vernant, JP | 1 |
| Blazar, B; Filipovich, A; Kersey, J; McGlave, P; Miller, W; Ramsay, N; Weisdorf, D | 1 |
| Aschan, J; Klaesson, S; Ljungman, P; Lönnqvist, B; Ringdén, O; Sundberg, B | 1 |
| Buckley, JD; Feig, SA; Hammond, GD; Kim, T; Lampkin, B; Nesbit, ME; Versteeg, CM; Woods, WG | 1 |
| Appelbaum, FR; Bakke, L; Bensinger, WI; Bianco, JA; Bowden, RA; Buckner, CD; Clift, RA; McDonald, GB; Schubert, M; Singer, JW | 1 |
| Amylon, MD; Chao, NJ; Dagis, AC; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Schmidt, GM | 1 |
| Daum, F; Grancher, K; Mandel, F; Markowitz, J | 1 |
| Ford, D; Lam-Po-Tang, R; Shing, MM; Trickett, AE; Vowels, MR | 1 |
| Belanger, R; Boileau, J; Bonny, Y; Kassis, J; Lacombe, M; Lalonde, Y; Lavallee, R; Perreault, C; Roy, DC; von Bueltzingsloewen, A | 1 |
| Biggs, JC; Champlin, RE; Deeg, HJ; Dicke, K; Gale, RP; Horowitz, MM; Masaoka, T; Powles, RL; Ringdén, O; Sondel, P | 1 |
| Jelkmann, W; Wolff, M | 1 |
| Kragballe, K | 1 |
| Hasan, RI; Sriwatanawongsa, V; Wallwork, J; White, DJ | 1 |
| Green, C; Hawk, JL | 1 |
| Anasetti, C; Choo, SY; Hansen, JA; Longton, GM; Martin, PJ; Mickelson, EM; Petersdorf, EW; Smith, AG | 1 |
| Aurer, I; Bogdanić, V; Kovacević-Metelko, J; Labar, B; Maravić, N; Mrsić, M; Nemet, D; Radman, I; Zupancić-Salek, S | 1 |
| Harrison, PE; Menter, A; Morris, LF; Phillips, CM; Sander, HM | 1 |
| Alessandrino, EP; Aversa, F; Calori, E; Dini, G; Garbarino, L; Lamparelli, T; Lanino, E; Locatelli, F; Marenco, P; Medugno, D | 1 |
| Akimoto, Y; Hino, K; Ishiyama, T; Koike, M; Nakamaki, T; Tomoyasu, S; Tsuruoka, N; Ueno, H; Yamada, K | 1 |
| Kozarek, RA | 1 |
| Briedigkeit, L; Göbel, U; Gross, WL; Natusch, R; Rheinhold-Keller, E; Ulmer, M | 1 |
| Chakravarty, BJ | 1 |
| Hunter, A; Rogers, S; Russell, N | 1 |
| Anasetti, C; Anderson, JE; Appelbaum, FR; Bensinger, WI; Bryant, E; Buckner, CD; Chauncey, T; Clift, RA; Gooley, T; Schoch, G | 1 |
| Brugger, SA; Dieckmann, KU; Fischer, G; Geissler, K; Greinix, HT; Haas, O; Hinterberger, W; Hocker, P; Jager, U; Kalhs, P; Keil, F; Lechner, K; Linkesch, W; Mannhalter, C; Reiter, E; Schneider, B; Schwarzinger, I | 1 |
| Arseniev, L; Diedrich, H; Link, H | 1 |
| Debatin, KM; Friesen, C; Herr, I; Krammer, PH | 1 |
| Jamieson, SW; Kapelanski, DP; Kriett, J; Sakakibara, N; Wolf, P | 1 |
| Bailey, LL; Bouchart, F; Fukushima, N; Gundry, SR; Matsumiya, G; Zuppan, C | 1 |
| Issaragrisil, S; Piankijakum, A; Suvatte, V; Tang-naitrisorana, Y; Visuthisakchai, S | 1 |
| Benisovich, VI; Cohen, E; Silverman, L; Slifkin, R; Stone, N | 1 |
| Sandborn, WJ | 1 |
| De Benedetti, F; Martini, A; Ravelli, A; Viola, S | 1 |
| Arseniev, L; Bähre, O; Diedrich, H; Kadar, JG; Link, H; Poliwoda, H | 1 |
| Amend, WJ; Ellis, CN; Krueger, GG; Lebwohl, M; Menter, MA; Morison, WL; Prystowsky, JH; Roenigk, HH; See, JA; Shupack, JL; Silverman, AK; Weinstein, GD; Yocum, DE; Zanolli, MD | 1 |
| Asaka, M; Hashino, S; Imamura, M; Kasai, M; Kobayashi, S; Noto, S; Sakurada, K; Tanaka, J | 1 |
| Emery, P; Richardson, C | 1 |
| Bacigalupo, A; Brinch, L; Cook, G; Domingo-Albos, A; Finke, J; Garcia-Conde, J; Gratwohl, A; Labopin, M; Lambertenghi-Deliliers, G; Lange, A; Laporte, JP; Majolino, I; Rozman, C; Schmitz, N | 1 |
| Brodsky, I; Bulova, S; Crilley, P; Marks, DI; Styler, MJ; Topolsky, D | 1 |
| Busse, WW; Jarjour, NN; McGill, K | 1 |
| Guilhou, JJ | 1 |
| Carotti, M; Cervini, C; Salaffi, F | 1 |
| Shak, AK | 1 |
| Lacki, JK; Mackiewicz, S; Mackiewicz, U; Samborski, W | 1 |
| Burke, M; Crawford, DH; Hunt, BJ; Thomas, JA; Walker, H; Yacoub, M | 1 |
| Alegre, A; Benet, I; Besalduch, J; Brunet, S; Carreras, E; de la Rubia, J; Díaz, MA; Domingo-Albós, A; García-Conde, J; Hernández, F; Moraleda, JM; Ojeda, E; Petit, J; Rozman, C; Sanz, G; Solano, C; Urbano-Ispizua, A; Vivancos, P | 1 |
| Bermas, BL; Hill, JA | 1 |
| Barnes, PJ | 1 |
| Bartoli, E; Casatta, L; Ferraccioli, G | 1 |
| Goodyear, N; Kahan, BD; Murthy, JN; Napoli, KL; Soldin, SJ | 1 |
| Lichtenstein, GR; Stotland, BR | 1 |
| Aresu, G; Ledda, MA; Pascalis, L; Pia, G; Rosetti, L | 1 |
| Raez, LE; Saldana, M; Temple, JD | 1 |
| Kaplan, MM | 1 |
| Bacigalupo, A; Fiere, D; Frassoni, F; Gluckman, E; Gorin, NC; Harrousseau, JL; Jouet, JP; Labopin, M; Reiffers, J; Ringdén, O; Vernant, JP | 1 |
| Appelbaum, FR; Bensinger, WI; Benyunes, M; Buckner, CD; Clift, R; Demirer, T; Lee, M; Martin, P; Rowley, S; Schiller, G; Shannon-Dorcy, K; Storb, R | 1 |
| Blay, JY; Bonnotte, B; Bourhis, JH; Burdiles, AM; Caignard, A; Carayol, G; Chehimi, J; Chouaib, S; Dietrich, PY; Hayat, M; Ibrahim, A; Kubin, M; Pardoux, C; Pico, JL; Robinet, E | 1 |
| Arakawa, M; Hasegawa, H; Nakano, M; Nishi, S; Saito, T; Ueno, M | 1 |
| Iversen, L; Kragballe, K; Svendsen, M | 1 |
| Bjerring, P; Heickendorff, L; Zachariae, H | 1 |
| Altmeyer, P; Nüchel, C | 1 |
| Adams, EM; Villalba, L | 1 |
| Thomas, AL; Warbrick, EV; Williams, CM | 1 |
| Ramsey-Goldman, R; Schilling, E | 1 |
| Kuijpers, AL; van de Kerkhof, PC; van Dooren-Greebe, JV | 1 |
| Tremaine, WJ | 1 |
| Ciccarelli, A; de Crescenzo, G; de Paulis, A; Marinò, D; Marinò, I; Marone, G | 1 |
| Ciesielski, CJ; Mei, J; Neton, JT; Piccinini, LA | 1 |
| Homma, M | 1 |
| Alarcón, GS | 1 |
| Apperley, JF; Gratwohl, A; Niederwieser, D; Ruutu, T | 1 |
| Spector, SL | 1 |
| Baker, KS; DeLaat, CA; Filipovich, AH; Gross, TG; Harris, R; Loechelt, B; Shapiro, RS; Steinbuch, M | 1 |
| Haagsma, CJ; van Riel, PL | 1 |
| Bertz, H; Finke, J; Mertelsmann, R; Potthoff, K | 1 |
| De'Arce, M; Gardiner, N; Lawler, M; McCann, SR; O'Riordan, J | 1 |
| Grigg, A; Harun, MH; Szer, J | 1 |
| Erttmann, R; Hassan, HT; Krog, C; Krüger, W; Stockschläder, M; Zander, AR; Zeller, W | 1 |
| Cerezo, L; Domínguez, P; López, M; Marín, A; Martín De Vidales, C; Pérez Torrubia, A; Zapatero, A | 1 |
| Brooks, RH; Pincus, T; Stein, CM | 1 |
| Brooks, RH; Gluck, O; Kraag, G; McKendry, R; Pincus, T; Stein, CM; Tesser, J; Torley, H; Tugwell, P; Wells, G; Yocum, D | 1 |
| Katz, HI | 1 |
| Schölmerich, J | 1 |
| Modigliani, R | 1 |
| Anasetti, C; Appelbaum, FR; Bensinger, W; Buckner, CD; Chauncey, T; Clift, R; Deeg, HJ; Doney, K; Flowers, ME; Hansen, JA; Leisenring, W; Martin, P; Pepe, M; Pettinger, M; Sanders, J; Storb, R; Sullivan, KM; Thomas, ED; Witherspoon, R | 1 |
| Cooper, DK; Hancock, WW; Kobayashi, T; Kosanke, S; Neethling, FA; Niekrasz, M; Rose, AG; Taniguchi, S; White, DJ; Wright, LJ; Ye, Y | 1 |
| Akan, H; Arslan, O; Beksaç, M; Dilek, I; Gürman, G; Ilhan, O; Koç, H; Konuk, N; Ozcan, M; Uysal, A | 1 |
| Antich Rojas, J; Balaguer, H; Cladera, A | 1 |
| Auzuki, A; Matsuoka, Y | 1 |
| Bernstein, BH; Franke, E; Rawlings, DJ; Reiff, A; Richardson, L; Shaham, B; Szer, IS | 1 |
| Asano, S; Kikuchi, A; Nishikawa, T; Okamoto, S; Takahashi, S | 1 |
| Amill, B; Berlanga, JJ; Boqué, C; Brunet, S; Canals, C; Cancelas, JA; Domingo-Albós, A; Ferra, C; Gallardo, D; García-López, J; Grañena, A; Martín-Henao, G; Martínez, C; Martino, R; Picón, M; Sureda, A; Torrico, C | 1 |
| Brown, PJ; Cains, GD; Georgouras, KE; Zagarella, SS | 1 |
| Gooley, T; Hackman, RC; Ko, CW; Lee, SP; McDonald, GB; Myerson, D; Sale, GE; Schoch, HG; Shulman, HM | 1 |
| Baert, F; Rutgeerts, P | 2 |
| Bunin, N; Darbyshire, PJ; Davies, SC; Dinndorf, P; Kurtzberg, J; Leisenring, W; Mentzer, WC; Patience, M; Roberts, IA; Rogers, ZR; Scott, JP; Smith, FO; Sullivan, KM; Wall, DA; Walters, MC; Wayne, AS; Wiley, J; Yeager, A | 1 |
| Cowie, FJ; Pinkerton, CR; Pritchard-Jones, K; Renshaw, J | 1 |
| Hirabayashi, N; Ikeda, Y; Ishida, A; Matsuoka, S; Moriki, T; Okamoto, S; Wakui, M; Watanabe, R | 1 |
| Aranda, R; Horgan, K | 1 |
| Amici, F; Danieli, G; Danieli, MG; Fratini, M; Giovagnoni, A; Rossetti, L | 1 |
| Bacigalupo, A; Berisso, G; Bregante, S; De Stefano, F; Frassoni, F; Gualandi, F; Lamparelli, T; Mordini, N; Occhini, D; Soracco, M; Van Lint, MT; Vitale, V; Zikos, P | 1 |
| Menninger, H | 1 |
| Pincus, T | 1 |
| Riccieri, V; Sensi, F; Sili Scavalli, A; Spadaro, A; Taccari, E; Zoppini, A | 1 |
| Dutz, JP; Ho, VC | 1 |
| McCune, WJ; Singer, NG | 1 |
| Tytgat, GN; van Deventer, SJ | 1 |
| Bailey, LL; Gundry, SR; Hancock, WW; Matsumiya, G; Morimoto, T; Slater, J; Xu, H; Zuppan, CW | 1 |
| Chiominto, B; Faggian, G; Forni, A; Mazzucco, A | 1 |
| Bandini, G; Bonini, A; Campanini, E; Mangianti, S; Motta, MR; Remiddi, C; Rizzi, S; Rondelli, D; Rosti, G; Testoni, N; Tura, S; Zuffa, E | 1 |
| Bizan, P; Gröger, M; Kiener, H; Redlich, K; Schett, G; Smolen, J; Steiner, G; Tohidast-Akrad, M; Xu, Q | 1 |
| Pasquini, R; Scola, RH; Werneck, LC; Zétola, VH | 1 |
| Flowers, ME; Longton, G; Schubert, M; Storb, R; Sullivan, KM; Wagner, JL | 1 |
| O'Dell, JR | 1 |
| Beksac, M; Bernaudin, F; Brichard, B; Gluckman, E; Locatelli, F; Miniero, R; Nagler, A; Roberts, I; Rocha, V; Saracco, P; Yaniv, I | 1 |
| Landaw, EM; Paquette, RL; Tran, L | 1 |
| Abbattista, AD; Catena, G; Di Donato, R; La Vigna, G; Parisi, F; Squitieri, C; Vinciguerra, G | 1 |
| Boccadoro, M; Caracciolo, D; Cavallaro, AM; Corradini, P; Indovina, A; Majolino, I; Marcenò, R; Palumbo, A; Pileri, A; Santoro, A; Scimè, R; Tarella, C | 1 |
| Antin, JH; Avalos, B; Buell, DN; Christiansen, NP; Devine, SM; Fay, JW; Fitzsimmons, WE; Herzig, RH; Karanes, C; Klein, JL; Litzow, MR; Longo, WL; Maher, RM; Nademanee, A; Nash, RA; Petersen, FB; Przepiorka, D; Ratanatharathorn, V; Storb, R; van der Jagt, R; Weisdorf, D; Wingard, JR; Wolff, SN | 1 |
| Blanco, R; García-Porrúa, C; González-Gay, MA; Ibáñez, D; Marenco, JL; Sánchez-Bursón, J; Vázquez-Caruncho, M | 1 |
| Bessell, EM; Byrne, JL; Haynes, AP; Hyde, H; Miflin, G; Russell, NH; Stainer, C | 1 |
| Anasetti, C; Leisenring, W; Sanders, J; Sandmaier, BM; Storb, R; Stucki, A | 1 |
| Ciesielski, CJ; Mei, J; Pflug, JJ; Piccinini, LA | 1 |
| Ciesielski, CJ; Mei, J; Piccinini, LA | 1 |
| Sieper, J | 1 |
| Aschan, J; Carlens, S; Hägglund, H; Klaesson, S; Ljungman, P; Lönnqvist, B; Mattsson, J; Remberger, M; Ringdén, O; Svahn, BM; Winiarski, J | 1 |
| Favre, H; Lemoine, R; Miescher, PA; Tamagnini, P | 1 |
| Barrett, AJ; Bunjes, D; Hale, G; Horowitz, MM; Prentice, HG; Spence, D; Waldmann, H; Zhang, MJ | 1 |
| Hibi, S; Imashuku, S; Kasubuchi, Y; Tsunamoto, K | 1 |
| Dimitrijevic, M; Glisic, B; Obradovic, S; Pejnovic, N; Popovic, M; Popovic, R; Stefanovic, D | 1 |
| Dieckman, K; Fischer, G; Greinix, HT; Kalhs, P; Keil, F; Lechner, K; Leitner, G; Malzer, R; Rabitsch, W; Reiter, E | 1 |
| Cukrová, V; Dolezalová, L; Gasová, Z; Hrabánek, J; Hrubá, A; Kobylka, P; Korínková, P; Loudová, M; Marinov, J; Sajdová, J; Sieglová, Z; Vítek, A | 1 |
| Hołowiecki, J; Kopera, M; Krawczyk-Kuliś, M; Kruzel, T; Markiewicz, M; Wojciechowska, M; Wojnar, J | 1 |
| Dick, AD; Forrester, JV; Kilmartin, DJ | 1 |
| Berger, C; Braumann, D; de Witt, M; Erttmann, R; Fiedler, W; Grimm, J; Horstmann, M; Hossfeld, KD; Illiger, HJ; Kabisch, H; Kröger, N; Krüger, W; Kuse, R; Schönrock, P; Stockshläder, M; Weh, HJ; Zander, AR; Zeller, W | 1 |
| Hashimoto, T | 1 |
| Georgouras, K; Wong, KC | 1 |
| Carreras, E; Marín, P; Martínez, C; Montfort, N; Montserrat, E; Rovira, M; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
| Boers, M; Cranney, A; Pham, B; Tugwell, P; Verhoeven, AC; Wells, G | 1 |
| Haruki, Y; Inaba, Y; Kobayashi, H; Ogawa, H; Ohkawara, A; Ohkido, M; Ohno, Y; Ozawa, A | 1 |
| Deykin, A; Israel, E | 1 |
| Glomstein, A; Gustafsson, G; Jonmundsson, G; Mellander, L; Nysom, K; Ringdén, O; Saarinen-Pihkala, UM; Schroeder, H | 1 |
| Balfour-Lynn, I | 1 |
| Bielack, S; de Wit, M; Dürken, M; Erttmann, R; Jaburg, N; Kabisch, H; Kröger, N; Krüger, W; Löliger, C; Renges, H; Rüssmann, B; Stockschläder, M; Wacker-Backhaus, G; Zabelina, T; Zander, AR | 1 |
| Hanauer, SB; Stein, RB | 1 |
| Klassen, LW; Moore, GF; O'Dell, JR | 1 |
| Heathcote, EJ | 1 |
| Drewe, J; Fricker, G; Gutmann, H; Miller, DS; Toeroek, M | 1 |
| Kaplan, HJ; Van Gelder, RN | 1 |
| Roenigk, HH | 1 |
| Koo, J | 1 |
| Sharathkumar, A; Shaw, P | 1 |
| Allen, BR; Barker, JN; Chalmers, RJ; Clark, CM; Davison, S; Emerson, R; Griffiths, CE; Kirby, B; Morris, AD; Saihan, EM; Zaki, I | 1 |
| Abboud, C; Constine, L; DiPersio, J; Duerst, R; Liesveld, J; Linder, T; McKenna, B; Packman, C; Rapoport, A; Rowe, J; Silverman, W; Swift, S; Wedow, L; Zwetsch, L | 1 |
| Breedveld, FC; den Ottolander, GJ; Janssen, HL; van Hoek, B; van Krieken, JH; van Laar, JM | 1 |
| Itoh, T; Matsushita, H; Mitsuoka, S; Uji, M | 1 |
| Schattner, A | 1 |
| Canterbury, A; Clarke, E; Cornish, JM; Goodman, S; Green, A; Hale, G; Hunt, L; Lankester, A; Marks, DI; Oakhill, A; Pamphilon, DH; Steward, CG; Waldmann, H | 1 |
| Bergna, MI; Cánepa, C; Gardenal, L; Gil, MA; Italiano, C; Klein, G; Malacalza, J; Mansilla, E; Marin, GH; Mendez, MC; Menna, ME; Orlando, S; Perez, M; Piccinelli, G; Saba, S | 1 |
| Hurst, NP | 1 |
| Gooley, T; Hansen, JA; Lin, MT; Martin, EG; Martin, PJ; Pei, J; Petersdorf, EW; Smith, AG; Tseng, LH | 1 |
| Gómez-Almaguer, D; Herrera-Garza, J; Ibarra-Peart, R; Jaime-Pérez, J; Montemayor, J | 1 |
| Bouvenot, G; Chaudier, B; Chouc, PY; Fulpin, J; Jeandel, P; Sebahoun, G | 1 |
| Johns, KR; Littlejohn, GO | 1 |
| Amylon, MD; Blume, KG; Chao, NJ; Dagis, AC; Forman, SJ; Long, GD; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, PM; Ross, M; Schmidt, GM; Smith, EP; Snyder, DS; Stein, AS; Wong, RM | 1 |
| Kougo, Y | 1 |
| Padovan, M; Trotta, F | 1 |
| Scarpa, R | 1 |
| Masereeuw, R; Miller, DS; Russel, FG; Terlouw, SA; van Aubel, RA | 1 |
| Linden, KG; Weinstein, GD | 1 |
| Biggs, JC; Gale, RP; Giralt, S; Goldman, JM; Herzig, RH; Horowitz, MM; Klein, JP; McGlave, PB; Rowlings, PA; Schiller, G; Szydlo, R; Veum-Stone, J | 1 |
| Kasai, M; Kato, C; Kitaori, K; Morishima, Y; Sao, H; Shimokawa, T; Ueda, R; Yamanishi, H | 1 |
| Gelfand, JM; Lebwohl, M; Tan, MH | 1 |
| Weinblatt, ME | 1 |
| Cherikuri, A; Donnelly, S; Farrell, RJ; Keeling, PW; Kelleher, D; Long, A; Mahmud, N; Murphy, A; O'Toole, D; Weir, DG | 1 |
| Ewe, K; Gassull, MA; Geboes, K; Jewell, D; Meuwissen, SG; Pallone, F; Rachmilewitz, D; Rask-Madsen, J; Riddell, BH; Sandborn, BJ; Schmuck, ML | 1 |
| Baraldo, M; Ferraccioli, G; Furlanut, M; Gremese, E; Pea, F | 1 |
| Allerberger, F; Gruber, J; Krugmann, J; Müller, T; Offner, FA; Sailer-Höck, M | 1 |
| Yokota, S | 1 |
| Deeg, HJ; Linsley, P; Nash, RA; Sale, G; Seidel, K; Storb, R; Yu, C | 1 |
| Bargalló, N; Berenguer, J; Buñesch, L; Burrel, M; Cofan, F; Mercader, JM | 1 |
| van Rijthoven, AW | 1 |
| Jankowska, R; Kraus-Filarska, M; Małolepszy, J; Nadobna, G; Nowak, I; Zak-Nejmark, T | 1 |
| Benz, MS; Kramer, D; Murray, TG; Scott, IU; Toledano, S | 1 |
| Basara, N; Bischoff, M; Blau, WI; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Schmetzer, B | 1 |
| Drosos, AA; Katsaraki, A; Voulgari, PV; Zikou, AK | 1 |
| Bartůnková, J; Charvát, F; Jarosová, K; Kafková, J; Machácek, S; Nemcová, D; Studýnková, J; Vencovský, J | 1 |
| Byrne, JL; Carter, GI; Cull, GM; Hale, G; Haynes, AP; Miflin, G; Rebello, P; Russell, NH; Waldmann, H | 1 |
| Legg, J; Warner, J | 1 |
| Albrechtsen, D; Brinch, L; Egeland, T; Evensen, SA; Heldal, D; Solheim, BG; Steen, R; Tjønnfjord, G | 1 |
| Amylon, MD; Bluzme, KG; Chao, NJ; Forman, SJ; Fung, H; Hu, WW; Jain, M; Johnston, LJ; Kashyap, A; Kohler, S; Krishnan, A; Long, GD; Molina, A; Nademanee, AP; Negrin, RS; Niland, JC; O'Donnell, MR; Parker, P; Rodriguez, R; Snyder, DS; Spielberger, R; Stein, A; Stockerl-Goldstein, KE; Tierney, DK; Wong, RM | 1 |
| Martio, J | 1 |
| Dobashi, H; Hiraishi, T; Mitsunaka, H; Takahara, J; Tokuda, M | 1 |
| Bridge, PJ; Coppes, MJ; Egeler, RM; Graham, GE; Graham, LM; Maclaren, LD | 1 |
| Foster, CS; Gion, N; Stavrou, P | 1 |
| Asano, M; Bailey, LL; Fagoaga, O; Gundry, SR; Izutani, H; Zuppan, CW | 1 |
| Bailey, LL; Gundry, SR; Hancock, W; Matsumiya, G; Xu, H | 1 |
| Ammatuna, E; Barbera, V; Florena, AM; Franco, V; Gerlando, Q; Mariani, G | 1 |
| Flores, F; Kerdel, FA | 1 |
| Adebajo, A; Conaghan, PG; Emery, P; Gough, A; Green, MJ; Griffiths, B; Helliwell, P; Huston, G; Isaacs, J; Martin, M; McGonagle, D; Miles, S; Pease, C; Proudman, SM; Reece, RJ; Richardson, C; van der Heijde, DM; Veale, DJ; Wakefield, RJ | 1 |
| Coles, JG; Straatman, LP | 1 |
| Arcese, W; Bacigalupo, A; Bruno, B; Dallorso, S; Di Bartolomeo, P; Fagioli, F; Lawler, M; Locasciulli, A; Locatelli, F; McCann, S; Van-Lint, MT; Zecca, M | 1 |
| Bertz, H; Engelhardt, M; Finke, J; Hahn, J; Holler, E; Kunzmann, R; Reisser, S; Veelken, H; Wäsch, R | 1 |
| Anasetti, C; Antin, JH; Avalos, BR; Bartels, P; Buell, D; Davies, S; Fay, JW; Fitzsimmons, W; Karanes, C; Nash, RA; Petersen, FB; Przepiorka, D; Ratanatharathorn, V; Storb, R; Yeager, AM | 1 |
| Bekasi, A; Cornish, J; Gadner, H; Klingebiel, T; Locatelli, F; Minkov, M; Niethammer, D; Ortega, J; Peters, C; Souillet, G; Stary, J; Vossen, J | 1 |
| Elonen, E; Juvonen, E; Parkkali, T; Ruutu, T; Volin, L | 1 |
| Chakrabarti, S; Chakraverty, RK; Chopra, R; de Elvira, MC; Devereux, S; Goldstone, AH; Hale, G; Kottaridis, PD; Linch, DC; Mackinnon, S; Mahendra, P; Marsh, JC; Milligan, DW; Morgan, GJ; Peggs, K; Pettengell, R; Robinson, S; Schey, S; Verfuerth, S; Waldmann, H; Williams, CD | 1 |
| de Berker, D | 1 |
| García-Vicuña, R; González-Alvaro, I; Laffon, A; Ortiz, AM; Sánchez-Madrid, F; Sancho, D | 1 |
| Carella, AM; Cavaliere, M; Corsetti, MT; De Stefano, F; Ferrara, R; Lambelet, P; Lerma, E; Loni, C; Pinotti, G; Romanelli, A; Tedeschi, L; Valbonesi, M; Verdiani, S; Vinci, M | 1 |
| Blond, S; de Seze, J; Decoulx, M; Destée, A; Ferriby, D; Hachulla, E; Hatron, PY; Stojkovic, T; Vermersch, P; Wallaert, B | 1 |
| Brink, NS; Goldstone, AH; Kottaridis, PD; Linch, DC; Mackinnon, S; McKeag, N; Peggs, KS; Preiser, W; Tedder, RS | 1 |
| Inman, RD; Stone, M | 1 |
| Boeckh, M; Seidel, K; Storb, R; Wagner, JL | 1 |
| Egan, LJ; Lipsky, JJ; Mays, DC; Sandborn, WJ; Tremaine, WJ | 1 |
| Mathieu, A; Passiu, G; Pittau, E | 1 |
| Ohashi, H; Ohno, R | 1 |
| Cantú, OG; Gómez-Almaguer, D; González-Llano, O; Jaime-Pérez, JC; Ruiz-Argüelles, A; Ruiz-Argüelles, GJ | 1 |
| Cho, CS; Kim, HY; Kim, WU; Lee, SK; Lee, WK; Paek, SI; Park, SH; Seo, YI; Song, HH | 1 |
| Kaklamani, VG; Kaklamanis, PG | 1 |
| Kremer, JM | 1 |
| Callen, JP | 1 |
| Durrant, S; Irving, I; Mollee, P; Morton, AJ | 1 |
| Feldman, S | 1 |
| Bedocs, NM; Crook, S; Hellmann, DB; Hoffman, GS; Stone, JH; Uhlfelder, ML | 1 |
| Basara, N; Bischoff, M; Blau, W; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Römer, E; Schmetzer, B | 1 |
| Lichtenstein, GR | 1 |
| Bernstein, B; Gallagher, K; Reiff, A; Sadeghi, S; Shaham, B; Stout, A; Stout, T; Takei, S | 1 |
| O'Dell, J | 1 |
| Hönigsmann, H | 1 |
| Go, RS; Li, CY; Phyliky, RL; Tefferi, A | 1 |
| Ilan, Y; Menachem, Y; Nagler, A | 1 |
| Blume, KG; Chauncey, T; Feinstein, L; Flowers, C; Georges, G; Kiem, HP; Little, MT; Maloney, D; Maris, M; McSweeney, PA; Nash, RA; Niederwieser, D; Radich, J; Sandmaier, B; Shizuru, J; Storb, R; Woolfrey, A; Zaucha, JM | 1 |
| Remer, CF; Wallace, DJ; Weisman, MH | 1 |
| Ancín, I; Berlanga, J; Ferrá, C; Gallardo, D; Gonzalez, JR; Grañena, A; Peris, J; Virgili, N | 1 |
| Blomqvist, K; Davidsson, S; Molin, L; Mørk, C; Sigurgeirsson, B; Zachariae, H; Zachariae, R | 1 |
| Antin, JH; Bierer, BE; Cowan, MJ; Ho, WG; Jiao, J; Kaizer, H; Lazarus, HM; Linker, C; Miller, KB; Petersen, FB; Petrarca, MA; Schiller, GJ; Small, T; Territo, MC; Tonetta, SA; Wingard, JR; Winston, DJ; Wolff, SN | 1 |
| Chan, GZ; Kapoor, M | 1 |
| Chen, MG; Gastineau, DA; Gertz, MA; Harmsen, WS; Inwards, DJ; Kumar, S; Lacy, MQ; Litzow, MR; Tefferi, A | 1 |
| Domingues-Martins, M; França, CM; Pallotta Filho, RS; Soares de Araújo, N; Volpe, A | 1 |
| Simpson, D | 1 |
| Weissel, M | 1 |
| Ali, S; Lebwohl, M | 1 |
| Kanda, H; Kubo, K; Mimura, T | 1 |
| Burden, D; Leman, J | 1 |
| Alessandrino, PE; Bacigalupo, A; Barbanti, M; Bosi, A; Bruno, B; Bruzzi, P; di Bartolomeo, P; Guidi, S; Lamparelli, T; Oneto, R; Sacchi, N; Van Lint, MT | 1 |
| Battmer, K; Dammann, E; Eder, M; Ganser, A; Hambach, L; Heil, G; Hertenstein, B; Stucki, A | 1 |
| Ashihara, E; Fujita, N; Hatsuse, M; Inaba, T; Nakagawa, M; Noda, Y; Ochiai, N; Okano, A; Shimazaki, C; Takahashi, R | 1 |
| Doña Naranjo, MA; Riesco Díaz, M; Vargas Lebrón, C | 1 |
| Steen, VD | 1 |
| Paré, P | 1 |
| Pisetsky, DS; St Clair, EW | 1 |
| Benedetti, F; Bordignon, C; Bregni, M; Ciceri, F; Corradini, P; Dodero, A; Falda, M; Gianni, AM; Ladetto, M; Lucesole, M; Olivieri, A; Pileri, A; Rambaldi, A; Sajeva, MR; Tarella, C; Tresoldi, M; Voena, C; Zallio, F | 1 |
| Ait Arkoub, Z; Arnulf, B; Chebbi, F; Fillet, AM; Lefrere, F; Varet, B | 1 |
| Braun, J; Buss, B; Faerber, L; Machein, U; Rudwaleit, M; Sieper, J; Spiller, I | 1 |
| Bandekar, RR; Ellis, CN; Fendrick, AM; Reiter, KL | 1 |
| Baltatzis, S; Ekong, A; Foster, CS; Michel, SS | 1 |
| Arranz, R; Brunet, S; Bueno, J; Cabrera, R; Carreras, E; Conde, E; Conde, JG; Fernández-Rañada, JM; Iriondo, A; Maldonado, J; Marín, P; Odriozola, J; Pajuelo, FJ; Petit, J; Rodriguez-Salvanés, F; Sanz, MA | 1 |
| Di Poi, E; Fabris, M; Ferraccioli, G; Mecchia, F | 1 |
| Huang, H; Huang, J; Jin, J; Lin, M; Luo, Y; Meng, H; Qian, W | 1 |
| Flores, RH; Hochberg, MC; Tracy, JK | 1 |
| Baker, KS; Nagarajan, R; Neglia, J; Ramsay, N | 1 |
| Chen, H; Ji, S; Wang, H | 1 |
| Arreghini, M; Battafarano, N; Cagnoli, M; Cerase, A; Marchesoni, A; Pellerito, R; Priolo, F; Prudente, P; Tosi, S | 1 |
| Lublin, FD | 1 |
| Döhner, H; Gabler, A; Haas, R; Hartmann, F; Hensel, M; Ho, AD; Jung, W; Schlenk, RF; Trümper, L; Weber-Nordt, R | 1 |
| Kehlen, A; Langner, J; Riemann, D; Thiele, K | 1 |
| Debatin, KM; Osen, W; Strauss, G | 1 |
| Eibl, M; Greinix, HT; Gritsch, B; Hinterberger, W; Kalhs, P; Knöbl, P; Krieger, O; Lechner, K; Linkesch, W; Lutz, D; Nachbaur, D; Niederwieser, D; Rosenmayr, A | 1 |
| Fu, J; Huang, H; Lin, M; Zhang, R; Zheng, W | 1 |
| Chen, L; Ding, X; Hou, J; Li, H; Lou, J; Min, B; Song, X; Tong, S; Wang, J; Zhang, W | 1 |
| Chen, Y; Gao, Z; Guo, N; Huang, X; Lu, D; Ren, H; Xu, L; Zhang, Y | 1 |
| Damato, R; Di Poi, E; Favret, G; Ferraccioli, GF; Gremese, E; Tomietto, P | 1 |
| Acar, P; Bodemer, C; Bonnet, D; Fournet, JC; Le Bidois, J; Ouachée-Chardin, M; Prieur, AM; Quartier, P | 1 |
| Lashner, BA; Wolf, JM | 1 |
| Heiligenhaus, A; Heinz, C; Hoeft, S; Hudde, T; Neudorf, U; Steuhl, KP | 1 |
| Konishi, M; Takahashi, K; Yoneda, K; Yoshimoto, E | 1 |
| Hirohata, S | 1 |
| Flores, PA; Vierling, JM | 1 |
| Assaloni, R; De Marchi, G; Di Poi, E; Fabris, M; Ferraccioli, GF; Gremese, E | 1 |
| Gordon, KB; McClure, SL; Valentine, J | 1 |
| Caballero, D; Chopra, R; Craddock, C; García-Conde, J; Goldstone, AH; Hunter, A; Kottaridis, PD; Leon, A; Linch, DC; Mackinnon, S; Martino, R; Milligan, DW; Parker, A; Pérez-Simón, JA; San Miguel, JF; Schey, S; Sierra, J; Sureda, A; Urbano-Ispizua, A; Yong, K | 1 |
| Aschan, J; Barkholt, L; Eriksson, B; Hentschke, P; Holmberg, K; Myrbäck, KE; Remberger, M; Ringdén, O; Svahn, BM | 1 |
| Bertouch, JV; Lim, IG | 1 |
| Bernaudin, F; Blatt, J; Brichard, B; Brochstein, JA; Ertem, M; Garnier, F; Giorgiani, G; Gluckman, E; Grafakos, S; Haut, PR; Ionescu, I; Kurtzberg, J; Li, X; Locatelli, F; Lubin, BH; Lutz, P; Miniero, R; Nagler, A; Nugent, DJ; Raja, T; Reed, W; Roberts, I; Rocha, V; Rubin, CM; Tannoia, N; Vermylen, C; Walters, MC; Will, AM; Woodard, P; Yaniv, I | 1 |
| Ayuk, F; Erttmann, R; Horstmann, M; Kabisch, H; Kordes, U; Kröger, N; Krüger, W; Renges, H; Rischewski, J; Schrum, J; Zabelina, T; Zander, AR | 1 |
| van de Kerkhof, P | 1 |
| Aletaha, D; Smolen, JS | 1 |
| Chen, HR; Ji, SQ; Liu, J; Wang, HX; Xue, M; Xun, CQ; Yan, HM; Zhu, L | 1 |
| Tanaka, Y; Tsujimura, S | 1 |
| Akaho, R; Akiyama, H; Hagiya, K; Mori, S; Nakagome, K; Sakamaki, H; Sasaki, T; Yoshino, M | 1 |
| Asano, M; Bailey, LL; Cannarella, SN; Fagoaga, O; Gundry, SR; Izutani, H | 1 |
| Chang, HK; Lee, DH | 1 |
| Gross, WL; Schnabel, A | 1 |
| Aoki, K; Chiba, S; Goyama, S; Hirai, H; Kanda, Y; Kandabashi, K; Kawazu, M; Komeno, Y; Kurokawa, M; Motokura, T; Nakamoto, T; Nannya, Y; Niino, M; Ogawa, S; Takeshita, M; Tsujino, S | 1 |
| Daly, AS; Hasegawa, W; Jamal, H; Kiss, TL; Kotchetkova, N; Lipton, JH; Messner, HA; Yi, QL | 1 |
| Bos, JD; de Rie, MA; Heydendael, VM; Piskin, G; Teunissen, MB | 1 |
| Lim, BG; Ng, KH; Wong, KP | 1 |
| Bruijn, GA; Bruyn, GA; Dijkmans, BA; Gerards, AH; Goei Thé, HS; Laan, RF; Landewé, RB; Prins, AP | 1 |
| Flowers, ME; Leisenring, W; Maloney, DG; Maris, MB; Martin, PJ; Mielcarek, M; Sandmaier, BM; Storb, R | 1 |
| Argyros, G; Niven, AS | 1 |
| Ju, XP; Li, HM; Song, XM; Tong, SP; Wang, JM; Zhang, WP | 1 |
| Ferrero, S; Ragni, N | 1 |
| Chowers, Y; Eliakim, R; Lavy, A; Odes, HS | 1 |
| Baggott, JE; Choc, MG; Fox, RI; Morgan, SL; Robbins, BA; Smith, HT | 1 |
| Bravo-Hernández, G; Estrada, E; Gómez-Rangel, D; López-Martínez, B; Manuel Hernández, J; Marín-López, A; Ruiz-Argüelles, GJ | 1 |
| Fujimori, Y; Hara, H; Kakishita, E; Mori, A; Okada, M; Okamoto, T; Takatsuka, H; Wakae, T | 1 |
| Arreghini, M; Battafarano, N; Gallazzi, M; Marchesoni, A; Panni, B; Tosi, S | 1 |
| Kaur, I; Kumar, B; Sandhu, K; Saraswat, A | 1 |
| Førre, Ø; Haga, HJ; Johnsen, V; Kvien, TK; Mikkelsen, K; Nordvåg, BY; Rødevand, E | 1 |
| Kawano, Y; Koga, Y; Nagatoshi, Y; Okamura, J | 1 |
| Pariente, A | 1 |
| Kon, OM | 1 |
| Benner, A; Goerner, M; Ho, AD; Hoepfner, S; Luft, T; Weber-Nordt, R | 1 |
| Araghi, P; Bianchi, G; Ciabattoni, M; Icardi, A; Lazzarini, P; Romano, U | 1 |
| Ghoreschi, K; Mrowietz, U; Röcken, M | 1 |
| Bermudez, M; Cañete, A; Castel, V; De la Rubia, J; Fernandez, J; Verdeguer, A | 1 |
| Dück, N; Heiligenhaus, A; Hudde, T; Koch, J; Michel, D; Steuhl, KP | 1 |
| Kormeili, T; Lowe, NJ; Patnaik, R; Rizk, D; Yamauchi, PS | 1 |
| Lebwohl, M | 1 |
| Hartung, HP; Kieseier, BC | 1 |
| Fujisawa, Y; Hamaki, T; Heike, Y; Hori, A; Imataki, O; Kami, M; Kim, SW; Kishi, Y; Kojima, R; Makimoto, A; Masuo, S; Murashige, N; Sakiyama, M; Takaue, Y; Tanosaki, R | 1 |
| Bos, JD; Bossuyt, PM; de Borgie, CA; de Rie, MA; Goldschmidt, WF; Heydendael, VM; Opmeer, BC; Reitsma, JB; Spuls, PI | 1 |
| Lasserson, T; Paramothayan, S; Walters, EH | 1 |
| Chen, Y; Han, W; Hong, H; Huang, X; Lu, D | 1 |
| Balabanova, RM | 1 |
| Belin, V; Tebib, J; Vignon, E | 1 |
| Istok, R; Rovensky, J; Stancíková, M; Svík, K | 1 |
| Adkins, D; Blum, W; Brown, R; Chohan, R; Devine, S; DiPersio, JF; Goodnough, LT; Graubert, T; Khoury, H; Tomasson, M; Vij, R | 1 |
| Bonanno, D; Fedele, R; Ferlazzo, B; Minciullo, P; Quattrocchi, P | 1 |
| Alfieri, G; Atzeni, F; Beyene, NB; Cazzola, M; Chérié-Lignière, EL; Corbelli, V; D'Ingianna, E; Fiorentini, F; Fiorini, T; Fumagalli, M; Locati, M; Mastaglio, C; Menozzi, G; Monti, G; Panni, B; Saccardo, F; Sarzi-Puttini, P; Scarpellini, M; Severi, C | 1 |
| Aulagner, G; Bertrand, Y; Bleyzac, N; Galambrun, C; Jelliffe, RW; Maire, PH; Martin, P; Souillet, G | 1 |
| Butt, NM; Clark, RE; McGinnity, N | 1 |
| Lebwohl, M; Maryles, S; Rozenblit, M | 1 |
| Saxne, T; Wollheim, FA | 1 |
| Conaghan, PG; Emery, P | 1 |
| Kin, M; Ohyama, M; Sasaki, R; Shiba, H; Yamana, J; Yamana, S | 1 |
| Liu, QF; Liu, XL; Meng, FY; Sun, J; Xu, B; Xu, D; Zhang, Y; Zhou, SY | 1 |
| Issaragrisil, S; Sangruchi, T; Udomsakdi-Auewarakul, C; Visuthisakchai, S | 1 |
| Höffken, K; Issa, MC; Kasper, C; Mügge, LO; Sayer, HG; Schilling, K; Scholl, S | 1 |
| Pleyer, U | 1 |
| Cimino, L; Finzi, G; Gandolfi, SA; Mora, P; Orsoni, JG; Zavota, L | 1 |
| Chan, G; Foss, FM; Gorgun, G; Grodman, H; Lawrence, D; Mahajan, A; Miller, KB; Relias, V; Roberts, TF; Schenkein, DP; Sprague, K | 1 |
| Atul, S; Mohan, H; Sarbmeet, L; Singh, R; Vikas, A | 1 |
| Black, MM; Reynaert, S | 1 |
| Bigby, M | 1 |
| Atsuta, Y; Furukawa, T; Hamajima, N; Hirabayashi, N; Hirai, H; Hiraoka, A; Iseki, T; Iwato, K; Izutsu, K; Kanda, Y; Kasai, M; Kawa, K; Kodera, Y; Maruta, A; Mitsui, H; Okamoto, S; Sakamaki, H | 1 |
| Darmawan, J; Nuralim, H; Rasker, JJ | 1 |
| Orsoni, JG; Pellistri, I; Rama, P; Vincenti, V; Zavota, L | 1 |
| White, DA | 1 |
| Aschan, J; Larsson, K; Ljungman, P; Remberger, M; Ringdén, O; Winiarski, J | 1 |
| Bardy, P; Doherty, K; Grigg, A; Heatley, S; Hughes, T; Mullighan, C; Schwarer, A; Szabo, F; Szer, J; Tait, B; To, B | 1 |
| Fujioka, T; Ishida, Y; Numaoka, H; Omori, S; Ono, Y | 1 |
| Rodriguez, C; Sifontes, S; Sterba, G; Vigilanza, P | 1 |
| de Rie, MA; Heydendael, VM; Rentenaar, RJ; ten Berge, IJ; van Diepen, FN | 1 |
| Friedman, S | 1 |
| Burmester, GR; Müller-Ladner, U; Rüther, W | 1 |
| Hirokawa, M; Miura, I; Sawada, K | 1 |
| Bos, JD; Bossuyt, PM; De Borgie, CA; De Rie, MA; Heydendael, VM; Opmeer, BC; Spuls, PI | 1 |
| Cooper, AJ; Lee, MR | 1 |
| Job-Deslandre, C; Kahan, A; Sornay-Soares, C | 1 |
| Choi, SJ; Kim, S; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Seol, M | 1 |
| Andresen, S; Bolwell, B; Kalaycio, M; Kuczkowski, E; Pohlman, B; Rybicki, L; Sobecks, R | 1 |
| Gordon, FD; Simpson, M | 1 |
| Emery, P; Suarez-Almazor, M | 1 |
| Lebwohl, MG; Stebbins, WG | 1 |
| Bishop, GA; Clark, DA; den Dulk, M; Hibberd, AD; Li, J; McCaughan, GW; Terpstra, OT; Wang, C | 1 |
| Dejaco, C; Knoflach, P; Petritsch, W; Reinisch, W; Tilg, H; Vogelsang, H | 1 |
| Dijkmans, BA; Emery, P; Fraser, AD; Gerards, AH; Karim, Z; Landewé, R; Steinfeld, SD; van Kuijk, AW; Veale, DJ; Wakefield, R; Westhovens, R | 1 |
| Heath, M; Raugi, GJ | 1 |
| de Rie, MA; Spuls, PI; Tuut, MK; van Everdingen, JJ | 1 |
| Chen, H; Chen, YH; Dong, LJ; Han, W; Huang, XJ; Jiang, Q; Liu, DH; Liu, KY; Lu, DP; Lu, J; Ren, HY; Wang, JB; Wu, T; Xu, LP | 1 |
| Angelucci, E; Caprilli, R; Cocco, A; Viscido, A; Zippi, M | 1 |
| Feldman, SR; Margolis, DJ; Nijsten, T; Rolstad, T | 1 |
| Siegmund, B; Zeitz, M | 1 |
| Dadlani, C; Orlow, SJ | 1 |
| Aberra, FN; Lichtenstein, GR | 1 |
| Choi, SJ; Kim, WK; Lee, JH; Lee, JS; Lee, KH; Lee, YS; Ryu, SG; Seol, M | 1 |
| Diaconescu, R; Maloney, DG; Maris, MB; McSweeney, P; Parikh, CR; Sandmaier, BM; Schrier, RW; Sorror, ML; Storb, R; Storer, B | 1 |
| Feldman, SR; Margolis, DJ; Nijsten, T; Rolstad, T; Stern, RS | 1 |
| Banks, M; Kitas, GD; Raza, K | 1 |
| Balon, J; Bieniaszewska, M; Bieniaszewski, L; Hałaburda, K; Hellmann, A; Pawłowski, R; Piekarska, A; Reichert, M | 1 |
| Fenk, R; Germing, U; Graef, T; Haas, R; Hinke, A; Kobbe, G; Neumann, F; Steidl, U; Tapprich, C; Vaupel, M | 1 |
| Ashouri, A; Bahar, B; Eghbal, L; Ghavamzadeh, A; Gholibeikian, S; Iravani, M; Mousavi, A; Samiee, S | 1 |
| Griffiths, CE; Naldi, L | 1 |
| Henrickson, M; Higgins, G; Hummell, D; Kimura, Y; Pinho, P; Reiff, A; Szer, I; Walco, G; Watcher, S | 1 |
| Fath, R | 1 |
| Burmester, GR | 1 |
| Evans, C; Feldman, SR; Russell, MW | 1 |
| Joseph, K; Kaplan, AP; Marsland, AM; Soundararajan, S | 1 |
| Cather, JC; Menter, A | 1 |
| Filipovich, AH; Gadner, H; Henter, JI; Horne, A; Imashuku, S; Janka, G; Ladisch, S; Locatelli, F; Maarten Egeler, R; Montgomery, SM; Webb, D; Winiarski, J | 1 |
| Ahmed, M; Foster, CS; Kiss, S; Letko, E | 1 |
| Laube, S; Smith, AG; Stephens, M; Tan, BB; Whittaker, SJ | 1 |
| Cozzi, E; Schuurman, HJ; Smith, HT | 1 |
| Deeg, HJ; Leisenring, W; Martin, PJ; Sorror, ML; Storb, R | 2 |
| Akioka, T; Hanafusa, T; Hara, S; Oka, S; Tsuji, M; Yamano, T; Yokote, T | 1 |
| Choy, EH; Hoogendijk, JE; Lecky, B; Winer, JB | 1 |
| Brunet, S; Caballero, MD; Carreras, E; de León, A; del Cañizo, MC; Díez-Campelo, M; López-Fidalgo, J; Martino, R; Pérez-Simón, JA; San Miguel, JF; Sierra, J; Urbano, A; Valcárcel, D | 1 |
| Bennett, DB; Lechuga-Ballesteros, D; Stevenson, CL | 1 |
| Chauncey, TR; Deeg, HJ; Flowers, ME; Kahl, C; Leisenring, W; Martin, PJ; Sanders, JE; Storb, R | 1 |
| Boumpas, DT; Choulaki, C; Kouroumali, H; Koutala, H; Kritikos, H; Mamoulaki, M; Raptopoulou, A; Siakka, P; Sidiropoulos, PI | 1 |
| Naldi, L; Rzany, B | 2 |
| Genth, E; Hunzelmann, N; Kaufmann, J; Krieg, T | 1 |
| Bélanger, R; Busque, L; Chamakhi, I; Dhédin, N; Ducruet, T; Fish, D; Perreault, C; Roy, DC; Roy, J; Sauvageau, G | 1 |
| Fujimori, Y; Hara, H; Itoi, H; Itsukuma, T; Kai, S; Misawa, M; Nakajima, T; Nishioka, K; Nomura, K; Ogawa, H; Okada, M; Takatsuka, H; Toda, A; Wakae, T | 1 |
| Kress, DW | 1 |
| Gordon, KB; Ruderman, EM | 1 |
| Abreu, MT; Cohen, R; Lichtenstein, GR; Tremaine, W | 2 |
| Bradstock, KF; Gottlieb, D; Grigg, A; Hertzberg, M; Hoyt, R; Huang, G; Roberts, A; Szer, J | 1 |
| Bachta, A; Tłustochowicz, M | 1 |
| Kupatawintu, P; O-Charoen, R; Seksarn, P; Vanichsetakul, P | 1 |
| Alessandrino, PE; Bacigalupo, A; Barisione, G; Bosi, A; Bruno, B; Bruzzi, P; di Bartolomeo, P; Guidi, S; Lamparelli, T; Oneto, R; Sacchi, N; van Lint, MT | 1 |
| Lesiak, A; McCauliffe, DP; Salamon, M; Sysa-Jedrzejowska, A; Wozniacka, A | 1 |
| Andersen, LS; de Carvalho, A; Ellingsen, T; Hansen, G; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Junker, P; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Pødenphant, J; Skjødt, H; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Østergaard, M | 1 |
| Caggiari, L; De Re, V; De Vita, S; Fabris, M; Ferraccioli, G; Franzolini, N; Gasparotto, D; Marzotto, A; Quartuccio, L; Scott, CA | 1 |
| Cakmak, SK; Erdem, R; Gönül, M; Gül, U; Gündüz, H; Kiliç, A | 1 |
| Adami, F; Briani, C; Marcolongo, R; Pavan, A; Rondinone, R; Scarlato, M | 1 |
| Aydin, F; Canturk, T; Senturk, N; Turanli, AY | 1 |
| Menon, K; Siu, K; Strober, BE | 1 |
| Furst, DE; Georges, GE; Henstorf, G; Langston, AA; Lee, J; McSweeney, PA; Nash, RA; Nelson, JL; Shulman, H; Storb, R; Sullivan, KM; Wener, M | 1 |
| Catovsky, D; Del Giudice, I; Grech, H; Matutes, E; Osuji, N; Swansbury, JG; Tjonnfjord, G; Wotherspoon, A | 1 |
| Blanche, S; Casanova, JL; Cavazzana-Calvo, M; Fischer, A; Le Deist, F; Neven, B; Ouachée-Chardin, M; Picard, C; Renella, R | 1 |
| Lasserson, TJ; Paramothayan, S; Walters, EH | 1 |
| Iida, H; Kitaori, K; Kohno, A; Matsuo, K; Morishita, Y; Ozeki, K; Sakamaki, H; Sao, H; Yokozawa, T | 1 |
| Mosekilde, L; Rejnmark, L; Vestergaard, P | 1 |
| Jiang, XF; Sheng, BJ | 1 |
| Dissemond, J; Grabbe, S | 1 |
| Formánková, R; Hubácek, P; Keslová, P; Król, L; Kulich, M; Sedlácek, P; Srámková, L; Starý, J | 1 |
| Papp, KA; Rosoph, L; Toth, D | 1 |
| Balkrishnan, R; Camacho, F; Crane, MM; Feldman, SR; Fleischer, AB; Higgins, KB; Pearce, DJ; Stealey, KH | 1 |
| Hamaguchi, M; Iida, H; Kohno, A; Matsuo, K; Miyamura, K; Morishita, Y; Murata, M; Narimatsu, H; Oba, T; Sawa, M; Terakura, S; Uchida, T; Watanabe, M | 1 |
| Arce, JA; Bollard, CM; Brenner, MK; Carrum, G; Gottschalk, S; Heslop, HE; Kennedy-Nasser, AA; Khan, SP; Krance, RA; Leung, KS; Mahajan, A; Weiss, HL | 1 |
| Bacigalupo, A; Lawler, M; Locasciulli, A; Locatelli, F; McCann, S; Passweg, J; Ryan, J; Schrezenmeier, H | 1 |
| Badgwell, C; Rosen, T | 1 |
| Gan, LS; Liu, N; Miwa, GT; Xia, CQ | 1 |
| Ceović, R; Husar, K; Kostović, K; Lipozencić, J; Murat-Susić, S; Pasić, A; Skerlev, M | 1 |
| Altmaier, EM; Carter, S; Davies, SM; Henslee-Downey, J; Hochhausen, N; McQuellon, R; Papadopolous, E | 1 |
| Gyulai, R; Kemény, L | 1 |
| Gniadecki, R; Larsen, R; Ryder, LP; Svejgaard, A | 1 |
| Saito, E; Suwa, A; Suzuki, Y; Wakabayashi, T | 2 |
| Kawai, S; Kitahara, K | 1 |
| Girard, C; Guilhou, JJ | 1 |
| Jiang, ZX; Liu, LX; Sun, H; Sun, L; Wan, DM; Xie, XS | 1 |
| Holler, E | 1 |
| Chen, J; Li, JP; Zhang, T; Zhong, J; Zhu, KE | 1 |
| Tłustochowicz, W | 1 |
| Tłustochowicz, M | 1 |
| Bobrowska-Snarska, D; Brzosko, M; Lukjanowicz, M | 1 |
| Beaugerie, L; Cosnes, J; Daniel, F; Marteau, P; Seksik, P | 1 |
| Gawlicka, G; Giebel, S; Holowiecki, J; Markiewicz, M; Miszczyk, L; Tomaszewska, R; Wojnar, J; Wyleioł, I | 1 |
| Boki, K; Ioannidou, P; Karafoulidou, A; Katsarou, O; Linardaki, G | 1 |
| Hara, M; Hino, M; Hori, A; Kami, M; Kanda, Y; Kim, SW; Mineishi, S; Mori, S; Ohashi, Y; Saito, AM; Suzuki, R; Takami, A; Takaue, Y; Takemoto, Y; Taniguchi, S; Yamaguchi, M; Yoshida, T | 1 |
| Bos, JD; Bossuyt, PM; de Rie, MA; deBorgie, CA; Heydendael, VM; Opmeer, BC; Spuls, PI | 1 |
| Bahlis, NJ; Balogh, A; Brown, CB; Chaudhry, MA; Geddes, M; Larratt, L; Quinlan, D; Russell, JA; Savoie, ML; Stewart, DA; Storek, J; Turner, AR | 1 |
| Andrei, S; Enache, V; Renetti, A; Spiroiu, C; Zemba, M; Zugravu, V | 1 |
| Amital, H; Arnson, Y; Dovrish, Z; Hadari, R | 1 |
| Chiba, S; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Oshima, K; Sato, H | 1 |
| Blanche, S; de Saint Basile, G; Fischer, A; Mahlaoui, N; Neven, B; Ouachée-Chardin, M; Picard, C | 1 |
| Joshi, VR; Samant, R; Singh, S | 1 |
| Remberger, M; Ringdén, O | 1 |
| Abe, T; Aizawa, Y; Furukawa, T; Izumi, N; Kurasaki, T; Masuko, M; Okazuka, K; Sato, N; Takahashi, M; Toba, K; Tsukada, N; Yano, T | 1 |
| Chau, L; Choy, EH; Farewell, V; Hassell, A; Scott, DL; Smith, CM; Walker, D | 1 |
| Rebora, A | 1 |
| McHugh, NJ; Soriano, ER | 1 |
| De Jong, EM; Langewouters, AM; Van De Kerkhof, PC; Van Erp, PE | 1 |
| Alvarez, I; Arranz, R; Caballero, D; Canales, M; Cavet, J; Garcia-Conde, J; Goldstone, AH; Hunter, A; Linch, DC; Mackinnon, S; Mahendra, P; Milligan, D; Parker, A; Peggs, KS; Qian, W; Ribera, JM; Sanz, G; Sierra, J; Sureda, A; Thomson, K; Urbano-Ispizua, A | 1 |
| Dolianitis, C; Street, AC; Tuxen, AJ; Yong, MK | 1 |
| Andersen, LS; Ellingsen, T; Hansen, GV; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Junker, P; Jurik, AG; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Skjødt, H; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Vestergaard, A; Østergaard, M | 1 |
| Arai, S; Asai, T; Chiba, S; Hangaishi, A; Hosoya, N; Izutsu, K; Kanda, Y; Kurokawa, M; Motokura, T; Nakasone, H; Nishimoto, N; Oshima, K; Sato, H; Watanabe, T | 1 |
| Stiefelhagen, P | 1 |
| Bergbrant, IM; Flytström, I; Stenberg, B; Svensson, A | 1 |
| Carter, SL; Freifeld, AG; Godder, KT; High, KP; Kernan, NA; Mendizabal, AM; Papanicolaou, GA; van Burik, JA; Wagner, JE; Yanovich, S | 1 |
| Choi, G; Hong, W; Kim, YC; Shin, J; Song, H | 1 |
| Das, P; Diezi, M; Doyle, J; Dupuis, LL; Price, V; Punnett, A; Sung, L | 1 |
| Curtis, DJ; Grigg, AP; Hoyt, R; Macgregor, L; Ritchie, DS; Roberts, AW; Szer, J | 1 |
| Aghdaie, MH; Azarpira, N; Daraie, M; Geramizadeh, B; Ramzi, M | 1 |
| Chen, H; Chen, Y; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Lu, DP; Shi, HX; Wang, JZ; Wang, Y; Xu, LP; Zhang, XU; Zhang, YC | 1 |
| Alimoghaddam, K; Ashouri, A; Ghaffari, H; Ghavamzadeh, A; Hadjibabaie, M; Iravani, M; Mahdavi, N; Mousavi, SA; Namdar, R; Nedaeifard, L; Shamshiri, A | 1 |
| Alegre de Miguel, V; Martínez Casimiro, L; Sánchez Carazo, JL | 1 |
| Chen, H; Chen, YH; Han, W; Huang, XJ; Liu, DH; Liu, KY; Shi, HX; Wang, Y; Xu, LP | 1 |
| Nascimento, NG; Olivo, RA; Silveira, PF; Teixeira, CF | 1 |
| Appelbaum, FR; Carpenter, PA; Deeg, HJ; Doney, K; Flowers, ME; Furlong, T; Kiem, HP; Martin, PJ; Mielcarek, M; Nash, RA; Storb, R | 1 |
| Beutner, KR; Bhushan, R; Elmets, CA; Feldman, SR; Gordon, KB; Gottlieb, A; Koo, JY; Korman, NJ; Lebwohl, M; Leonardi, CL; Menter, A; Van Voorhees, AS | 1 |
| Iorizzo, LJ; Jorizzo, JL | 1 |
| Jansson, L; Karlsson, A; Karlsson, L; Melgar, S; Michaëlsson, E; Rehnström, E; Utkovic, H | 1 |
| Ayuk, F; Bacher, U; Binder, T; Diyachenko, G; Eiermann, T; Erttmann, R; Fehse, B; Kabisch, H; Kröger, N; Panse, J; Wolschke, C; Zabelina, T; Zander, AR | 1 |
| Adil, S; Ahmed, P; Ansari, S; Farzana, T; Hashmi, K; Irfan, M; Khan, B; Panjwani, V; Shamsi, T | 1 |
| Feagan, B; Ghosh, S; Panaccione, R; Rutgeerts, P; Sandborn, WJ; Schreiber, S | 1 |
| Alhan, E; Bayram, I; Celik, U; Dossaji, S; Ergin, M | 1 |
| Ganser, G; Heiligenhaus, A; Heinz, C; Michels, H; Roesel, M; Tappeiner, C | 1 |
| Gokdemir, G; Köşlü, A; Kutlu, S | 1 |
| Gottlieb, AB; Korman, N; Krueger, GG; Sterry, W; Van De Kerkhof, P | 1 |
| Andrianakos, A; Charalambopoulos, D; Karanikolas, G; Karras, D; Kaskani, E; Rapti, A; Sfikakis, PP; Vaiopoulos, G | 1 |
| Botturi, A; Bruzzone, MG; Ciceri, E; Erbetta, A; Potepan, P; Salmaggi, A; Sghirlanzoni, A; Silvani, A | 1 |
| Cordoro, KM | 1 |
| Alamanos, Y; Drosos, AA; Voulgari, PV | 1 |
| D'Angelo, S; Olivieri, I; Palazzi, C | 1 |
| Cai, Z; Deng, D; Lai, Y; Li, Q; Li, W; Liang, J; Luo, J; Luo, L; Ma, J; Peng, Z; Schwarzenberger, P; Yang, J; Zhou, J; Zhou, Y | 1 |
| Rogler, G | 1 |
| Kanda, Y | 1 |
| Burakoff, R | 1 |
| Al-Hemidan, AI; Tabbara, KF | 1 |
| Rudnicka, L; Sicińska, J | 1 |
| Gürer, MA; Ilter, N; Ozden, MG; Solaktekin, N; Suer, OE | 1 |
| Frank, J; Kucharekova, M; Poblete-Gutiérrez, P; Winnepenninckx, V | 1 |
| Hino, R; Kabashima, K; Ogata, M; Sugita, K; Tokura, Y | 1 |
| Kaplan, AP | 1 |
| Anis, AH; Bansback, N; Feldman, SR; Sizto, S; Willian, MK | 1 |
| Barba, P; Briones, J; Brunet, S; Delgado, J; Martino, R; Moreno, E; Piñana, JL; Sierra, J; Sureda, A; Valcárcel, D; Vega, M | 1 |
| Akpek, EK; Shan, SJ; Wu, EI | 1 |
| Gergely, P; Poór, G | 1 |
| Mimori, T; Yukawa, N | 1 |
| Mimori, T | 1 |
| Allaart, CF; Dijkmans, BA; Huizinga, TW; Kerstens, PJ; Klarenbeek, NB | 1 |
| Clark, LN; Lebwohl, M; Patel, RV; Weinberg, JM | 1 |
| Bejarano, V; Brown, AK; Buch, MH; Conaghan, PG; Emery, P; Proudman, SM | 1 |
| Anasetti, C; Appelbaum, FR; Carnevale-Schianca, F; Carpenter, PA; Deeg, HJ; Furlong, T; Kiem, HP; Leisenring, W; Martin, PJ; McDonald, GB; Nash, RA; Schoch, G; Storb, R | 1 |
| Audrain, M; Hamidou, MA; Hervier, B; Masseau, A; Mussini, JM | 1 |
| Adişen, E; Gülekon, A; Gürer, MA; Tekin, O | 1 |
| Förger, F; Østensen, M | 1 |
| Burkhart, CN; Morrell, DS; Shaw, MG | 1 |
| Bertz, H; Bethge, WA; Bornhäuser, M; Egger, M; Einsele, H; Finke, J; Grishina, O; Heim, DA; Holler, E; Kolb, HJ; Kolbe, K; Koza, V; Linkesch, W; Maertens, JA; Mayer, J; Ottinger, HD; Ruutu, T; Schmoor, C; Schwerdtfeger, R; Socié, G; Stelljes, M; Volin, L; Zander, AR | 2 |
| Dubertret, L | 1 |
| Barker, J; Bos, JD; Burmester, GR; Chimenti, S; Dubertret, L; Eberlein, B; Erdmann, R; Ferguson, J; Girolomoni, G; Gisondi, P; Giunta, A; Griffiths, C; Hönigsmann, H; Hussain, M; Jobling, R; Karvonen, SL; Kemeny, L; Kopp, I; Leonardi, C; Maccarone, M; Menter, A; Mrowietz, U; Naldi, L; Nast, A; Nijsten, T; Ormerod, AD; Ortonne, JP; Orzechowski, HD; Pathirana, D; Rantanen, T; Reich, K; Reytan, N; Richards, H; Rzany, B; Saiag, P; Smith, C; Spuls, PI; Thio, HB; van de Kerkhof, P | 1 |
| Al-Ghamdi, A; Al-Mohareb, F; Al-Sharif, F; Al-Zahrani, H; Aljurf, M; Ayas, M; Chaudhri, N; Mohammed, SY; Nassar, A; Tabbara, KF | 1 |
| Böhlke, M; Henry, K; Kim, J; Maher, TJ; Sani, SN; Stricker-Krongrad, A | 1 |
| Choy, EH; Gordon, P; Hoogendijk, JE; Lecky, B; Winer, JB | 1 |
| Koulaouzidis, A | 1 |
| Andrade, RJ; Cotta, J; Lucena, MA; Robles, M; Toscano, E | 1 |
| Kato, K; Kato, S; Kawase, T; Kigasawa, H; Kodera, Y; Kojima, S; Morishima, Y; Muramatsu, H; Sakamaki, H; Tsuchida, M; Yabe, H; Yagasaki, H | 1 |
| Salgo, R; Thaçi, D | 1 |
| Chang, YJ; Huang, XJ; Huo, MR; Liu, DH; Liu, KY; Xu, LP; Zhao, XY | 1 |
| Cury, DB; Moss, AC | 1 |
| Hassan, Z; Mattsson, J; Olsson, R; Omazic, B; Remberger, M; Ringdén, O | 1 |
| Grigg, AP; Hoyt, R; Ritchie, DS; Szer, J; Wirth, A | 1 |
| Hillman, T; Murphy, P; Rajakulasingam, K | 1 |
| Alomar, A; Barco, D; Puig, L; Vilarrasa, E | 1 |
| Alkhalifah, A; Alsantali, A; McElwee, KJ; Shapiro, J; Wang, E | 1 |
| Bao, Y; Guérin, A; Gupta, SR; Latremouille-Viau, D; Mulani, PM; Saurat, JH; Wu, EQ; Yu, AP | 1 |
| Barba, P; Brunet, S; Carreras, E; Fernández-Avilés, F; Martínez, C; Martino, R; Piñana, JL; Rovira, M; Sierra, J; Sureda, A; Valcárcel, D | 1 |
| Ashouri, A; Babaie, MH; Ghavamzadeh, A; Iravani, M; Khatami, F; Tavakoli, E | 1 |
| Cooper, AJ; Dolianitis, C; Foley, PA; Hack, SP; Quirk, C; Sullivan, JR; Thirunavukkarasu, K | 1 |
| Browne, P; Chadwick, N; Conneally, E; Crotty, GM; Flynn, C; Fortune, AF; Kelly, K; O'Brien, D; Quinn, F; Sargent, J; Thornton, P; Vandenberghe, E | 1 |
| Cao, YB; Da, WM; Gao, CJ; Li, HH; Li, XH; Ma, J; Wu, XX; Yu, L | 1 |
| Abbassi, V; Henzke, A; Sobel, DO | 1 |
| Andersen, LS; Ejbjerg, BJ; Ellingsen, T; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Jacobsen, S; Junker, P; Jurik, AG; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Pødenphant, J; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Vestergaard, A; Østergaard, M | 1 |
| Farmaki, E; Kanakoudi-Tsakalidou, F; Pratsidou-Gertsi, P; Spoulou, V; Theodoridou, M; Trachana, M; Tritsoni, M | 1 |
| Fukuhara, N; Harigae, H; Ishizawa, K; Kameoka, J; Kohata, K; Ohba-Ohtsuka, R; Ohguchi, H; Ohnishi, Y; Okitsu, Y; Tohmiya, Y; Yamada, MF; Yamamoto, J; Yokoyama, H | 1 |
| Boulinguez, S | 2 |
| Bakker, MF; Bijlsma, JW; Jacobs, JW; Lafeber, FP; Linn-Rasker, SP; van der Veen, MJ; van der Werf, JH; Welsing, PM | 1 |
| McFadden, JP; Wee, JS; White, IR; White, JM | 1 |
| Jensen, P; Skov, L; Zachariae, C | 1 |
| Gooley, TA; Kiem, HP; Sale, G; Sandmaier, BM; Santos, EB; Storb, R; Thakar, MS | 1 |
| Aghakhani, R; Alavi, S; Arzanian, MT; Gharib, A; Goudarzipour, K; Jadali, F; Rezaei, N; Shamsian, BS | 1 |
| Di Lernia, V; Guareschi, E | 1 |
| Beligere, GS; Chen, YY; Fishpaugh, JR; Grote, J; Harwick, LC; Lin, Z; Nair, RK; Rege, SD; Rupprecht, KR | 1 |
| Ahmed, S; Al-Anazi, K; Al-Mohareb, F; Al-Sharif, F; Al-Zahrani, H; Aljurf, M; Bakr, M; Chaudhri, N; Elhassan, T; Elkum, N; Hussain, F; Ibrahim, K; Mohamed, S; Nassar, A; Nurgat, Z; Patel, M; Rasheed, W; Saleh, AJ | 1 |
| Bonsmann, G; Kuhn, A; Ruland, V | 1 |
| Antivalle, M; Atzeni, F; Boccassini, L; Salaffi, F; Sarzi-Puttini, P | 1 |
| Bush, A; Saglani, S | 1 |
| Mehvar, R; Parasrampuria, R | 1 |
| Abdelqader, S; Abonour, R; Baute, J; Cornetta, K; Farag, SS; Fausel, CA; Kalsekar, I; Kiel, PJ; Nelson, RP; Robertson, MJ; Rosenbeck, LL; Schwartz, J; Srivastava, S; Sullivan, CK; Vargo, C; Wood, L | 1 |
| Becker, EM; Gattu, S; Koo, JY | 1 |
| Brocard, A; Dréno, B; Knol, AC; Peuvrel, L; Quéreux, G; Renaut, JJ | 1 |
| Carsetti, R; D'Amelio, R; Diamanti, AP; Germano, V; Giorda, E; Laganà, B; Podestà, E; Rosado, M; Scarsella, M | 1 |
| Di Lernia, V | 1 |
| Bodur, S; Gümüşel, M; Mevlitoğlu, I; Özdemir, M | 1 |
| Thonhofer, R | 1 |
| O'Rielly, DD; Rahman, P | 1 |
| Lamy, T; Loughran, TP | 1 |
| Beschmann, H; Boehncke, S; Boehncke, WH; Diehl, S; Fichtlscherer, S; Garbaraviciene, J; Hardt, K; Salgo, R; Thaçi, D | 1 |
| Chun, C; Fang, JP; Huang, K; Huang, SL; Xu, HG; Xue, HM; Zhou, DH | 1 |
| Lotti, T; Pescitelli, L; Prignano, F; Ricceri, F; Ruffo, G | 1 |
| Fleck, M; Klein, A; Landthaler, M; Vogt, T; Wenzel, SM | 1 |
| Cai, Z; Han, X; He, J; Huang, H; Li, L; Lin, M; Luo, Y; Shi, J; Tan, Y; Xie, W; Ye, X; Zhao, Y; Zheng, Y | 1 |
| Matuszewska, A; Misterska-Skóra, M; Wiland, P | 1 |
| Brzosko, I; Fliciński, J; Ostanek, L; Prajs, K; Przepiera-Bedzak, H | 1 |
| Krecipro-Nizińska, E; Morgiel, E; Smiechowicz, H; Wiland, P | 1 |
| Ortonne, JP; Paul, C | 1 |
| Aractingi, S; Aubin, F; Bachelez, H; Cribier, B; Gallini, A; Joly, P; Jullien, D; Le Maître, M; Maza, A; Misery, L; Montaudié, H; Ortonne, JP; Paul, C; Richard, MA; Sbidian, E | 1 |
| Battistella, M; Le Maître, M | 1 |
| Dubinsky, MC; Ford, AC; Khan, KJ; Moayyedi, P; Talley, NJ; Ullman, TA | 1 |
| Appelbaum, FR; Carpenter, PA; Deeg, HJ; Flowers, ME; Furlong, T; Inamoto, Y; Kiem, HP; Martin, PJ; Mielcarek, M; Nash, RA; Storb, RF; Storer, BE; Witherspoon, RP | 1 |
| Jarvis, JN; Kim, NN; Lio, PA; Morgan, GA; Pachman, LM | 1 |
| Botti, E; Chimenti, S; Costanzo, A; Spallone, G; Talamonti, M; Teoli, M | 1 |
| Rallis, E; Verros, CD | 1 |
| Currimbhoy, Z; Desai, M; Joshi, R; Phatarpekar, A | 1 |
| Blumenstein, I; Bock, H; Dignass, A; Filmann, N; Hartmann, F; Herrmann, E; Schröder, O; Stein, J; Tacke, W; Zeuzem, S; Zosel, C | 1 |
| Simon, D | 1 |
| Augustin, M; Glaeske, G; Radtke, M; Reich, K; Schäfer, I | 1 |
| Antin, JH | 1 |
| Battistella, M; Boulinguez, S | 1 |
| Asako, K; Kikuchi, H; Ono, Y; Shirasaki, R; Takayama, M; Yamamoto, T | 1 |
| Cerri, A; Colombo, L; Crespi, E; Gualandri, L; Mapelli, ET; Marconi, M; Menni, S | 1 |
| Chaturvedi, A; Ishak, GE; Iyer, RS; Khanna, PC; Pruthi, S | 1 |
| Díaz-Llopis, M; García-Delpech, S; López-Prats, MJ; Salom, D; Sanz-Marco, E; Udaondo, P | 1 |
| Antonini, G; Benedetti, L; Briani, C; Cocito, D; Falcone, Y; Fazio, R; Grimaldi, S; Jann, S; Matà, S; Nobile-Orazio, E; Paolasso, I; Sabatelli, M | 1 |
| de-la-Cuadra-Oyanguren, J; Esteve-Martínez, A; García-Rabasco, A; Miralles, J | 1 |
| Denniston, AK; Murray, PI; Sreekantam, S | 1 |
| Cheng, J; Ding, JH; Liu, J; Wang, J; Wu, F; Yu, ZP; Zhao, G | 1 |
| Arida, A; Fragiadaki, K; Giavri, E; Karanikolas, GN; Katsalira, A; Komninou, E; Koukli, EM; Lasithiotakis, I; Petrou, D; Sfikakis, PP; Vaiopoulos, G; Zacharioudaki, A | 1 |
| Mishra, OP; Mittal, R; Prasad, R; Singh, UK | 1 |
| Clifford, R; Danby, R; Ellis, A; Hatton, C; Littlewood, T; Malladi, R; Medd, P; Monk, I; Peniket, A; Roberts, D; Vyas, P | 1 |
| Dankó, K; Vincze, M | 1 |
| Byekova, Y; Elewski, B; Hughey, L | 1 |
| Kiss, CG; Kiss, E; Poór, G | 1 |
| Chu, DH; Rosenbach, M; Van Voorhees, AS | 1 |
| Hetland, ML | 1 |
| Bell, SJ; Brown, SJ; Chan, FK; Chan, H; Chow, DK; Connell, WR; De Cruz, P; Desmond, PV; Kamm, MA; Leong, RW; Lust, M; Ng, SC; Prideaux, L; Sung, JJ; Williams, J; Wu, JC | 1 |
| Bertz, H; Engelhardt, M; Finke, J; Grüllich, C; Ihorst, G; Marks, R; Spyridonidis, A; Wäsch, R | 1 |
| Bachelez, H; Paul, C | 1 |
| El-Eishi, NH; Hegazy, RA; Kadry, D; Rashed, L | 1 |
| Fujiki, Y; Hanafusa, T; Hata, K; Makino, S; Ozaki, T; Takeuchi, T; Yoshida, S; Yoshikawa, A | 1 |
| Arcese, A; Camplone, G; Carlesimo, M; Di Russo, PP; Gamba, A; La Pietra, M; Mari, E; Orsini, D | 1 |
| Arevalo, JF; Benitez-Del-Castillo, JM; Blanco, R; Cordero-Coma, M; Díaz-Llopis, M; Fernandez-Cid, C; Fonollosa, A; Garcia-Aparicio, AM; Garcia-de-Vicuña, C; Olea, JL; Ortega, G; Ortego, N; Rio-Pardo, MJ; Salom, D; Suarez-de-Figueroa, M | 1 |
| Dong, H; Hu, S; Ma, R; Wang, C; Wang, W; Xiao, Z | 1 |
| Burton, L; Chiuzan, C; Garrett-Mayer, E; Heath, TS; Hudspeth, MP; Nista, E; Ragucci, D | 1 |
| Beck, LA; Denby, KS | 1 |
| Lubrano, E; Scarpa, R | 1 |
| Miller, AV; Ranatunga, SK | 1 |
| Kher, A; Kher, V | 1 |
| Chinoy, H; Foulkes, AC; Griffiths, CE; Warren, RB | 1 |
| Dutta, TK; Karyampudi, A; Krishnamurthy, A; Vishwanath, VK | 1 |
| Callens, C; Cellier, C; Cerf-Bensussan, N; Duong Van Huyen, JP; Hermine, O; Kaltenbach, S; Lenglet, J; Macintyre, E; Malamut, G; Meresse, B; Montcuquet, N; Radford-Weiss, I; Rahmi, G; Ranque, B; Samaha, E; Verkarre, V | 1 |
| Frambach, Y; Gerdes, S; Mössner, R; Philipp, S; Rotterdam, S; Weyergraf, A; Wilsmann-Theis, D | 1 |
| Aggarwal, R; Oddis, CV | 1 |
| Dahllöf, G; Garming-Legert, K; Karlsson, H; Mattsson, J; Remberger, M; Ringdén, O; Svenberg, P; Uhlin, M; Uzunel, M | 1 |
| Brito, MJ; Conde, M; Queirós, G; Romeira, AM | 1 |
| Ichinose, A; Ieko, M; Inoue, M; Kasahara, Y; Kurita, T; Majima, T; Matsuoka, M; Onodera, T; Souri, M; Takahashi, D | 1 |
| Gonzalez, ME; Tan, AU | 1 |
| Burgner, D; Kuijpers, TW; Kuipers, IM; Tacke, CE | 1 |
| Eassa, B; El-Khalawany, MA; Ghonaim, N; Hassan, H; Shaaban, D | 1 |
| Fujisawa, S; Fujita, H; Kanamori, H; Kanda, Y; Kobayashi, T; Mori, T; Nakaseko, C; Nannya, Y; Ohashi, K; Okamoto, S; Sakamaki, H; Sakura, T; Takahashi, S; Tanaka, M; Yokota, A | 1 |
| Bogaards, NA; de Vries, AC; Hooft, L; Lebwohl, M; Pasch, M; Spuls, PI; Velema, M | 1 |
| Chandrashekar, L; Mohanan, S; Ramassamy, S; Thappa, DM | 1 |
| Kane, SV; Yarur, A | 1 |
| Beato Merino, MJ; Gómez-Fernández, C; Hernández-Maraver, D; Herranz Pinto, P; Maldonado Cid, P; Noguera Morel, L; Sendagorta Cudós, E | 1 |
| Dalton, JT; Devine, SM; Edwards, RB; Farag, SS; Grever, MR; Hofmeister, CC; Jansak, BS; Johnston, JS; Lucas, DM; Phelps, MA; Poi, MJ | 1 |
| Abrahamsen, B; Andersen, LS; Ellingsen, T; Hansen, I; Hansen, MS; Hetland, ML; Hyldstrup, L; Hørslev-Petersen, K; Jensen, TW; Junker, P; Jurik, AG; Langdahl, B; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Pødenphant, J; Skjødt, H; Stengaard-Petersen, K; Svendsen, AJ; Tarp, U; Vestergaard, A; Zerahn, B; Østergaard, M | 1 |
| Abdel-Rahman, F; Adil, SN; Ahmed, P; Alabdulaaly, A; Alimoghaddam, K; Aljurf, M; Alseraihy, A; Bazarbachi, A; Bekadja, MA; Ben Othman, T; Benchekroun, S; Dennison, D; Elhaddad, A; Ghavamzadeh, A; Hamidieh, A; Hamladji, R; Hussain, F; Ibrahim, A; Jarrar, M; Mohamed, SY; Ramzi, M; Rasheed, W | 1 |
| Andresen, S; Bolwell, B; Copelan, E; Dean, R; Duong, H; Hamilton, BK; Hanna, R; Hill, B; Kalaycio, M; Pohlman, B; Rybicki, L; Sobecks, R | 1 |
| McNeil, C | 1 |
| Cai, Z; He, J; Huang, H; Lai, X; Li, L; Lin, M; Luo, Y; Shi, J; Tan, Y; Xie, W; Ye, X; Zhang, J; Zheng, W; Zhu, X | 1 |
| Gupta, R; Koo, J; Levin, E; Liao, W; Wu, JJ | 1 |
| Aydin, F; Canturk, T; Senturk, N; Turanli, AY; Yuksel, EP | 1 |
| Andersen, LS; Christensen, AF; Ellingsen, T; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Jacobsen, S; Junker, P; Jurik, AG; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Møller, BK; Pedersen, JK; Skjødt, H; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Thorsen, J; Vestergaard, A; Østergaard, M | 1 |
| Flohr, C; Irvine, AD | 1 |
| Heinecke, GM; Lebwohl, MG; Levitt, JO; Luber, AJ | 1 |
| Haufe, E; Nast, A; Rosumeck, S; Schmitt, J; Sporbeck, B; Thomaschewski, G | 1 |
| Deleuran, B; Greisen, SR; Hetland, ML; Hvid, M; Hørslev-Petersen, K; Rasmussen, TK; Stengaard-Pedersen, K | 1 |
| Jones, OY; Katz, JD; Rider, LG | 1 |
| Bagel, J; Blauvelt, A; Hsu, S; Hugh, J; Lebwohl, M; Nijhawan, RI; Van Voorhees, AS; Weinberg, JM | 1 |
| Askar, M; Mossad, S; Rybicki, L; Sobecks, R; Taimur, S; Warshawsky, I | 1 |
| Kuester, D; Limpens, J; Roekevisch, E; Schmitt, J; Spuls, PI | 1 |
| Shapiro, J | 1 |
| Burden, AD; Burfield, L | 1 |
| Komagata, Y | 1 |
| Gladman, DD; Ibañez, D; Touma, Z; Urowitz, MB | 1 |
| Cope, AP; Dahanayake, C; Lewis, CM; Ma, MH; Scott, DL; Scott, IC; Seegobin, SD | 1 |
| Joshi, L; Lightman, S; McCluskey, P; Sandhu, S; Talat, L; Taylor, SR; Wakefield, D; Yaganti, S | 1 |
| Imamura, Y | 1 |
| Adamkovich, N; Bagdi, E; Borbényi, Z; Kispál, M; Krenács, L | 1 |
| Constable, H; Jones, K; Wood, F | 1 |
| Flohr, C; Tsakok, T | 1 |
| Irvine, AD | 1 |
| Bhattacharya, R; Biswas, A; Park, E | 1 |
| Alsina-Gibert, M; Belinchón, I; Carazo, C; Carrascosa, JM; Carretero, G; Dauden, E; De la Cueva-Dobao, P; Ferrán, M; Ferrandiz, C; García-Doval, I; Gómez-García, FJ; Herrera-Ceballos, E; Jiménez-Puya, R; López-Estebaranz, JL; Rivera, R; Sánchez-Carazo, JL; Torrado, R; Vanaclocha Sebastián, F | 1 |
| Abrahams, A; Auret, J; Heckmann, JM; Prince, S | 1 |
| Habal, FM; Huang, VW | 1 |
| Begolka, WS; Berger, TG; Bergman, JN; Block, J; Chamlin, SL; Cohen, DE; Cooper, KD; Cordoro, KM; Davis, DM; Eichenfield, LF; Elmets, CA; Feldman, SR; Hanifin, JM; Harrod, CG; Krol, A; Margolis, DJ; Paller, AS; Schwarzenberger, K; Sidbury, R; Silverman, RA; Simpson, EL; Tom, WL; Williams, HC | 1 |
| Haranaka, M; Imada, C; Ishii, K; Kiyonaga, Y; Maeshima, K; Shibata, H | 1 |
| Chiarolanza, I; Di Lernia, V; Ficarelli, E; Lallas, A; Possemato, N; Salvarani, C | 1 |
| Cope, AP; Dahanayake, C; Ma, MH; Scott, DL; Scott, IC | 1 |
| Strober, BE | 1 |
| Pedroza-Seres, M; Serna-Ojeda, JC | 1 |
| Kikuchi, H; Nakamura, H; Odani, T; Shimizu, Y; Takeda, T | 1 |
| Djulbegovic, B; Kharfan-Dabaja, M; Kumar, A; Mhaskar, R; Perkins, JB; Pidala, J; Reljic, T | 1 |
| Davis, SA; Feldman, SR; Fleischer, AB; Shaw, MK | 1 |
| Chen, YH; Hou, J; Hu, DM; Huang, XJ; Jiang, M; Lai, YR; Li, QC; Liu, KY; Liu, L; Liu, QF; Schwarzenberger, P; Zhang, ZM | 1 |
| Allaart, CF; de Vries-Bouwstra, JK; Han, KH; Huizinga, TW; Kerstens, PJ; Lems, WF; Markusse, IM; Schouffoer, AA; van der Lubbe, PA | 1 |
| Brod, BA; Callis Duffin, K; Gelfand, JM; Kalb, RE; Krueger, GG; Linn, KA; Robertson, AD; Schleicher, SM; Shin, DB; Shinohara, RT; Sperber, BR; Stierstorfer, MB; Takeshita, J; Troxel, AB; Van Voorhees, AS; Wang, S; Weisman, JD | 1 |
| Batat, E; Bitterman, H; Cohen, AD; Cohen, S; Comanesther, D; Feldhamer, I; Greenberg-Dotan, S; Shalom, G; Zisman, D | 1 |
| Chang, YT; Chen, CC; Chen, DY; Chen, YJ; Ho, HJ; Kuo, KN; Liu, HN; Shen, JL; Wu, CY | 1 |
| Bunce, C; Calder, VL; Haskard, DO; Lightman, S; Longhurst, H; Lynn, W; Moots, R; Stanford, M; Taylor, SR; Tomkins-Netzer, O; Yang, D | 1 |
| Ahlehoff, O; Bryld, LE; Gislason, G; Gniadecki, R; Hansen, PR; Iversen, L; Kristensen, SL; Lasthein, S; Lindhardsen, J; Skov, L; Torp-Pedersen, C | 1 |
| Adachi, S; Atsuta, Y; Azuma, E; Chin, M; Goto, H; Hatakeyama, N; Hyakuna, N; Igarashi, S; Inoue, M; Kato, K; Koh, K; Kudo, K; Murata, M; Ogawa, A; Ohshima, K; Sakata, N; Sawada, A; Takahashi, Y; Takami, A; Tanaka, S; Umeda, K | 1 |
| Basile, L; Calafiore, S; Ciarnella, A; Guglielmelli, F; Laganà, B; Mutolo, MG; Recupero, SM; Verrilli, S | 1 |
| Chen, HR; Chen, P; Guo, Z; He, XP; Liu, XD; Lou, JX; Yang, K; Zhang, Y; Zhu, F | 1 |
| Abounader, D; Bolwell, B; Copelan, E; Dean, R; Duong, H; Haddad, H; Hamilton, BK; Hanna, R; Hill, BT; Kalaycio, M; Majhail, NS; Rybicki, L; Sobecks, R | 1 |
| Anelli, MG; Cacciapaglia, F; Covelli, M; Iannone, F; Lapadula, G; Rinaldi, A; Scioscia, C; Serafino, L | 1 |
| Kirby, B; Ryan, C | 1 |
| Foley, P; Kelly, JB; Strober, BE | 1 |
| Foulkes, AC; Warren, RB | 1 |
| Abeni, D; Giannantoni, P; Paradisi, A; Tabolli, S | 1 |
| Charron, D; Couture, F; Filion, A; Guillemette, C; Lalancette, M; Laverdière, I; Lévesque, É; Loiseau, P; Peffault de Latour, R; Robin, M; Socié, G; Tamouza, R; Tourancheau, A | 1 |
| Chakravarty, K; Choy, E; Cooper, RG; Danko, K; Doré, CJ; Gordon, P; Griffiths, B; Hakim, A; Ibrahim, F; Isenberg, D; Kitas, G; Lecky, B; Scott, DL; White-Alao, B; Winer, J | 1 |
| Beck, J; Gruhn, B; Steinbach, D; Weiss, M; Zintl, F | 1 |
| Ara, M; Gracia, T; Pastushenko, E | 1 |
| López-González, R; Martín-Martínez, MA; Pérez-Vicente, S; Silva-Fernández, L | 1 |
| Chen, F; Chen, S; Fu, Z; Han, Y; Jin, S; Jin, Z; Liu, L; Ma, X; Miao, M; Qiu, H; Sun, A; Tang, X; Wang, X; Wu, D; Zhang, X | 1 |
| Horneff, G; Nimmrich, S | 1 |
| Al-Ismail, D; Anderson, E; Batul Syed, S; Burden-Teh, E; Carmichael, A; Caruana, D; Darne, S; Dolman, S; Glover, M; Helbling, I; Hughes, B; Hughes, J; Jones, V; Jury, C; Kalavala, M; Katugampola, R; Lam, ML; McPherson, T; Moore, A; Murphy, R; Natarajan, S; Richards, L; Taibjee, SM; Taylor, A; Webster, S | 1 |
| Gupta, V; Hamad, N; Kim, DD; Kuruvilla, J; Lipton, JH; Messner, HA; Michelis, FV; Seftel, M; Shanavas, M; Uhm, J | 1 |
| Frambach, Y; Gerdes, S; Jacobi, A; Mössner, R; Philipp, S; Weyergraf, AJ; Wilsmann-Theis, D | 1 |
| de Bruin-Weller, MS; Deinum, J; Garritsen, FM; Roekevisch, E; Spuls, PI; van der Schaft, J | 1 |
| Gao, YT; Qian, LL; Shen, JP; Wen, XW; Ye, BD; Zhang, Y; Zhou, YH | 1 |
| Bitterman, H; Cohen, AD; Cohen, Y; Dreiher, J; Feldhamer, I; Greenberg-Dotan, S; Hammerman, A; Harman-Boehm, I; Moser, H; Shalom, G; Zisman, D | 1 |
| Abou Chahla, W; Jissendi-Tchofo, P; Lolli, V; Pruvo, JP; Soto Ares, G | 1 |
| Liu, X; Zhang, M | 1 |
| Chen, CJ; Cheng, TT; Lin, JC; Lin, KM | 1 |
| Ogushi, N; Sasaki, K; Shimoda, M | 1 |
| Arita, M; Furuta, K; Hotta, M; Ikeda, S; Ikeo, S; Ishida, T; Ito, A; Nishiyama, A | 1 |
| Chen, H; Han, W; Huang, XJ; Liu, DH; Liu, KY; Wang, FR; Wang, JZ; Wang, Y; Xu, LP; Yan, CH | 1 |
| Akpek, G; Alousi, AM; Antin, JH; Arora, M; Cairo, MS; Chao, NJ; Couriel, DR; Cutler, CS; Flowers, ME; Gale, RP; Gupta, V; Hamilton, BK; Hayashi, RJ; Hemmer, MT; Inamoto, Y; Kharfan-Dabaja, MA; Marks, DI; Martin, PJ; Nishihori, T; Reshef, R; Ringdén, OT; Saad, A; Shah, A; Socié, G; Solh, MM; Spellman, SR; Tallman, MS; Teshima, T; Urbano-Ispizua, A; Wang, T; Wirk, B | 1 |
| Dreyer, J; Gruenewald, T; Herscovici, C; Israeli, M; Levy-Assaraf, M; Mechoulam, R; Peck, A; Raanani, P; Ram, R; Shargian, L; Shpilberg, O; Yeshurun, M | 1 |
| Bachta, A; Bogusławska-Walecka, R; Duda, K; Juszkiewicz, A; Kisiel, B; Kruszewski, R; Kłos, K; Płoski, R; Raczkiewicz, A; Staniszewska-Varga, J; Tłustochowicz, M; Tłustochowicz, W | 1 |
| Adan, AM; Aparicio, Á; Blanco, A; Blanco, R; Calvo-Río, V; Cordero-Coma, M; Fonollosa, A; García Serrano, JL; González-Gay, MA; González-Suárez, S; González-Vela, C; Herreras, JM; Loricera, J; Maíz, O; Mesquida, M; Ortego-Centeno, N; Peiteado-Lopez, D; Pina, T; Riancho-Zarrabeitia, L; Sánchez-Bursón, J; Santos-Gómez, M | 1 |
| Akpek, EK; Doroslovacki, P; Karakus, S; O'Donnell, JJ | 1 |
| Braddock, M; Chen, YP; Huang, GQ; Huang, S; Lin, YQ; Shi, KQ; Wang, JT; Wang, LR; Wu, YM; Zheng, MH; Zhou, MT; Zhou, ZR; Zhu, GQ | 1 |
| Bangsgaard, N; Rørbye, C; Skov, L | 1 |
| Afanasyev, B; Al Seraihy, A; Aljurf, M; Ancliff, P; Bierings, M; Calvillo, M; de Wreede, L; Donadieu, J; Dufour, C; Fioredda, F; Fischer, A; Ganser, A; Gaspar, B; Iacobelli, S; Kalwak, K; Ljungman, P; Marsh, J; Matthes-Martin, S; Morreale, G; Or, R; Ozturk, G; Peffault de Latour, R; Peters, C; Sánchez de Toledo Codina, J; Smith, O; van 't Veer-Tazelaar, N; van Biezen, A; Veys, P; Wynn, R; Yesilipek, A | 1 |
| Igras, E; Kennedy, S; MacDermott, EJ; Murphy, CC | 1 |
| Go, DJ; Kang, EH; Kwon, HM; Lee, EB; Lee, YJ; Park, JK; Song, YW | 1 |
| Armstrong, AW; Blauvelt, A; Krueger, GG | 1 |
| Au, SC; Garber, C; Gottlieb, A; Plotnikova, N; Sorensen, EP | 1 |
| Creighton-Smith, M; Dumont, N; Garber, C; Gottlieb, AB; Sorensen, EP | 1 |
| Klufas, DM; Strober, BE; Wald, JM | 1 |
| McHugh, NJ; Tansley, SL; Vermaak, E | 1 |
| Augustin, M; Mrowietz, U; Radtke, MA; Reich, K; Rustenbach, SJ; Spehr, C; Thaci, D | 1 |
| Balcı, YI; Greenwood, T; Kenar, F; Koçyiğit, A; Özgürler Akpınar, F; Polat, A; Tesi, B; Yalçın, N | 1 |
| Doi, T; Fujisawa, T; Mizutani, Y; Ogura, S; Seishima, M; Suzuki, S; Yoshida, S | 1 |
| Luger, TA; Tsianakas, A | 1 |
| Murata, M | 1 |
| Arenberger, P; Bachelez, H; Barker, J; Dauden, E; de Jong, EM; Feist, E; Gisondi, P; Jacobs, A; Jobling, R; Kemény, L; Maccarone, M; Mrowietz, U; Nast, A; Ormerod, AD; Papp, KA; Paul, C; Reich, K; Rosumeck, S; Saiag, P; Smith, C; Spuls, PI; Talme, T; Thio, HB; van de Kerkhof, P; Werner, RN; Yawalkar, N | 1 |
| Androutsakos, T; Aroni, K; Hatzis, G; Stamopoulos, P | 1 |
| Åhlin, A; Hagelberg, S; Olsson, RF; Ringdén, O; Schiller, B; Truedsson, L | 1 |
| Ariga, T; Cho, Y; Iguchi, A; Kobayashi, R; Ohshima, J; Sato, TZ; Sugiyama, M; Terashita, Y | 1 |
| Beffermann C, N; Ocqueteau T, M; Pilcante S, J; Sarmiento M, M | 1 |
| Notaro, ER; Sidbury, R | 1 |
| Armstrong, AW; Karunaratne, M; Papp, KA; Reich, K; Valdecantos, W | 1 |
| Dankó, K; Farkas, F; Nagy-Vince, M; Szalmás, O | 1 |
| Bae, SH; Kim, SJ; Lee, JB; Lee, SC; Won, YH; Yun, SJ | 1 |
| Abasq, C; Aubin, F; Barbarot, S; Begon, E; Boralevi, F; Bourrat, E; Bursztejn, AC; Charbit, L; Chiaverini, C; Droitcourt, C; Hadj-Rabia, S; Lasek, A; Mahé, E; Mallet, S; Maruani, A; Mazereeuw-Hautier, J; Phan, A; Plantin, P; Souillet, AL | 1 |
| Allain-Launay, E; Angioloni, S; Apaz, MT; Avcin, T; Bernard-Medina, AG; Bica, B; Bracaglia, C; Brochard, K; Cespedes-Cruz, A; Cimaz, R; Corona, F; Couillault, G; Cuttica, R; Dolezalova, P; Dressler, F; Ferriani, V; Fischbach, M; Flato, B; Gerloni, V; Herlin, T; Joos, R; Magnusson, B; Martini, A; Meini, A; Oliveira, S; Pilkington, C; Pistorio, A; Quartier, P; Ravelli, A; Ruperto, N; Russo, R; Sterba, G; Tardieu, M; Trachana, M; Vargova, V; Wouters, C; Wulffraat, N; Zulian, F | 1 |
| Miossec, P | 1 |
| Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R | 1 |
| Lubrano, E; Marchesoni, A; Perrotta, FM | 1 |
| Aldredge, L; Armstrong, AW; Yamauchi, PS | 1 |
| Chang, W; Chen, F; Fu, C; Jin, Z; Ma, X; Miao, M; Qiu, H; Ruan, C; Sun, A; Tang, X; Wu, D; Xue, S | 1 |
| Adachi, S; Ago, H; Atsuta, Y; Eto, T; Fukuda, T; Iwato, K; Kanamori, H; Kobayashi, N; Miyamura, K; Mori, T; Morishima, Y; Morita, S; Murata, M; Nagamura-Inoue, T; Ohashi, K; Oshima, K; Sakai, R; Sakamaki, H; Taguri, M; Taniguchi, S | 1 |
| Carpentieri, A; De Marco, IM; Loconsole, F; Loiacono, A; Pacello, L; Picconi, O | 1 |
| Wang, L; Zhang, FC; Zhang, X | 1 |
| Amazan, E; Boralevi, F; Ezzedine, K; Milpied, B; Seneschal, J; Taïeb, A; Védie, AL | 1 |
| Alfageme Roldán, F; Bermejo Hernando, A; Calvo González, JL; Marqués Sánchez, P | 1 |
| Oddis, CV | 1 |
| Rosen, D; Sinno, MG; Wittler, R | 1 |
| Laffitte, E; Quenan, S | 2 |
| Dixit, A; Gupta, M; Madkaikar, M; Patil, V | 1 |
| Takei, S | 1 |
| Markham, T; O'Gorman, SM; Storan, ER | 1 |
| Dale, A; Goldacre, B; Milosevic, I | 1 |
| Angioloni, S; Martini, A; Pistorio, A; Ravelli, A; Ruperto, N | 1 |
| Faia, LJ; Thanos, A; Yonekawa, Y | 1 |
| Orchard, D; Yee, J | 1 |
| Exton, LS; Kirby, B; Mohd Mustapa, MF; Smith, CH; Warren, RB; Weatherhead, SC; Yesudian, PD | 1 |
| Bader-Meunier, B; Baildam, E; Bellutti Enders, F; Constantin, T; Dolezalova, P; Feldman, BM; Lahdenne, P; Magnusson, B; McCann, LJ; Nistala, K; Ozen, S; Pilkington, C; Ravelli, A; Russo, R; Uziel, Y; van Brussel, M; van der Net, J; van Royen-Kerkhof, A; Vastert, S; Wedderburn, LR; Wulffraat, N | 1 |
| Jones, N | 1 |
| Garming-Legert, K; Itälä-Remes, M; Ljungman, P; Mattsson, J; Remberger, M; Remes, K; Ringdén, O; Törlén, J; Winiarski, J | 1 |
| Alsina, M; Belinchón, I; Carrascosa, JM; Carretero, G; Dauden, E; Dávila-Seijo, P; De la Cueva-Dobao, P; Descalzo, MA; Ferrán, M; Ferrandiz, C; García-Doval, I; Gómez-García, FJ; Herrera-Ceballos, E; Jiménez-Puya, R; Llamas, M; López-Estebaranz, JL; Rivera, R; Sánchez-Carazo, JL; Torrado, R; Vanaclocha, F | 1 |
| Andersen, LS; Ejbjerg, BJ; Ellingsen, T; Eshed, I; Glinatsi, D; Hansen, IT; Hanson, LG; Hetland, ML; Hørslev-Petersen, K; Junker, P; Jurik, AG; Krogh, NS; Lindegaard, H; Lottenburger, T; Møller-Bisgaard, S; Pedersen, JK; Pødenphant, J; Skjødt, H; Stengaard-Pedersen, K; Svendsen, AJ; Tarp, U; Thomsen, H; Torfing, T; Vestergaard, A; Østergaard, M | 1 |
| Chan, YC; Chandran, NS; Ho, MS; Koh, MJ; Lim, YL; Tang, MB; Tay, YK; Thirumoorthy, T | 1 |
| Deleuran, MS; Hjuler, KF; Iversen, L; Jakobsen, L; Olsen, M; Riis, JL; Vestergaard, C | 1 |
| Cordoro, K; Eichenfield, LF; Flohr, C; Lara-Corrales, I; Logan, K; Paller, AS; Proudfoot, L; Schmitt, J; Siegfried, E; Sugarman, J; Tom, W; Totri, CR | 1 |
| Abraham, S; Augustin, M; Bieber, T; Elsner, P; Fölster-Holst, R; Homey, B; Kleinheinz, A; Novak, N; Schmitt, J; Stephan, V; Sticherling, M; Trautmann, F; Weidinger, S; Werfel, T | 1 |
| Atsuta, Y; Fukuda, T; Ichinohe, T; Inamoto, Y; Kanamori, H; Murata, M; Ohashi, K; Onishi, Y; Ozawa, Y; Sakai, R; Takahashi, S; Takanashi, M; Terakura, S; Teshima, T; Uchida, N; Wake, A; Yamaguchi, H; Yamaguchi, T | 1 |
| Alpsoy, E; Bulbul-Baskan, E; Ergun, T; Onsun, N; Salman, A; Saricam, MH; Sarioz, A; Seckin Gencosmanoglu, D | 1 |
| Andreoli, A; Boissel, N; de Latour, RP; Dhédin, N; Granier, C; Larghero, J; Lengliné, E; Masson, E; Robin, M; Schlageter, MH; Socié, G; Vignon, M | 1 |
| Chen, HR; Chen, P; Guo, Z; He, XP; Liu, XD; Lou, JX; Yang, K; Zhang, Y | 1 |
| Cline, A; Feldman, SR; Smith, J | 1 |
| Danylesko, I; Nagler, A; Shem-Tov, N; Shimoni, A; Shouval, R; Yerushalmi, R | 1 |
| Choi, CW; Kim, BR; Seo, E; Youn, SW | 1 |
| Annese, V; Ardizzone, S; Armuzzi, A; Biancone, L; Calabrese, E; Caprioli, F; Castiglione, F; Comberlato, M; Cottone, M; D'Incà, R; Danese, S; Daperno, M; Frieri, G; Fries, W; Gionchetti, P; Kohn, A; Latella, G; Meucci, G; Milla, M; Orlando, A; Papi, C; Petruzziello, C; Riegler, G; Rizzello, F; Saibeni, S; Scribano, ML; Vecchi, M; Vernia, P | 1 |
| Arenberger, P; Cetkovska, P; Dolezal, T; Fialova, J; Gkalpakiotis, S; Jircikova, J; Kojanova, M | 1 |
| Chong, JH; Koh, MJA | 1 |
| Croney, S | 1 |
| Davidson, BR; Eusebi, LH; Gurusamy, KS; Saffioti, F; Thorburn, D; Tsochatzis, E | 1 |
| Aggarwal, R; Bayat, N; Cimaz, R; Constantin, T; Cuttica, RJ; Davidson, JE; de Oliveira, SK; Dressler, F; Erman, B; Feldman, BM; Huber, AM; Lachenbruch, PA; Lindsley, CB; Magalhaes, CS; Magnusson, B; Miller, FW; Pilkington, CA; Pistorio, A; Punaro, M; Ravelli, A; Reed, AM; Rider, LG; Rinaldi, M; Rockette, H; Rouster-Stevens, K; Ruperto, N; Russo, R; van Royen-Kerkhof, A; Vencovsky, J; Villa, L | 1 |
| Jerome, D; Kim, WB; Yeung, J | 1 |
| Amano, W; Hayashi, M; Kakimoto, K; Katsuda, Y; Kimoto, Y; Konishi, N; Shinozaki, Y; Taniai-Riya, E; Tanimoto, A; Toyoda, K; Yamamoto, Y | 1 |
| Baek, S; Choi, EJ; Choi, Y; Jeon, M; Jo, JC; Joo, YD; Kang, YA; Kang, YL; Kim, DY; Kim, H; Kim, SH; Ko, SH; Lee, JH; Lee, KH; Lee, YS; Lim, SN; Park, HS; Seol, M; Yun, SC | 1 |
| Beck, LA; Prezzano, JC | 1 |
| Bertz, H; Bethge, WA; Finke, J; Grishina, O; Heim, D; Ottinger, H; Schmoor, C; Socie, G; Stelljes, M; Volin, L | 1 |
| Borok, J; Davis, DM; Lio, P; Spergel, J; Udkoff, J | 1 |
| Addis, A; Adenubiova, E; Busard, CI; Cazzaniga, S; Cohen, AD; Feldhamer, I; Gkalpakiotis, S; Hutten, BA; Kojanova, M; Lichem, R; Naldi, L; Quehenberger, F; Spuls, PI; Stern, RS; Wolf, P | 1 |
| Bulbul Baskan, E; Yazici, S | 1 |
| Cordero-Coma, M; Espinosa, G; Gómez-Gómez, A; Herreras, JM; Loza, E; Morales, JMGR; Muñoz-Fernández, S; Rosario, MP | 1 |
| Du, L; Kijlstra, A; Liang, L; Qi, J; Wang, C; Wu, L; Yang, P; Ye, Z; Zhou, Q | 1 |
| Juvonen, E; Nihtinen, A; Niittyvuopio, R; Ruutu, T; Volin, L | 1 |
| Al-Khalili, A; Dutz, JP | 1 |
| Al-Lawati, H; Aliabadi, HM; Lavasanifar, A; Makhmalzadeh, BS | 1 |
| Kandolf-Sekulović, L; Mijušković, Ž; Milenković, Z; Pecelj-Broćić, T; Tarabar, D; Tarabar, O; Tatomirović, Ž | 1 |
| Guo, C; Wu, R; Zheng, N | 1 |
| Brahe, CH; Dehlendorff, C; Ellingsen, T; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Jacobsen, S; Johansen, JS; Junker, P; Jurik, AG; Lindegaard, H; Lottenburger, T; Stengaard-Pedersen, K; Ørnbjerg, LM; Østergaard, M | 1 |
| Lacour, JP | 1 |
| Beneton, N; Bouzillé, G; Droitcourt, C; Dupuy, A; Law Ping Man, S; Safa, G | 1 |
| Bruijnzeel-Koomen, CAFM; de Bruin-Weller, MS; Garritsen, FM; Maitland-van der Zee, AH; van den Broek, MPH; van den Heuvel, JM | 1 |
| Berti, E; Damiani, G; Fiore, M; Leone, S; Maraolo, AE | 1 |
| Fei, Y; Feng, R; Lai, Y; Peng, L; Wang, L; Wang, M; Zeng, X; Zhang, F; Zhang, P; Zhang, W; Zhang, X; Zhao, Y | 1 |
| Golsari, A; Keller, S; Yamamura, J | 1 |
| Ashoor, F; Baron, S; Beattie, P; Browne, F; Flohr, C; Irvine, AD; Jones, AP; O'Neill, L; Rosala-Hallas, A; Sach, T; Spowart, C; Taams, L; Walker, C; Wan, M; Webb, N; Williamson, P | 1 |
| Bredius, RGM; Bresters, D; Jacobse, J; Kollen, WJW; Mensink, H; van der Stoep-Yap, MYEC | 1 |
| Denny, JWL; Natkunarajah, J; Valiallah, N | 1 |
| Chua, EP; Dahiya, S; Mallett, RB | 1 |
| Akahane, D; Gotoh, M; Kobayashi, C; Ohyashiki, JH; Ohyashiki, K; Saitoh, Y; Umezu, T; Yoshizawa, S | 1 |
| Bevans, SL; Fowler, PG; Pavlidakey, PG; Sami, N; Stoll, M; Theos, AJ | 1 |
| Abate, LE; Friedman, AJ; Qureshi, AA; Yosipovitch, G | 1 |
| Bercovitch, L; Drucker, AM | 1 |
| Börjesson, C; Guinard, E; Konstantinou, MP; Livideanu, CB; Mazereeuw-Hautier, J; Meyer, N; Paul, C; Tauber, M | 1 |
| Bigi, L; Conti, A; Lasagni, C; Pellacani, G | 1 |
| Abedini, R; Babahosseini, H; Balighi, K; Daneshpazhooh, M; Ghandi, N; Ghodsi, SZ; Kamyab, K; Kiani, A; Lajevardi, V; Mahmoudi, H; Mohammadi, M; Tavakolpour, S; Teimourpour, A | 1 |
| Fernandez, AP; Hu, JZ; Husni, ME; Mazloom, SE; Warren, CB; Ya, J; Yan, D | 1 |
| Ashcroft, DM; Griffiths, CEM; Jabbar-Lopez, ZK; Kleyn, CE; Mason, KJ; McElhone, K; Owen, CM; Reynolds, NJ; Smith, CH; Warren, RB; Williams, S; Wilson, N; Yiu, ZZN | 1 |
| Genere, N; Stan, MN | 1 |
| Amy de la Breteque, M; Avenel-Audran, M; Bastien, M; Beauchet, A; Bégon, E; Beneton, N; Boyé, T; Fougerousse, AC; Girard, C; Khemis, A; Maccari, F; Mahé, E; Pallure, V; Parier, J; Perrot, JL; Reguiai, Z; Tournier, A | 1 |
| Baran, R; Chiheb, S; Daniel, CR; Di Chiacchio, N; Gregoriou, S; Grover, C; Haneke, E; Iorizzo, M; Pasch, M; Piraccini, BM; Rich, P; Richert, B; Rigopoulos, D; Rompoti, N; Rubin, AI; Singal, A; Starace, M; Tosti, A; Triantafyllopoulou, I; Zaiac, M | 1 |
| Alexander, H; Flohr, C; Jabbar-Lopez, ZK; Manca, A; Patton, T | 1 |
| Guex-Crosier, Y; Ribi, C; Rossi, DC | 1 |
| Carrascosa, JM; Daudén, E; Guisado, C; Puig, L; Sulleiro, S | 1 |
| Gautam, RK; Gupta, A; Sardana, K | 1 |
| Geng, H; Jia, E; Jiang, Y; Qiu, X; Wei, J; Xiao, M; Xiao, Y; Xie, J; Zhang, J; Zhang, Y; Zhong, L | 1 |
| Fukushima, T; Hosaka, S; Imadome, KI; Imai-Saito, A; Iwabuchi, A; Jimbo, T; Kato, Y; Kobayashi, C; Kosaki, K; Masumoto, K; Nanmoku, T; Onodera, M; Saito, H; Sumazaki, R; Suzuki, R; Takada, H; Watanabe, N | 1 |
| Arnone, M; Bernardo, WM; Carvalho, AVE; Takahashí, MDF | 1 |
| Cuttica, R; Fischbach, M; Fueri, E; Giancane, G; Lavarello, C; Magnusson, B; Marini, R; Martini, A; Martino, S; Oliveira, SK; Pagnier, A; Pastore, S; Pistorio, A; Ravelli, A; Ruperto, N; Soler, C; Staņēvicha, V; Ten Cate, R; Uziel, Y; Vojinovic, J; Zulian, F | 1 |
| Arnone, M; Azulay-Abulafia, L; Bernardo, WM; Bortoletto, MCC; Bressan, AL; Carvalho, AVE; Felix, PAO; Fieri, LC; Jaime, TJ; Magalhaes, RF; Neffá, JM; Nunes, DH; Oliveira, MFSP; Ramos, AMC; Romiti, R; Souza, CDS; Takahashi, MDF; Terena, AC | 1 |
| Gieler, U; Husein-ElAhmed, H; Steinhoff, M | 1 |
| Chen, M; He, X; Huang, B; Lin, X; Zhang, Y; Zhang, Z; Zheng, Z; Zhong, C | 1 |
| Ichikawa, T; Kishida, D; Otuki, T; Sekijima, Y; Shimojima, Y; Ueno, KI | 1 |
| Jamali, Z; Pirhadi, R; Pourahmad, J; Ramazani, M; Salimi, A; Yousefsani, BS | 1 |
| Chen, Y; Cong, Y; Dong, L; Omar, D | 1 |
| Bulut, H; Engin, B; Gökalp, E; Kutlubay, Z; Özkoca, D; Serdaroğlu, S; Songür, A; Tanakol, A; Tüzün, Y; Vehid, HE | 1 |
| Goto, T; Julamanee, J; Kamoshita, S; Kiyoi, H; Koyama, D; Miyamura, K; Miyao, K; Murata, M; Nishida, T; Okuno, S; Ozawa, Y; Takagi, E; Terakura, S | 1 |
| Ellingsen, T; Horn, HC; Ruhoff, JT | 1 |
| Andreadou, I; Ikonomidis, I; Kapniari, I; Katsimbri, P; Loukeri, E; Makavos, G; Papadavid, E; Parissis, J; Pavlidis, G; Rafouli-Stergiou, P; Theodoropoulos, K; Thymis, J; Triantafyllidi, H; Tsoumani, M; Varoudi, M | 1 |
| Amiri, N; Baldwin, C; De Vera, MA; Rebić, N; Sayre, EC; Zusman, EZ | 1 |
| Benvenuti, F; Doria, A; Gatto, M; Iaccarino, L; Larosa, M; Montesso, G; Saccon, F; Zen, M | 1 |
| Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Farley Prater, EA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Wong, EB; Wu, JJ | 1 |
| Cai, SCS; Lee, JSS; Tan, LS; Tee, SI | 1 |
| Lim, YL; Toh, JJ; Yew, YW | 1 |
| Ellingsen, T; Hornung, N; Odderskov, C; Stengaard-Pedersen, K | 1 |
| Bavaharan, B; Kawali, A; Mahendradas, P; Mohan, A; Sanjay, S; Shetty, B | 1 |
| Mosca, M; Panzuti, P; Pin, D | 1 |
| Behfar, M; Ghavamzadeh, A; Hamidieh, AA; Khodayari-Namini, N; Koochakzadeh, L; Rostami, T; Salajegheh, P; Yazdanian, N | 1 |
| Couban, S; Couture, F; Devins, G; Elemary, M; Foley, R; Gallagher, G; Kerr, H; Kuruvilla, J; Lee, SJ; Moore, J; Nevill, T; Panzarella, T; Popradi, G; Roy, J; Schultz, KR; Szwajcer, D; Toze, C; Walker, I | 1 |
| Silverberg, JI; Singh, P | 1 |
| Armstrong, AW; Connor, C; Cordoro, KM; Davis, DMR; Elewski, BE; Elmets, CA; Gelfand, JM; Gordon, KB; Gottlieb, AB; Hariharan, V; Kaplan, DH; Kavanaugh, A; Kiselica, M; Kivelevitch, D; Korman, NJ; Kroshinsky, D; Lebwohl, M; Leonardi, CL; Lichten, J; Lim, HW; Mehta, NN; Menter, A; Paller, AS; Parra, SL; Pathy, AL; Prater, EF; Rahimi, RS; Rupani, RN; Siegel, M; Stoff, B; Strober, BE; Tapper, EB; Wong, EB; Wu, JJ | 1 |
| Cai, C; Han, Y; Lv, X; Pan, T; Qi, J; Shi, B; Tang, Y; Zhou, M | 1 |
| Ariëns, LFM; Bakker, DS; de Bruin-Weller, MS; de Graaf, M; de Ridder, I; Haeck, I; Kamsteeg, M; Oosting, AJ; Romeijn, GLE; Schuttelaar, MLA; Sloeserwij, A; Spekhorst, LS; Thijs, JL; van der Schaft, J | 1 |
| Arents, BWM; Bohdanowicz, M; Burton, T; Di Giorgio, S; Drucker, AM; Ellis, AG; Flohr, C; Küster, D; Mashayekhi, S; Rochwerg, B; Schmitt, J; Siegels, D; Spuls, PI; Yiu, ZZN | 1 |
| Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G | 1 |
| Chen, M; Lian, N; Liu, L; Shi, L | 1 |
| D, S; Dogra, S; Rajagopalan, M | 1 |
| Brammer, JE; Braunstein, Z; Freud, AG; Mishra, A; Porcu, P; Staub, A | 1 |
| Abramovits, W; Schlessinger, J | 1 |
| Cordeiro, G; Dias, AM; Estevinho, MM; Magro, F | 1 |
| Arber, D; Avigan, DE; Foss, FM; Gascoyne, RD; Hogan, WJ; Horning, SJ; Jegede, O; Lazarus, HM; Litzow, MR; Luger, SM; Miller, KB; Sprague, KA; Stadtmauer, EA; Strair, RK; Tallman, MS; Wagner, H; Wang, XV; Whiteside, TL | 1 |
| Asilian, A; Fatemi Naeini, F; Jelvan, M; Mohaghegh, F; Saber, M | 1 |
| Haghighat, S; Haghighinejad, H; Namdari, N; Ramzi, M | 1 |
| Lai, VWY; Sinclair, R | 1 |
| Amit, O; Pasvolsky, O; Pek, A; Raanani, P; Ram, R; Rozovski, U; Rubinstein, M; Sela-Navon, M; Shargian-Alon, L; Wolach, O; Yeshurun, M; Zuckerman, T | 1 |
| Danylesko, I; Nagler, A; Shem-Tov, N; Shimoni, A; Yerushalmi, R | 1 |
| Dahllöf, G; Garming Legert, K; Mattsson, J; Remberger, M; Ringdén, O; Törlén, J | 1 |
| Kromer, C; Lippert, U; Mössner, R; Schön, MP | 1 |
| Atsuta, Y; Ichinohe, T; Iida, H; Katayama, Y; Kato, J; Miyamoto, T; Mori, T; Onishi, Y; Onizuka, M; Ota, S; Ozawa, Y; Shingai, N; Takenaka, K; Uchida, N; Yamaguchi, H; Yamazaki, H; Yoshioka, S | 1 |
| Expósito-Serrano, V; Garbayo-Salmons, P | 1 |
| Hammad, I; Porter, TF | 1 |
| Ahmed, P; Ansar, I; Anwer, F; Ashraf, R; Chaudhry, QUN; Farhan, M; Ghafoor, T; Iftikhar, R; Khan, M; Khan, MA; Khattak, TA; Mahmood, SK; Marsh, J; Neupane, K; Rafae, A; Rehman, J; Satti, TM; Shahbaz, N; Shamshad, GU | 1 |
| Villani, AP | 1 |
| Chavan, D; Jamale, V; Kale, M; Nikam, B; Shah, S | 1 |
| Al-Niaimi, F; Ali, FR; Searle, T | 1 |
| Caldarola, G; Chiricozzi, A; D'Urso, DF; De Simone, C; Gori, N; Malvaso, D; Peris, K | 1 |
| Buizen, L; Butler, JP; Chang, K; Cooney, J; Curley, C; Durrant, S; Gartlan, KH; Gottlieb, D; Henden, AS; Hill, GR; Kennedy, GA; Misra, A; Moore, J; Morton, AJ; Olver, SD; Paul, SK; Ritchie, D; Subramoniapillai, E; Tey, SK; Varelias, A | 1 |
| Borzutzky, A; Concha, S; Hoyos-Bachiloglu, R; Poli, MC; Rey-Jurado, E | 1 |
| Bennett, M; Bourke, J; Bowe, S; Kiely, L; Murphy, M; O'Connor, C | 1 |
| Bennett, C; Chen, S; Hannon, CW; Lima, HC; McCourt, C | 1 |
| Altincatal, A; Berdofe, A; Centonze, D; de Moor, C; Jung, E; Kim, M; Nagpal, A; Naylor, ML; Popescu, C; Radhakrishnan, M; Rajbhandari, R; Reder, AT; Sandrock, AW; Smirnakis, K | 1 |
| Al-Shaibani, Z; Chen, C; Kim, DDH; Kumar, R; Lam, W; Law, AD; Lipton, JH; Loach, D; Mattsson, J; Michelis, FV; Nampoothiri, RV; Viswabandya, A | 1 |
| Bergqvist, C; Chosidow, O; Fiani, C; Hua, C; Lebre, C; Ortonne, N; Simantov, A; Wolkenstein, P | 1 |
| Castillo Tokumori, F; Dong, N; Isenalumhe, L; Knepper, TC; Mo, Q; Shao, H; Sokol, L; Tandon, A; Zhang, L; Zhang, Y | 1 |
| Bayerl, C; Herr, R; Kromer, C; Pino Lopez, J; Schaarschmidt, ML; Schmieder, A | 1 |
| Ahn, KJ; Cho, YA; Choe, YB; Hong, JR; Hong, JY; Jeong, H; Kim, H; Kim, SM; Lee, YW; Yang, HS | 1 |
| Chat, VS; Han, G; Kearns, DG; Uppal, SK; Wu, JJ | 1 |
| Brunello, L; Bruno, B; Busca, A; Butera, S; Cerrano, M; Dellacasa, CM; Faraci, DG; Giaccone, L; Mordini, N; Sorasio, R; Vassallo, S; Zallio, F | 1 |
| Biswasroy, P; Ghosh, G; Kar, B; Pradhan, D; Rath, G | 1 |
| Aylı, M; Caliskan, E; Coban, SN; Esme, P; Ugur, B | 1 |
| Acosta Felquer, ML; Galimberti, ML; LoGiudice, L; Mazzuoccolo, L; Rosa, J; Soriano, ER | 1 |
| Al-Obaidi, M; Ciurtin, C; Doolan, G; Faizal, NM; Foley, C; Jury, EC; Lieberman, SM; Price, E; Ramanan, AV | 1 |
| Bernigaud, C; Chiaverini, C; Ferries, L; Ingen-Housz-Oro, S; Milpied, B; Palladini, A; Staumont-Sallé, D; Tieulié, N; Valois, A | 1 |
| Aljurf, M; Bazarbachi, A; Bondarenko, S; Bourhis, JH; Brissot, E; Bug, G; Canaani, J; Choi, G; Ciceri, F; Cornelissen, JJ; Dholaria, B; Esteve, J; Gedde-Dahl, T; Giebel, S; Koc, Y; Labopin, M; Meijer, E; Mohty, M; Nagler, A; Niittyvuopio, R; Savani, B; Socié, G; Spyridonidis, A; Wu, D | 1 |
| Ardeleanu, M; Daoud, M; de Bruin-Weller, M; Ferrucci, SM; Jayawardena, S; Patrizi, A; Pink, AE; Schuttelaar, MLA; Svensson, A; Tauber, M | 1 |
| Jendoubi, F; Masson Regnault, M; Paul, C; Shourick, J; Tauber, M | 1 |
| Bajel, A; Barmanray, RD; Collins, J; Hillman, M; Lim, ABM; Mason, K; Ramanan, R; Ritchie, D; Szer, J; Tan, JLC | 1 |
| Agner, T; Alfonso, JH; de Graaf, M; De Schepper, S; Deleuran, M; Despontin, K; Elenius, V; Ghislain, PD; Huilaja, L; Janmohamed, SR; Johansson, EK; Kvenshagen, BK; Mandelin, JM; Olset, H; Schuttelaar, MLA; Svensson, A; Thyssen, JP; van Tuyll van Serooskerken, AM; Vestergaard, C | 1 |
| Krebs, B; Menter, AM; Valdecantos, WC; Weiss, J; Zema, CL | 1 |
| Chang, YT; Chou, YJ; Pan, TY; Wu, CY | 1 |
| Munawar, L; Norden, A; Oulee, A; Thyssen, J; Wu, J | 1 |
| Imafuku, S; Sato, E; Takano-Kawasaki, S; Yamaguchi, K | 1 |
| Cheirif-Wolosky, O; Elizalde-Jiménez, IG; Romero, MTG | 1 |
| Edwards Mayhew, RG; Leslie, L; Li, T; McCann, P; Palestine, AG; Strong Caldwell, A | 1 |
| Adam, DN; Beecker, JR; Gooderham, MJ; Hong, CH; Jack, CS; Jain, V; Lansang, P; Lynde, CW; Papp, KA; Prajapati, VH; Turchin, I; Yeung, J | 1 |
| Carrascosa, JM | 1 |
| Alabas, OA; Bewley, A; Griffiths, CEM; Hampton, PJ; Laws, PM; Lunt, M; Mason, KJ; Owen, CM; Reynolds, NJ; Smith, CH; Warren, RB; Yiu, ZZN | 1 |
| Blanchard, I; Kodali, N; Kunamneni, S; Lebwohl, MG | 1 |
| Aichinger, C; Binder, M; Buxhofer-Ausch, V; Clausen, J; Hasengruber, P; Kaynak, E; Machherndl-Spandl, S; Milanov, R; Nikoloudis, A; Petzer, A; Stiefel, O; Strassl, I; Weltermann, A; Wipplinger, D | 1 |
| Abdel-Fattah, RM; El Gammal, MM; Elhaddad, AM; Maher, MA; Mahmoud, HK; Mansour, OM; Samra, MA; Shouman, MT | 1 |
| Acharya, NR; Artornsombudh, P; Begum, HA; Bhatt, NP; Buchanich, JM; Daniel, E; Dreger, KA; Dunn, JP; Fitzgerald, TD; Foster, CS; Gangaputra, SS; Goldstein, DA; Helzlsouer, KJ; Holland, GN; Jabs, DA; Kaçmaz, RO; Kempen, JH; Khachatryan, N; Kothari, S; Leiderman, YI; Levy-Clarke, GA; Liesegang, TL; Lowder, CY; Maghsoudlou, A; Newcomb, CW; Nussenblatt, RB; Pak, CM; Payal, AR; Pujari, SS; Read, RW; Rosenbaum, JT; Sen, HN; Sobrin, L; Suga, HK; Suhler, EB; Thorne, JE; Washington, TL | 1 |
| Bei, W; Feng, H; Kai, C; Liuqing, C; Qian, J; Ruili, J; Zilu, Q | 1 |
| Ashoor, F; August, S; Baron, S; Beattie, P; Brown, SJ; Browne, F; Cork, MJ; Esdaile, B; Flohr, C; Gach, JE; Greenblatt, D; Hearn, R; Hilger, E; Howard, E; Irvine, AD; Jones, AP; Lovgren, ML; McPherson, T; O'Kane, D; Ravenscroft, J; Rosala-Hallas, A; Sach, TH; Shaw, L; Sinha, MD; Spowart, C; Taams, LS; Thomas, BR; Wan, M; Williamson, PR | 1 |
| Ding, H; Jia, Y; Xia, Z; Xiang, R; Ye, J | 1 |
280 review(s) available for methotrexate and cyclosporine
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Treatment of systemic sclerosis.
Topics: Cyclosporine; Humans; Methotrexate; Penicillamine; Photochemotherapy; Raynaud Disease; Scleroderma, Systemic | 1992 |
[Therapeutic alternatives in Crohn disease and in ulcero-hemorrhagic rectocolitis: current findings].
Topics: Antineoplastic Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Methotrexate | 1992 |
New approaches to the management of rheumatoid arthritis.
Topics: Acquired Immunodeficiency Syndrome; Antibodies, Monoclonal; Arthritis, Rheumatoid; CD4 Antigens; Cyclosporine; Drug Therapy, Combination; Humans; Immunotherapy; Magnetic Resonance Imaging; Methotrexate; Photochemotherapy; Rheumatic Diseases; Rheumatology | 1992 |
Cyclosporine in rheumatoid arthritis: beyond experimentation.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Forecasting; Humans; Methotrexate; Synovial Membrane | 1992 |
Bone marrow transplantation for chronic myeloid leukaemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Accelerated Phase; Leukemia, Myeloid, Chronic-Phase; Methotrexate; Recurrence; Time Factors; Transplantation, Homologous | 1992 |
Current issues of methotrexate and cyclosporine.
Topics: Arthritis, Rheumatoid; Cyclosporine; Humans; Methotrexate | 1992 |
Histamine and histamine type-2 receptor antagonists in psoriasis. Mechanisms and speculations.
Topics: Cyclosporine; Histamine; Histamine Antagonists; Histamine H2 Antagonists; Humans; Methotrexate; Psoriasis; Ranitidine | 1991 |
Allogeneic bone marrow transplantation for severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Survival Analysis; Transplantation, Homologous | 1991 |
Current status of the medical treatment of children with juvenile rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Cyclosporine; Humans; Immunization, Passive; Immunosuppressive Agents; Methotrexate; Steroids; Terminology as Topic | 1991 |
[New approaches to the therapy of diffuse inflammatory diseases of the connective tissue].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Connective Tissue Diseases; Cyclosporine; Drug Therapy, Combination; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymph; Methotrexate; Plasmapheresis; Synovitis | 1991 |
Therapeutic progress. II: Treatment of psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Calcitriol; Coal Tar; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Emollients; Humans; Immunosuppressive Agents; Methotrexate; Phototherapy; Psoriasis; Retinoids; Tacrolimus; United Kingdom | 1994 |
Corticosteroid sparing agents in asthma.
Topics: Adrenal Cortex Hormones; Asthma; Cyclosporine; Gold; Humans; Hydroxychloroquine; Methotrexate | 1995 |
Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; History, 20th Century; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications | 1995 |
Current therapies for systemic vasculitis.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunization, Passive; Methotrexate; Plasmapheresis; Vasculitis | 1994 |
Adverse drug interactions clinically important for the dermatologist.
Topics: Anti-Bacterial Agents; Antifungal Agents; Cyclosporine; Dermatology; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Histamine Antagonists; Humans; Methotrexate; Retinoids; Risk Factors | 1995 |
Alternative pharmacotherapies for steroid-dependent asthma.
Topics: Adrenal Cortex Hormones; Asthma; Clinical Trials as Topic; Cyclosporine; Dapsone; Furosemide; Gold; Humans; Hydroxychloroquine; Magnesium Sulfate; Methotrexate; Treatment Outcome; Troleandomycin | 1995 |
Maintenance of symptomatic remission in patients with Crohn's disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Recurrence; Remission Induction; Sulfasalazine | 1993 |
Drug-induced disorders of bone metabolism. Incidence, management and avoidance.
Topics: Adrenal Cortex Hormones; Aluminum; Anticonvulsants; Bone Diseases, Metabolic; Calcium; Cyclosporine; Diphosphonates; Fluorides; Heparin; Hormones; Humans; Methotrexate | 1994 |
[New experimental therapies for type I allergy].
Topics: Animals; Cyclosporine; Humans; Hypersensitivity; Immunoglobulin E; Immunoglobulins, Intravenous; Interferon-gamma; Methotrexate; Peptides; Receptors, Interleukin; Receptors, Interleukin-4; T-Lymphocyte Subsets | 1994 |
Medical management of patients with difficult-to-treat inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole | 1994 |
[The treatment of psoriasis].
Topics: Adrenal Cortex Hormones; Calcitriol; Cyclosporine; Dermatologic Agents; Humans; Methotrexate; Psoriasis; Ultraviolet Therapy | 1993 |
[Renal damage in rheumatoid arthritis].
Topics: Adult; Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclosporine; Female; Glomerulonephritis; Gold; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Methotrexate; Middle Aged; Penicillamine; Vasculitis | 1994 |
Immunosuppressive drug therapy.
Topics: Adrenal Cortex Hormones; Azathioprine; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Myositis; Pulmonary Fibrosis | 1994 |
Optimizing combination chemotherapy for rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate; Penicillamine | 1993 |
Immunosuppressive drug therapy of systemic lupus erythematosus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Leukocyte Count; Lupus Erythematosus, Systemic; Lymphocyte Subsets; Lymphocytes; Mechlorethamine; Methotrexate | 1994 |
Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
Topics: Acute Disease; Bone Marrow Transplantation; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methotrexate; Randomized Controlled Trials as Topic; Risk Factors | 1993 |
[Treatment of psoriasis].
Topics: Adrenal Cortex Hormones; Anthralin; Combined Modality Therapy; Cyclosporine; Humans; Methotrexate; Psoriasis; PUVA Therapy; Retinoids; Tars; Ultraviolet Therapy; Vitamin D | 1993 |
Review article: immunosuppressive therapy for inflammatory bowel disease.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate | 1993 |
Cisplatin-based chemotherapy in renal transplant recipients. A case report and a review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Cyclosporine; Doxorubicin; Humans; Kidney; Kidney Transplantation; Male; Methotrexate; Postoperative Period; Urinary Bladder Neoplasms; Vinblastine | 1996 |
A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
Topics: Algorithms; Azathioprine; Controlled Clinical Trials as Topic; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate | 1996 |
Clinical use of cyclosporin in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chemistry, Pharmaceutical; Cyclosporine; Drug Costs; Drug Therapy, Combination; Humans; Methotrexate | 1995 |
Combination therapy with cyclosporin in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate | 1995 |
Current management of asthma patients with corticosteroid resistance.
Topics: Anti-Inflammatory Agents; Asthma; Cyclosporine; Drug Resistance; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Steroids | 1996 |
Combination therapy with cyclosporin in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Forecasting; Humans; Methotrexate; Rheumatology | 1996 |
Effects of immunosuppressive drugs during pregnancy.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Animals; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infertility, Female; Mercaptopurine; Methotrexate; Mice; Pregnancy; Pregnancy Complications; Rheumatic Diseases | 1995 |
Immunomodulation as asthma therapy: where do we stand?
Topics: Adjuvants, Immunologic; Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Anti-Bacterial Agents; Antibodies, Monoclonal; Asthma; Bronchodilator Agents; Cell Adhesion; Cromolyn Sodium; Cyclosporine; Cytokines; Gold; Humans; Immunoglobulin G; Immunosuppressive Agents; Macrolides; Methotrexate; Nedocromil; Nitric Oxide Synthase; Phosphodiesterase Inhibitors; Theophylline | 1996 |
Newer treatments for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Nutritional Physiological Phenomena | 1996 |
Primary biliary cirrhosis.
Topics: Colchicine; Cyclosporine; Humans; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Methotrexate; Mitochondria, Liver; Prognosis; Ursodeoxycholic Acid | 1996 |
[Drug-induced renal disorders in patients with rheumatoid arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Humans; Kidney Diseases; Methotrexate; ortho-Aminobenzoates | 1996 |
[Systemic therapy of psoriasis].
Topics: Acitretin; Cyclosporine; Dermatologic Agents; Fumarates; Glucocorticoids; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Photochemotherapy; Phototherapy; Psoriasis | 1996 |
Update on therapy for refractory dermatomyositis and polymyositis.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Polymyositis; Tacrolimus | 1996 |
Immunosuppressive drug use during pregnancy.
Topics: Adrenal Cortex Hormones; Animals; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Methotrexate; Pregnancy; Pregnancy Complications; Rheumatic Diseases | 1997 |
Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
Topics: Acitretin; Aged; Aged, 80 and over; Calcitriol; Cyclosporine; Dermatitis, Exfoliative; Dermatologic Agents; Drug Combinations; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Methotrexate; Middle Aged; Prognosis; Psoriasis | 1997 |
Refractory IBD: medical management.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-10; Methotrexate | 1997 |
[ACR preliminary definition, of improvement in rheumatoid arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate; Quality of Life; Randomized Controlled Trials as Topic; Societies, Medical; Treatment Outcome; United States | 1996 |
Alternative treatments in the patient with intractable asthma.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Infective Agents; Antirheumatic Agents; Asthma; Cyclosporine; Dapsone; Humans; Hydroxychloroquine; Immunization, Passive; Immunosuppressive Agents; Methotrexate; Organogold Compounds; SRS-A; Troleandomycin | 1997 |
Combination of second-line antirheumatic drugs.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Azathioprine; Child; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome | 1997 |
Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
Topics: Acitretin; Administration, Topical; Calcitriol; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Drug Synergism; Drug Therapy, Combination; Etretinate; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Ointments; Phototherapy; Psoriasis; Risk; Safety; Treatment Outcome | 1997 |
Immunosuppressive treatment for refractory ulcerative colitis--where do we stand and where are we going?
Topics: Azathioprine; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Interleukin-10; Mercaptopurine; Methotrexate | 1997 |
Drug therapy for ulcerative colitis during pregnancy.
Topics: Adrenal Cortex Hormones; Antidiarrheals; Azathioprine; Breast Feeding; Colitis, Ulcerative; Cyclosporine; Female; Humans; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications; Sulfasalazine | 1997 |
[Current treatment of collagen diseases. 4. Immunosuppressive agents: key points in their application].
Topics: Azathioprine; Collagen Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Ribonucleosides | 1997 |
Systemic treatment of severe psoriasis.
Topics: Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Phototherapy; Prognosis; Psoriasis; Retinoids; Severity of Illness Index | 1997 |
Immunosuppressive drugs in the treatment of inflammatory bowel disease.
Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate | 1998 |
[Basic therapeutic combination therapy in chronic polyarthritis: an overview].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Treatment Outcome | 1998 |
Combination therapy for rheumatoid arthritis with methotrexate and cyclosporine.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Treatment Outcome | 1998 |
Immunosuppressive agents in dermatology. An update.
Topics: Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Dermatology; Humans; Immunosuppressive Agents; Methotrexate; Monitoring, Physiologic; Practice Guidelines as Topic; Skin Diseases; Treatment Outcome | 1998 |
Update on immunosuppressive therapy.
Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver; Lung; Lung Injury; Lupus Erythematosus, Systemic; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retina; Tacrolimus; Thalidomide | 1998 |
[Drug treatment of Crohn's disease].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Protocols; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Mesalamine; Methotrexate; Prednisone; Remission Induction; Treatment Outcome | 1998 |
Triple therapy with methotrexate, sulfasalazine, and hydroxychloroquine in patients with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome | 1998 |
[Familial hemophagocytic lymphohistiocytosis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Dexamethasone; Drug Administration Schedule; Etoposide; Genes, Recessive; Histiocytosis, Non-Langerhans-Cell; Humans; Methotrexate | 1998 |
Immunosuppressive drugs in the treatment of Crohn's disease.
Topics: Azathioprine; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Treatment Outcome | 1998 |
[Behçet's disease].
Topics: Behcet Syndrome; Cyclosporine; Immunosuppressive Agents; Methotrexate; Neutrophil Activation; Reference Standards | 1999 |
Newer therapeutic agents for asthma.
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Cyclosporine; Fluticasone; Forced Expiratory Volume; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Indoles; Leukotriene Antagonists; Lidocaine; Methotrexate; Phenylcarbamates; Salmeterol Xinafoate; Sulfonamides; Tosyl Compounds; Treatment Outcome | 1999 |
Difficult asthma: beyond the guidelines.
Topics: Asthma; Budesonide; Child; Chronic Disease; Cyclosporine; Drug Administration Routes; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Leukotriene Antagonists; Methotrexate; Patient Compliance; Patient Education as Topic; Terbutaline; Treatment Failure | 1999 |
Medical therapy for inflammatory bowel disease.
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Recurrence; Salicylates; Severity of Illness Index; Steroids | 1999 |
Evidence-based therapy of primary biliary cirrhosis.
Topics: Azathioprine; Bile Acids and Salts; Chlorambucil; Colchicine; Cyclosporine; Drug Therapy, Combination; Evidence-Based Medicine; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Methotrexate; Prednisolone; Treatment Outcome | 1999 |
Immunosuppression in uveitis therapy.
Topics: Administration, Oral; Administration, Topical; Animals; Arrestin; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Immunotherapy; Methotrexate; Rats; Steroids; Tacrolimus; Uveitis | 1999 |
Acitretin combination therapy.
Topics: Acitretin; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Humans; Keratolytic Agents; Methotrexate; Psoriasis; PUVA Therapy; Ultraviolet Therapy | 1999 |
Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results.
Topics: Acitretin; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Keratolytic Agents; Methotrexate; Psoriasis | 1999 |
[Recent progress in therapy of inflammatory bowel diseases].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Enteral Nutrition; Humans; Immunoglobulins, Intravenous; Leukapheresis; Mesalamine; Methotrexate; Receptors, Glucocorticoid; Steroids | 1999 |
[Trends in the treatment of rheumatic diseases].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Bone Marrow Transplantation; Cyclooxygenase Inhibitors; Cyclosporine; Hand; Humans; Immunoglobulins, Intravenous; Knee Joint; Methotrexate; Osteoarthritis; Plasmapheresis; Radiography; Rheumatic Diseases; Tumor Necrosis Factor-alpha | 1999 |
Psoriatic arthritis. Is something changing?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Psoriatic; Cyclosporine; Gold; Humans; Methotrexate; Spondylitis, Ankylosing; Sulfasalazine | 1999 |
Psoriasis: current perspectives with an emphasis on treatment.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Calcitriol; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; Drug Therapy, Combination; Humans; Keratolytic Agents; Methotrexate; Nicotinic Acids; Phototherapy; Psoriasis; PUVA Therapy; Retinoids; Severity of Illness Index; United States | 1999 |
Clinically significant therapeutic interactions for the practicing dermatologist.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Dermatology; Drug Interactions; Erythromycin; Humans; Methotrexate; Photosensitizing Agents; Practice Patterns, Physicians'; Psoriasis; PUVA Therapy | 1999 |
The role of current strategies in the future treatment of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Forecasting; Humans; Methotrexate | 1999 |
[The recent progress of the treatment for chronic idiopathic arthritides of childhood].
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Child; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate; Methylprednisolone; Plasma Exchange; Prednisolone; Pulse Therapy, Drug | 1999 |
Asthma--the changing face of drug therapy.
Topics: Adrenergic beta-Agonists; Anti-Asthmatic Agents; Asthma; Child; Cyclosporine; Enzyme Inhibitors; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Leukotriene Antagonists; Methotrexate; Phosphodiesterase Inhibitors | 2000 |
[Cytostatic drugs in the treatment of rheumatic and connective tissue diseases].
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Humans; Methotrexate; Podophyllotoxin | 1998 |
Other novel immunosuppressants.
Topics: Azathioprine; Chlorambucil; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Skin Diseases; Tacrolimus; Thioguanine | 2000 |
Management of nail psoriasis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Antifungal Agents; Cyclosporine; Dermatologic Agents; Female; Fluorouracil; Glucocorticoids; Humans; Keratosis; Male; Methotrexate; Nail Diseases; Psoriasis; Triamcinolone Acetonide | 2000 |
Recent developments in the therapy of spondyloarthropathies.
Topics: Alleles; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Reactive; Chronic Disease; Ciprofloxacin; Cyclosporine; Double-Blind Method; Drug Combinations; Follow-Up Studies; Forecasting; Glucosamine; Humans; Immunosuppressive Agents; Lymecycline; Meta-Analysis as Topic; Methotrexate; Multicenter Studies as Topic; Placebos; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Spondylarthropathies; Sulfasalazine; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
[Immunodeficiency induced by immunosuppressive agents].
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Methotrexate; Opportunistic Infections; Prednisolone; Prognosis; Tacrolimus | 2000 |
Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
Topics: Adjuvants, Immunologic; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Costs; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Risk Factors; Sulfasalazine | 2001 |
Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
Topics: Adult; Alkylating Agents; Antimetabolites; Azathioprine; Child; Chlorambucil; Cladribine; Cyclophosphamide; Cyclosporine; Drug Interactions; Female; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Rheumatic Diseases; Skin Diseases; Thioguanine | 2001 |
Advances in psoriasis treatment.
Topics: Acitretin; Administration, Topical; Anthralin; Anti-Inflammatory Agents; Coal Tar; Cyclosporine; Dermatologic Agents; Glucocorticoids; Humans; Methotrexate; Nicotinic Acids; Patient Education as Topic; Phototherapy; Psoriasis; PUVA Therapy; Quality of Life; Social Support; Triamcinolone | 2000 |
Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Etanercept; Female; Gastrointestinal Agents; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Receptors, Tumor Necrosis Factor; Thalidomide; Treatment Outcome | 2001 |
Phototherapy for psoriasis.
Topics: Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Psoriasis; PUVA Therapy; Retinoids; Skin; Ultraviolet Therapy | 2001 |
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Topics: Adult; Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclosporine; Disease Progression; Dogs; Forecasting; Graft Enhancement, Immunologic; Graft Survival; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Methotrexate; Middle Aged; Mycophenolic Acid; Neoplasms; Prednisone; Radiation Chimera; T-Lymphocytes, Cytotoxic; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2001 |
Malignancy and renal disease.
Topics: Acute Kidney Injury; Antineoplastic Agents; Bone Marrow Transplantation; Cisplatin; Cyclosporine; Hepatorenal Syndrome; Humans; Kidney Diseases; Methotrexate; Multiple Myeloma; Neoplasms; Renal Replacement Therapy | 2001 |
New developments in the prophylaxis and treatment of graft versus host disease.
Topics: Abatacept; Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Differentiation; Antimetabolites; Bone Marrow Transplantation; CD40 Ligand; Clinical Trials as Topic; CTLA-4 Antigen; Cyclosporine; Drug Design; Graft vs Host Disease; Guanidines; Guidelines as Topic; Humans; Immunoconjugates; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Methotrexate; Mycophenolic Acid; Sirolimus; T-Lymphocytes; Tacrolimus | 2001 |
Treatment of psoriasis. Part 2. Systemic therapies.
Topics: Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Psoriasis; Retinoids | 2001 |
[Treatment of steroid-resistant polymyositis and dermatomyositis].
Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Resistance; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Mycophenolic Acid; Polymyositis; Steroids; Tacrolimus | 2001 |
Psoriasis in children: a guide to its diagnosis and management.
Topics: Adrenal Cortex Hormones; Age of Onset; Child; Child, Preschool; Cyclosporine; Emollients; Humans; Immunosuppressive Agents; Methotrexate; Phototherapy; Practice Guidelines as Topic; Prevalence; Psoriasis; Retinoids; Vitamin D | 2001 |
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Cystitis; Cytarabine; Cytomegalovirus Infections; DNA, Neoplasm; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility; Humans; Hydroxyurea; Immunosuppressive Agents; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Mitoxantrone; Neoplasms, Second Primary; Prednisolone; Prostaglandins; Remission Induction; Topotecan; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2001 |
Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Clarithromycin; Combined Modality Therapy; Cyclosporine; Debridement; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotrexate; Minocycline; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Skin Ulcer; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2001 |
Treatment of systemic sclerosis.
Topics: Antirheumatic Agents; Cyclosporine; Drug Therapy, Combination; Humans; Interferons; Methotrexate; Middle Aged; Raynaud Disease; Scleroderma, Systemic | 2001 |
Management of fistulas in patients with Crohn's disease: antibiotic to antibody.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Colonic Diseases; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Mercaptopurine; Methotrexate; Rectal Fistula; Thalidomide | 2001 |
Progress in the treatment of rheumatoid arthritis.
Topics: Analgesics; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2001 |
"Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Maximum Tolerated Dose; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Treatment Outcome | 2001 |
Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation.
Topics: Bone Marrow; Cladribine; Combined Modality Therapy; Cyclosporine; Cytarabine; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant, Newborn; Mercaptopurine; Methotrexate; Methylprednisolone; Prednisone; Remission Induction; Transplantation, Homologous; Vinblastine | 2001 |
Therapeutic approaches to secondary progressive multiple sclerosis.
Topics: Anti-Inflammatory Agents; Azathioprine; Bone Marrow Transplantation; Cladribine; Clinical Trials as Topic; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Methotrexate; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Chronic Progressive | 2002 |
Inflammatory bowel disease: sorting out the treatment options.
Topics: Anti-Inflammatory Agents; Azathioprine; Clinical Trials as Topic; Cyclosporine; Fish Oils; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Practice Guidelines as Topic; Steroids; Sulfasalazine | 2002 |
[Non-steroid therapy for sarcoidosis].
Topics: Anti-Inflammatory Agents; Antimalarials; Azathioprine; Chlorambucil; Chloroquine; Cyclophosphamide; Cyclosporine; Humans; Methotrexate; Sarcoidosis; Steroids | 2002 |
[Central nervous system involvement in Behçet's disease].
Topics: Acute Disease; Behcet Syndrome; Biomarkers; Chronic Disease; Cyclosporine; HLA-B Antigens; HLA-B51 Antigen; Humans; Interleukin-6; Magnetic Resonance Imaging; Methotrexate | 2001 |
Evolving new therapies of autoimmune hepatitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Budesonide; Cyclophosphamide; Cyclosporine; Hepatitis, Autoimmune; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Signal Transduction; Tacrolimus | 2002 |
Comparative tolerability of systemic treatments for plaque-type psoriasis.
Topics: Acitretin; Cyclosporine; Dermatologic Agents; Drug Combinations; Eye Diseases; Humans; Keratolytic Agents; Liver Cirrhosis; Lymphoproliferative Disorders; Methotrexate; Nausea; Pancytopenia; Pneumonia; Pruritus; Psoriasis; PUVA Therapy; Skin Neoplasms | 2002 |
Vitamin D and systemic therapy.
Topics: Acitretin; Administration, Oral; Administration, Topical; Calcitriol; Clinical Trials as Topic; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Humans; Keratolytic Agents; Methotrexate; Ointments; Psoriasis | 2002 |
[Clinical implication of cyclosporin for rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Resistance, Multiple; Humans; Immunosuppressive Agents; Methotrexate | 2002 |
Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Family; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Histocompatibility Testing; HLA Antigens; Host vs Graft Reaction; Humans; Infections; Male; Methotrexate; Middle Aged; Parents; Risk; Siblings; Survival Analysis; Survival Rate; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |
Alternate treatments in asthma.
Topics: Anti-Asthmatic Agents; Anticoagulants; Asthma; Cyclosporine; Diuretics; Folic Acid Antagonists; Furosemide; Gold; Heparin; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; T-Lymphocytes; Troleandomycin | 2003 |
Inflammatory bowel disease: management issues during pregnancy.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Breast Feeding; Contraindications; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Maternal Nutritional Physiological Phenomena; MEDLINE; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2004 |
[Combination therapy in rheumatoid arthritis].
Topics: Adjuvants, Immunologic; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine | 2003 |
[Auto-immune hepatitis: therapeutic management].
Topics: Anti-Inflammatory Agents; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Mycophenolic Acid; Recurrence; Remission Induction; Risk Factors; Steroids; Tacrolimus; Treatment Outcome | 2003 |
Novel immunosuppressants in asthma.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Asthma; CD4 Antigens; Cross-Over Studies; Cyclosporine; Double-Blind Method; Humans; Immunosuppressive Agents; Methotrexate; Models, Immunological; Organogold Compounds; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus | 2000 |
[Kidney involvement in rheumatoid arthritis].
Topics: Amyloidosis; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Autopsy; Biopsy; Cyclosporine; Glomerulonephritis; Humans; Kidney; Kidney Diseases; Methotrexate; Nephritis, Interstitial; Penicillamine; Time Factors | 2003 |
A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses.
Topics: Cholecalciferol; Cyclosporine; Cytokines; Fumarates; Humans; Inflammation Mediators; Interleukin-4; Methotrexate; Phototherapy; Psoriasis; Th1 Cells; Th2 Cells; Vitamin A | 2003 |
Current systemic therapies for psoriasis: where are we now?
Topics: Acitretin; Antineoplastic Agents; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Humans; Hydroxyurea; Keratolytic Agents; Methotrexate; Psoriasis; Remission Induction | 2003 |
Combining the new biologic agents with our current psoriasis armamentarium.
Topics: Alefacept; Antibodies, Monoclonal; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Humans; Infliximab; Methotrexate; Phototherapy; Psoriasis; PUVA Therapy; Recombinant Fusion Proteins | 2003 |
Current disease-modifying therapies in multiple sclerosis.
Topics: Adjuvants, Immunologic; Analgesics; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclophosphamide; Cyclosporine; Glatiramer Acetate; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Peptides; Plasma Exchange | 2003 |
Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.
Topics: Antineoplastic Agents; Chloroquine; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Randomized Controlled Trials as Topic; Sarcoidosis, Pulmonary | 2003 |
[Current concepts of pharmacotherapy in rheumatoid arthritis].
Topics: Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Cyclophosphamide; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Feasibility Studies; Female; Glucocorticoids; Humans; Ibuprofen; Immunosuppressive Agents; Isoxazoles; Ketoprofen; Leflunomide; Male; Methotrexate; Prednisolone; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Sulfasalazine; Time Factors | 2003 |
Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.
Topics: Acitretin; Cyclosporine; Drug Therapy, Combination; Etretinate; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Phototherapy; Psoriasis; Recombinant Fusion Proteins; Treatment Outcome | 2003 |
[Immunomodulation in penetrating keratoplasty. Current status and perspectives].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Animals; Antiviral Agents; Azathioprine; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Keratitis, Herpetic; Keratoplasty, Penetrating; Methotrexate; Mice; Multicenter Studies as Topic; Mycophenolic Acid; Pilot Projects; Prospective Studies; Risk Factors; Sirolimus; Tacrolimus | 2003 |
Treating immunobullous diseases: an update.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Plasmapheresis; Rituximab; Skin Care; Skin Diseases, Vesiculobullous | 2004 |
Drug-induced pulmonary infection.
Topics: Aspergillosis; Communicable Diseases; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases; Methotrexate; Pneumonia, Pneumocystis; Purine Nucleosides; Tacrolimus; Tuberculosis; Tumor Necrosis Factor-alpha | 2004 |
General principles of medical therapy of inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Antibodies, Monoclonal; Azathioprine; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Methotrexate; Quality of Life | 2004 |
[Diagnosis and therapy of rheumatoid arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Arthroplasty; Cyclooxygenase Inhibitors; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Rheumatoid Factor; Sulfasalazine | 2004 |
[GVHD].
Topics: Antilymphocyte Serum; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Graft vs Host Disease; Humans; Methotrexate; Muromonab-CD3; Photopheresis; Prednisolone; Prognosis; Tacrolimus | 2004 |
Rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2003 |
Biologics in combination with nonbiologics: efficacy and safety.
Topics: Antibodies, Monoclonal; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Psoriasis | 2004 |
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Azathioprine; Cladribine; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunoglobulin G; Immunologic Factors; Immunotherapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Rituximab; Tacrolimus; Thalidomide | 2004 |
[The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis'].
Topics: Cyclosporine; Dermatologic Agents; Humans; Methotrexate; Photochemotherapy; Practice Guidelines as Topic; Psoriasis; Safety; Treatment Outcome; Ultraviolet Therapy | 2004 |
Efficacy of conventional immunosuppressive drugs in IBD.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Mycophenolic Acid; Tacrolimus; Thalidomide | 2004 |
Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis.
Topics: Antibodies, Monoclonal; Azathioprine; Cell Adhesion; Cell Movement; Cyclophosphamide; Cyclosporine; Gastrointestinal Agents; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Interleukin-10; Interleukin-12; Interleukin-18; Interleukins; Methotrexate; Oligodeoxyribonucleotides, Antisense; Phosphorothioate Oligonucleotides; Thionucleotides; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
Topics: Adolescent; Age Factors; Autoimmune Diseases; Child; Child, Preschool; Cyclosporine; Disease Susceptibility; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infections; Lymphoma; Male; Methotrexate; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Rheumatic Diseases; Skin Diseases | 2005 |
Review article: monitoring of immunomodulators in inflammatory bowel disease.
Topics: Azathioprine; Cyclosporine; Drug Monitoring; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate | 2005 |
Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks.
Topics: Administration, Oral; Chronic Disease; Cyclosporine; Dermatologic Agents; Ficusin; Fumarates; Humans; Immunosuppressive Agents; Methotrexate; Photosensitizing Agents; Psoriasis; PUVA Therapy; Retinoids; Risk Assessment; Ultraviolet Therapy | 2005 |
Combining traditional agents and biologics for the treatment of psoriasis.
Topics: Acitretin; Adalimumab; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Products; Clinical Trials as Topic; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Infliximab; Methotrexate; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins | 2005 |
Lymphomatoid papulosis in a patient with atopic eczema on long-term ciclosporin therapy.
Topics: Adult; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Lymphomatoid Papulosis; Male; Methotrexate | 2005 |
Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Topics: Azathioprine; Blood Component Removal; Cyclosporine; Dermatomyositis; Humans; Immunosuppressive Agents; Methotrexate; Plasma Exchange; Polymyositis; Randomized Controlled Trials as Topic | 2005 |
Pharmaceutical liquid crystals: the relevance of partially ordered systems.
Topics: Amyloid; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Chemistry, Pharmaceutical; Crystallization; Cyclosporine; Fenoprofen; Hypoglycemic Agents; Immunosuppressive Agents; Islet Amyloid Polypeptide; Itraconazole; Liquid Crystals; Macromolecular Substances; Methotrexate; Nafcillin; Pharmaceutical Solutions; Phase Transition; Solvents; Transition Temperature | 2005 |
Chronic plaque psoriasis.
Topics: Anthralin; Anti-Inflammatory Agents; Combined Modality Therapy; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Psoriasis; PUVA Therapy; Retinoids; Ultraviolet Therapy; Vitamin D | 2005 |
[The clinical spectrum of dermatomyositis].
Topics: Adult; Age Factors; Azathioprine; Biopsy; Child; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Dermatologic Agents; Dermatomyositis; Disease Progression; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Muscles; Mycophenolic Acid; Paraneoplastic Syndromes; Plasmapheresis; Prognosis; Sex Factors; Time Factors | 2005 |
The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Etanercept; Etretinate; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Keratolytic Agents; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2006 |
American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid; Recurrence | 2006 |
[Systemic management of autoimmune anterior uveitis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Autoimmune Diseases; Azathioprine; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Prednisolone; Uveitis, Anterior | 2005 |
Conventional systemic agents for psoriasis. A systematic review.
Topics: Acitretin; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hydroxyurea; Immunosuppressive Agents; Methotrexate; Practice Guidelines as Topic; Psoriasis; Thioguanine; Treatment Outcome | 2006 |
T-cell large granular lymphocyte leukemia: A report on the treatment of 29 patients and a review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Cyclophosphamide; Cyclosporine; Databases as Topic; Female; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Leukemia, T-Cell; Male; Methotrexate; Middle Aged; Pentostatin; Retrospective Studies | 2006 |
Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.
Topics: Antineoplastic Agents; Chloroquine; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Pentoxifylline; Prednisone; Randomized Controlled Trials as Topic; Sarcoidosis, Pulmonary | 2006 |
Chronic plaque psoriasis.
Topics: Adrenal Cortex Hormones; Alefacept; Anthralin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Combined Modality Therapy; Cyclosporine; Cytokines; Dermatologic Agents; Humans; Methotrexate; Nicotinic Acids; Psoriasis; PUVA Therapy; Recombinant Fusion Proteins; Retinoids; Ultraviolet Therapy; Vitamin D | 2006 |
[Biologics in the treatment of psoriasis].
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Child; Child, Preschool; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Pregnancy; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Time Factors | 2006 |
Cutaneous sarcoidosis therapy updated.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Allopurinol; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antigen Presentation; Antimalarials; Chlorambucil; Contraindications; Cyclosporine; Cytokines; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Laser Therapy; Leflunomide; Male; Melatonin; Methotrexate; Models, Immunological; Pentoxifylline; Pregnancy; Pregnancy Complications; Sarcoidosis; Skin Diseases; Tetracyclines; Th1 Cells; Thalidomide | 2007 |
Treatment of childhood psoriasis.
Topics: Adrenal Cortex Hormones; Anthralin; Calcitriol; Child; Cyclosporine; Humans; Methotrexate; Nicotinic Acids; Phototherapy; Psoriasis; Retinoids | 2006 |
[The immunology of psoriasis: from basic research to the bedside].
Topics: Acitretin; Adrenal Cortex Hormones; Alefacept; Anthralin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Autoimmunity; Biomedical Research; Cell Differentiation; Cell Proliferation; Cyclosporine; Dermatologic Agents; Humans; Immunity, Cellular; Immunosuppressive Agents; Infliximab; Keratinocytes; Keratolytic Agents; Methotrexate; Psoriasis; Recombinant Fusion Proteins; T-Lymphocytes, Regulatory; Ultraviolet Therapy | 2006 |
[Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Disease Progression; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Radiography; Remission Induction; Sulfasalazine | 2007 |
Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Safety; T-Lymphocytes; Tacrolimus; Tacrolimus Binding Proteins | 2007 |
[Psoriasis].
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Age Factors; Arthritis, Psoriatic; Calcitriol; Child; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; HIV Infections; Humans; Infant; Infant, Newborn; Keratolytic Agents; Methotrexate; Ointments; Phototherapy; Psoriasis; Skin; Time Factors; Vitamins | 2006 |
Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment.
Topics: Acute Disease; Adrenal Cortex Hormones; Calcineurin Inhibitors; Chronic Disease; Cyclosporine; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Mycophenolic Acid; Risk Assessment; T-Lymphocytes; Tacrolimus | 2007 |
[Rational therapeutic approach in rheumatoid arthritis].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Isoxazoles; Joint Prosthesis; Leflunomide; Methotrexate; Prostheses and Implants; Sulfasalazine | 2006 |
[Refractory proctitis].
Topics: Administration, Oral; Adrenal Cortex Hormones; Algorithms; Anesthetics, Local; Antibodies, Monoclonal; Aspirin; Azathioprine; Biopsy; Cyclosporine; Drug Therapy, Combination; Escherichia coli; Forecasting; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Lidocaine; Methotrexate; Nicotine; Patient Compliance; Probiotics; Proctitis; Randomized Controlled Trials as Topic; Rectum; Suppositories; Time Factors | 2007 |
[Pathologic condition of osteoporosis in rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Bone Remodeling; Bone Resorption; Cell Differentiation; Cyclosporine; Disease Progression; Glucocorticoids; Humans; Menopause; Methotrexate; Osteoclasts; Osteoporosis; RANK Ligand; Tumor Necrosis Factor-alpha | 2007 |
Conventional therapy of psoriatic arthritis: evidence-based review.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Sulfasalazine; Treatment Outcome | 2007 |
[Long-term control of psoriasis is necessary].
Topics: Acitretin; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Combined Modality Therapy; Comorbidity; Cyclosporine; Cytokines; Dermatologic Agents; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Quality of Life; Recurrence | 2008 |
The treatment and prognosis of dermatomyositis: an updated review.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Azathioprine; Cyclosporine; Dermatomyositis; Drug Administration Schedule; Exercise Therapy; Humans; Immunoglobulins, Intravenous; Methotrexate; Mycophenolic Acid; Plasma Exchange; Prognosis | 2008 |
Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease.
Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Adult; Algorithms; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Child; Clinical Protocols; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Intestinal Mucosa; Mercaptopurine; Methotrexate; Randomized Controlled Trials as Topic; Remission Induction; Severity of Illness Index | 2008 |
Hepatitis C virus-related arthritis.
Topics: Adrenal Cortex Hormones; Ankle; Antibodies, Viral; Arthralgia; Arthritis, Infectious; Arthritis, Rheumatoid; Chronic Disease; Cryoglobulinemia; Cyclooxygenase 2 Inhibitors; Cyclosporine; Hepacivirus; Hepatitis C; Humans; Hydroxychloroquine; Interferon-alpha; Methotrexate; Penicillamine; Purpura | 2008 |
[Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Quality of Life; Remission Induction; Risk Assessment; Risk Factors | 2008 |
[Graft-versus-host disease: friend or foe?].
Topics: Acute Disease; Cell Separation; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; T-Lymphocytes; Tacrolimus; Transplantation, Homologous | 2008 |
[Current treatment of systemic sclerosis. Part I. Immunosuppressive treatment].
Topics: Adrenal Cortex Hormones; Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Cytostatic Agents; Humans; Immunosuppressive Agents; Methotrexate; Musculoskeletal Diseases; Mycophenolic Acid; Scleroderma, Systemic | 2008 |
[New ways in the management of rheumatoid arthritis in Hungary].
Topics: Abatacept; Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmunity; Azathioprine; Chloroquine; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; Early Diagnosis; Etanercept; Humans; Hungary; Immunoconjugates; Immunoglobulin G; Immunologic Factors; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Prognosis; Receptors, Tumor Necrosis Factor; Rituximab; Sulfasalazine; Tumor Necrosis Factor-alpha | 2007 |
[Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Disease Progression; Drug Therapy, Combination; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Methotrexate; Penicillamine; Radiography; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus | 2009 |
[Immunosuppressants].
Topics: Azathioprine; Calcineurin Inhibitors; Collagen Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Rheumatic Diseases; Ribonucleosides; Risk Assessment; Tacrolimus | 2009 |
The BeSt story: on strategy trials in rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Infliximab; Methotrexate; Prednisolone; Sulfasalazine | 2009 |
Treatments for psoriasis and the risk of malignancy.
Topics: Biological Products; Cyclosporine; Dermatologic Agents; Humans; Methotrexate; Mycophenolic Acid; Psoriasis; PUVA Therapy; Skin Neoplasms; Ultraviolet Therapy | 2009 |
Management of RA medications in pregnant patients.
Topics: Abatacept; Acetaminophen; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Contraindications; Cyclosporine; Female; Gestational Age; Glucocorticoids; Humans; Immunoconjugates; Isoxazoles; Leflunomide; Methotrexate; Pregnancy; Pregnancy Complications; Rituximab; Sulfasalazine; Young Adult | 2009 |
Systemic therapies for pediatric atopic dermatitis: a review for the primary care physician.
Topics: Algorithms; Anti-Bacterial Agents; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Emollients; Glucocorticoids; Histamine Antagonists; Humans; Immunoglobulins; Immunologic Factors; Infant; Infusions, Intravenous; Interferon-gamma; Methotrexate; Mycophenolic Acid; Phototherapy; Primary Health Care; Severity of Illness Index; Treatment Outcome | 2009 |
Retinoids, methotrexate and cyclosporine.
Topics: Cyclosporine; Dermatologic Agents; Female; Humans; Male; Methotrexate; Psoriasis; Retinoids | 2009 |
WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Topics: Azathioprine; Blood Component Removal; Cyclosporine; Dermatomyositis; Humans; Immunosuppressive Agents; Methotrexate; Plasma Exchange; Polymyositis; Randomized Controlled Trials as Topic | 2009 |
Treatment of moderate-to-severe plaque psoriasis.
Topics: Abnormalities, Drug-Induced; Alefacept; Antibodies, Monoclonal; Clinical Trials as Topic; Contraindications; Cyclosporine; Etanercept; Female; Fumarates; Hematologic Diseases; Humans; Hypertension; Immunoglobulin G; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Photochemotherapy; Pregnancy; Pregnancy Complications; Psoriasis; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Retinoids; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2009 |
Therapeutic targets for persistent airway inflammation in refractory asthma.
Topics: Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Asthma; Cyclosporine; Drug Delivery Systems; Drug Resistance; Etanercept; Gold Compounds; Humans; Immunoglobulin G; Inflammation; Leukotriene Antagonists; Methotrexate; Omalizumab; Phosphodiesterase Inhibitors; Receptors, Tumor Necrosis Factor; Respiration Disorders | 2010 |
Treatment of acrodermatitis continua of Hallopeau with TNF-blocking agents: case report and review.
Topics: Acitretin; Acrodermatitis; Adalimumab; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Betamethasone; Clobetasol; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Methotrexate; Mycophenolic Acid; Nails; Paronychia; Psoriasis; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor Inhibitors | 2010 |
Alopecia areata update: part II. Treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia Areata; Animals; Child; Cyclopropanes; Cyclosporine; Hair; Haptens; Humans; Immunotherapy; Injections, Intralesional; Laser Therapy; Methotrexate; Minoxidil; Photochemotherapy; Randomized Controlled Trials as Topic; Rats; Recurrence; Research Design; Social Support; Sulfasalazine; Treatment Outcome; Triamcinolone Acetonide | 2010 |
Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence.
Topics: Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Phototherapy; Psoriasis; Receptors, Tumor Necrosis Factor | 2010 |
[Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].
Topics: Biological Products; Contraindications; Cyclosporine; Drug Administration Routes; Drug Monitoring; Female; Folic Acid; Humans; Immunosuppressive Agents; Kidney Diseases; Latent Tuberculosis; Liver Cirrhosis; Medical History Taking; Methotrexate; Pregnancy; Pregnancy Complications; Psoriasis; Pulmonary Fibrosis; Recurrence; Tumor Necrosis Factor-alpha; Vaccination | 2010 |
Systemic combination treatment for psoriasis: a review.
Topics: Biological Products; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Methotrexate; Photochemotherapy; Photosensitizing Agents; Psoriasis; Retinoids; Treatment Outcome | 2010 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Management of severe asthma in children.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Allergens; Anti-Asthmatic Agents; Asthma; Azathioprine; Bronchial Provocation Tests; Bronchodilator Agents; Budesonide; Budesonide, Formoterol Fumarate Drug Combination; Child; Clinical Trials as Topic; Comorbidity; Cyclosporine; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Eosinophils; Ethanolamines; Formoterol Fumarate; House Calls; Humans; Immunoglobulin E; Interdisciplinary Communication; Methotrexate; Off-Label Use; Risk Factors; Severity of Illness Index; Spirometry; Terbutaline; Tobacco Smoke Pollution; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
A rare case of non-Hodgkins B-cell lymphoma in a psoriatic patient: a case report and literature review.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Methotrexate; Middle Aged; Psoriasis | 2010 |
Pharmacogenetics of psoriasis.
Topics: Acitretin; Adrenal Cortex Hormones; Antibodies, Monoclonal; Cyclosporine; Genetic Predisposition to Disease; Humans; Methotrexate; Pharmacogenetics; Precision Medicine; Psoriasis | 2011 |
Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists.
Topics: Cyclosporine; Dermatology; Evidence-Based Practice; Humans; Methotrexate; Psoriasis; Retinoids; Treatment Outcome | 2011 |
Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Injections, Intramuscular; Mercaptopurine; Methotrexate; Remission Induction; Secondary Prevention; Treatment Failure | 2011 |
Systemic therapy of atopic dermatitis in children and adults.
Topics: Adrenal Cortex Hormones; Adult; Alitretinoin; Antibodies, Monoclonal; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon-gamma; Methotrexate; Mycophenolic Acid; Recombinant Proteins; Tretinoin | 2011 |
Immunosuppressive therapy in children.
Topics: Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nitriles; Sirolimus; Tacrolimus | 2011 |
[New therapeutic approaches for polymyositis and dermatomyositis].
Topics: Adrenal Cortex Hormones; Algorithms; Antineoplastic Agents; Azathioprine; Biological Therapy; Cell Movement; Cyclophosphamide; Cyclosporine; Dermatomyositis; Exercise Therapy; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Paraneoplastic Syndromes; Physical Therapy Modalities; Polymyositis; T-Lymphocytes; Tacrolimus | 2011 |
Systemic drugs in patients with skin diseases.
Topics: Cyclosporine; Fluconazole; Glucocorticoids; Humans; Immunologic Factors; Immunosuppression Therapy; Itraconazole; Methotrexate; Mycophenolic Acid; Naphthalenes; Retinoids; Skin Diseases; Terbinafine | 2011 |
[Systemic autoimmune disorders and pregnancy].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Remission Induction; Sjogren's Syndrome; Sulfasalazine; Teratogens; Tumor Necrosis Factor-alpha | 2011 |
Update on systemic therapies for atopic dermatitis.
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Kaposi Varicelliform Eruption; Male; Methotrexate; Mycophenolic Acid; Randomized Controlled Trials as Topic; Risk Factors | 2012 |
Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Clinical Trials as Topic; Cyclosporine; Evidence-Based Medicine; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Multicenter Studies as Topic; Nails; Skin; Sulfasalazine | 2012 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2012 |
Immunotherapy in renal diseases.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Diseases; Methotrexate; Plasmapheresis; Prognosis; Recurrence; Rituximab | 2012 |
Therapeutic advances in myositis.
Topics: Azathioprine; Cyclosporine; Dermatomyositis; Drug Resistance; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunomodulation; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Polymyositis; Randomized Controlled Trials as Topic; Tacrolimus | 2012 |
Management of severe atopic dermatitis in children.
Topics: Administration, Cutaneous; Adolescent; Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Baths; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Disinfectants; Humans; Immunosuppressive Agents; Infant; Methotrexate; Mycophenolic Acid; Sodium Hypochlorite; Ultraviolet Therapy | 2012 |
Management of acute and refractory Kawasaki disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Murine-Derived; Aspirin; Chemotherapy, Adjuvant; Coronary Aneurysm; Cyclosporine; Enzyme Inhibitors; Humans; Immunoglobulins, Intravenous; Methotrexate; Mucocutaneous Lymph Node Syndrome; Rituximab; Tumor Necrosis Factor-alpha | 2012 |
Interventions for nail psoriasis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatologic Agents; Humans; Infliximab; Methotrexate; Nail Diseases; Psoriasis; Quality of Life; Randomized Controlled Trials as Topic; Ustekinumab | 2013 |
Update on pregnancy and breastfeeding in the era of biologics.
Topics: Adalimumab; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Breast Feeding; Certolizumab Pegol; Colitis, Ulcerative; Contraindications; Crohn Disease; Cyclosporine; Female; Fertility; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Natalizumab; Polyethylene Glycols; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Tacrolimus | 2013 |
An update on drug-drug interactions with biologics for the treatment of moderate-to-severe psoriasis.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Products; Cyclosporine; Cytochrome P-450 Enzyme System; Drug Interactions; Etanercept; Humans; Immunoglobulin G; Infliximab; Male; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha; United States; Ustekinumab | 2014 |
Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials.
Topics: Biological Factors; Cyclosporine; Dermatologic Agents; Fumarates; Humans; Methotrexate; Psoriasis; Randomized Controlled Trials as Topic; Retinoids; Risk Factors; Treatment Outcome | 2014 |
Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.
Topics: Anti-Inflammatory Agents; Autoantibodies; Child; Cyclosporine; Dermatomyositis; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Myositis; Prednisone | 2013 |
From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies.
Topics: Acitretin; Antibodies, Monoclonal, Humanized; Biological Therapy; Cardiovascular Diseases; Cyclosporine; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Mycophenolic Acid; Psoriasis; PUVA Therapy; Tumor Necrosis Factor-alpha; Ustekinumab | 2014 |
Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-gamma; Methotrexate; Mycophenolic Acid | 2014 |
Current treatment of alopecia areata.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Alopecia Areata; Anthralin; Cyclobutanes; Cyclopropanes; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Injections, Intralesional; Methotrexate; Minoxidil; PUVA Therapy; Self-Help Groups | 2013 |
Psoriasis.
Topics: Acitretin; Administration, Topical; Cardiovascular Diseases; Cyclosporine; Dermatologic Agents; Humans; Methotrexate; Phototherapy; Psoriasis; Tumor Necrosis Factor-alpha | 2013 |
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 4. Macrophage activating syndrome and
Topics: Antirheumatic Agents; Connective Tissue Diseases; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Etoposide; gamma-Globins; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome; Methotrexate; Methylprednisolone; Pulse Therapy, Drug | 2013 |
[Hemophagocytic lymphohistiocytosis].
Topics: Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease Progression; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Methotrexate; Multiple Organ Failure; Prednisolone; Prednisone; Rituximab; Severity of Illness Index; Transplantation Conditioning; Vidarabine; Vincristine | 2014 |
From conception to delivery: managing the pregnant inflammatory bowel disease patient.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Anti-Bacterial Agents; Azathioprine; Biological Products; Breast Feeding; Cyclosporine; Female; Fertility; Humans; Inflammatory Bowel Diseases; Maternal Exposure; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications; Sulfasalazine | 2014 |
Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
Topics: Allografts; Calcineurin Inhibitors; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Randomized Controlled Trials as Topic; Recurrence; Tacrolimus | 2014 |
Ocular Inflammation: Can It Be a Sign of Activity of Weber-Christian Disease? A Case Report and Review of Literature.
Topics: Cataract Extraction; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Panniculitis, Nodular Nonsuppurative; Retinal Vasculitis; Uveitis; Visual Acuity; Young Adult | 2016 |
Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
Topics: Acitretin; Adipokines; Alcoholism; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Comorbidity; Cyclosporine; Dermatologic Agents; Diabetes Mellitus; Fumarates; Humans; Immunosuppressive Agents; Inflammation; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; Risk Factors; Smoking; Tumor Necrosis Factor-alpha; Ustekinumab | 2015 |
Current and future oral systemic therapies for psoriasis.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Cyclosporine; Fumarates; Humans; Hydroxyurea; Immunosuppressive Agents; Isoxazoles; Keratolytic Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Sulfasalazine; Thalidomide; Thioguanine | 2015 |
Pharmacogenomics and the resulting impact on psoriasis therapies.
Topics: Acitretin; Cyclosporine; Cytokines; HLA-C Antigens; Humans; Immunosuppressive Agents; Inflammation; Keratolytic Agents; Methotrexate; Pharmacogenetics; Phototherapy; Polymorphism, Genetic; Precision Medicine; Psoriasis; Research Design; Tumor Necrosis Factor-alpha | 2015 |
Etanercept combined with systemic drugs or phototherapy for treatment of psoriasis.
Topics: Acitretin; Antirheumatic Agents; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Methotrexate; Multicenter Studies as Topic; Prospective Studies; Psoriasis; Treatment Outcome; Ultraviolet Therapy | 2015 |
Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Bezafibrate; Bile Ducts; Colchicine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Male; Methotrexate; Middle Aged; Penicillamine; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
Treating Psoriasis During Pregnancy: Safety and Efficacy of Treatments.
Topics: Acitretin; Administration, Cutaneous; Adrenal Cortex Hormones; Calcineurin Inhibitors; Calcitriol; Coal Tar; Contraindications; Cyclosporine; Dermatologic Agents; Female; Humans; Immunosuppressive Agents; Methotrexate; Nicotinic Acids; Pregnancy; Pregnancy Complications; Psoriasis; PUVA Therapy; Tumor Necrosis Factor-alpha; Ultraviolet Therapy; Ustekinumab | 2015 |
Systemic Treatment of Recalcitrant Pediatric Psoriasis: A Case Series and Literature Review.
Topics: Adalimumab; Adolescent; Child; Child, Preschool; Cyclosporine; Dermatologic Agents; Etanercept; Female; Humans; Infliximab; Male; Methotrexate; Psoriasis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Ultraviolet Therapy; Ustekinumab | 2015 |
The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.
Topics: Adrenal Cortex Hormones; Azathioprine; Biological Products; Cyclosporine; Dermatomyositis; Evidence-Based Medicine; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Leukapheresis; Methotrexate; Plasmapheresis; Polymyositis; Practice Guidelines as Topic; Rituximab; Treatment Outcome | 2015 |
A case report of successful treatment of pyoderma gangrenosum in a patient with autoimmune hepatitis, and review of the literature.
Topics: Anti-Inflammatory Agents; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Methotrexate; Prednisolone; Pyoderma Gangrenosum; Young Adult | 2015 |
[Acquired hemophagocytic syndrome treated with HLH 94-04 chemotherapy protocol: Report of four cases].
Topics: Adult; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Early Diagnosis; Etoposide; Female; Ferritins; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Male; Methotrexate; Young Adult | 2015 |
Systemic Agents for Severe Atopic Dermatitis in Children.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Drug Administration Routes; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Severity of Illness Index; Thalidomide | 2015 |
Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Insurance, Health, Reimbursement; Keratolytic Agents; Medication Adherence; Methotrexate; Psoriasis; Symptom Flare Up; Thalidomide | 2016 |
Therapeutic advances for primary biliary cholangitis: the old and the new.
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cyclosporine; Enzyme Inhibitors; Fibric Acids; Glucocorticoids; Humans; Immunosuppressive Agents; Indoles; Liver Cirrhosis, Biliary; Mesenchymal Stem Cell Transplantation; Methotrexate; Mycophenolic Acid; Pyridones; Rituximab; Tacrolimus; Ursodeoxycholic Acid; Ustekinumab | 2016 |
Update on the pharmacological treatment of adult myositis.
Topics: Adrenocorticotropic Hormone; Adult; Azathioprine; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Myositis; Tacrolimus | 2016 |
[Pityriasis rubra pilaris].
Topics: Administration, Topical; Biological Products; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; Humans; Methotrexate; Phototherapy; Pityriasis Rubra Pilaris; Retinoids | 2016 |
[Diagnosis and treatment of juvenile idiopathic arthritis (JIA)].
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Juvenile; Biological Products; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Prognosis; Pulse Therapy, Drug; Severity of Illness Index | 2016 |
Monitoring recommendations for oral azathioprine, methotrexate and cyclosporin in a paediatric dermatology clinic and literature review.
Topics: Administration, Oral; Adolescent; Azathioprine; Blood Cell Count; Child; Child, Preschool; Creatinine; Cyclosporine; Drug Monitoring; Electrolytes; Female; Humans; Immunoglobulin E; Immunosuppressive Agents; Liver Function Tests; Male; Methotrexate; Methyltransferases; Retrospective Studies; Skin Diseases; Urea | 2018 |
Consensus-based recommendations for the management of juvenile dermatomyositis.
Topics: Cyclosporine; Dermatomyositis; Europe; Evidence-Based Medicine; Exercise Therapy; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Patient Care Team; Practice Guidelines as Topic; Prednisolone; Rituximab; Societies, Medical; Sunscreening Agents | 2017 |
Guidelines for the Management of Atopic Dermatitis in Singapore.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anti-Bacterial Agents; Azathioprine; Calcineurin Inhibitors; Coinfection; Cyclosporine; Dermatitis, Atopic; Dermatology; Disease Management; Emollients; Food Hypersensitivity; Humans; Immunosuppressive Agents; Methotrexate; Patient Education as Topic; Phototherapy; Practice Guidelines as Topic; Referral and Consultation; Severity of Illness Index; Singapore | 2016 |
Advances in Psoriasis.
Topics: Acitretin; Administration, Topical; Adrenal Cortex Hormones; Cyclosporine; Dermatologic Agents; Humans; Interleukins; Methotrexate; Phototherapy; Psoriasis; PUVA Therapy; Tumor Necrosis Factor-alpha; Vitamin D | 2017 |
Non-topical management of recalcitrant paediatric atopic dermatitis.
Topics: Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressive Agents; Medicine, Chinese Traditional; Methotrexate; Mycophenolic Acid; Phototherapy; Prebiotics; Probiotics; Recurrence; Ultraviolet Therapy | 2017 |
Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
Topics: Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Chronic Disease; Colchicine; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Mitochondria; Network Meta-Analysis; Penicillamine; Quality of Life; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2017 |
Diagnosis and management of psoriasis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Biological Factors; Cholecalciferol; Chronic Disease; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Phototherapy; Psoriasis; Severity of Illness Index | 2017 |
Long-Term Treatment of Atopic Dermatitis.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Azathioprine; Baths; Calcineurin Inhibitors; Cyclosporine; Dermatitis, Atopic; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Phototherapy; Randomized Controlled Trials as Topic; Skin Cream; Time Factors | 2017 |
Atopic dermatitis: phototherapy and systemic therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressive Agents; Interleukin-13; Interleukin-4; Methotrexate; Mycophenolic Acid; Phototherapy | 2017 |
Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis: A systematic literature review.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Azathioprine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Treatment Outcome; Uveitis, Anterior | 2017 |
Immunosuppression/Infections across Indications.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Candidiasis; Clinical Trials as Topic; Cyclosporine; Cytokines; Etanercept; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infliximab; Methotrexate; Psoriasis; Surgical Wound Infection; Tuberculosis; Ustekinumab; Virus Diseases | 2018 |
Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research.
Topics: Biomedical Research; Cyclosporine; Drug Delivery Systems; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Nanomedicine; Nanoparticles; Tacrolimus | 2018 |
Liver Illness and Psoriatic Patients.
Topics: Autoimmune Diseases; Chemical and Drug Induced Liver Injury; Cyclosporine; Humans; Inflammation; Liver; Liver Diseases; Methotrexate; Psoriasis | 2018 |
Pediatric ocular lichen planus and lichen planopilaris: One new case and a review of the literature.
Topics: Child; Cyclosporine; Eye; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lichen Planus; Methotrexate; Prednisolone; Scalp; Scalp Dermatoses | 2018 |
A systematic review of evidence-based treatments for prurigo nodularis.
Topics: Adrenal Cortex Hormones; Anticonvulsants; Antidepressive Agents; Antipruritics; Calcineurin Inhibitors; Calcitriol; Capsaicin; Cyclosporine; Evidence-Based Medicine; Humans; Immunosuppressive Agents; Methotrexate; Photochemotherapy; Prurigo; PUVA Therapy; Thalidomide | 2019 |
Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic review.
Topics: Acitretin; Adult; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Fumarates; Humans; Methotrexate; Multicenter Studies as Topic; Observational Studies as Topic; Psoriasis; Severity of Illness Index; Treatment Outcome | 2019 |
Current and Emerging Treatment Strategies for Graves' Orbitopathy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunotherapy; Methotrexate; Mycophenolic Acid; Rituximab; Selenium; Severity of Illness Index | 2019 |
Secukinumab (Cosentyx°) and plaque psoriasis.
Topics: Acitretin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Cyclosporine; Etanercept; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Psoriasis; PUVA Therapy; Severity of Illness Index; Treatment Failure; Tumor Necrosis Factor-alpha; Ultraviolet Therapy | 2017 |
Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus.
Topics: Acitretin; Administration, Oral; Administration, Topical; Adult; Aged; Biological Products; Consensus; Cyclosporine; Dermatologic Agents; Disease Management; Expert Testimony; Female; Humans; Injections, Intralesional; Male; Methotrexate; Middle Aged; Nail Diseases; Practice Guidelines as Topic; Psoriasis; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |
Novel systemic therapies in atopic dermatitis: what do we need to fulfil the promise of a treatment revolution?
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Randomized Controlled Trials as Topic | 2019 |
Treatment of chronic non-infectious uveitis and scleritis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Enzyme Inhibitors; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Scleritis; Uveitis | 2019 |
Diffuse pruritic erythema as a clinical manifestation in anti-SAE antibody-associated dermatomyositis: a case report and literature review.
Topics: Antibodies; Asian People; Cyclosporine; Dermatomyositis; Erythema; Female; Humans; Methotrexate; Middle Aged; Prednisolone; Pruritus; Thalidomide; Treatment Outcome; Ubiquitin-Activating Enzymes | 2019 |
Moderate to severe plaque psoriasis - treatment with drugs of the classic scheme.
Topics: Acitretin; Antibodies, Monoclonal; Brazil; Clinical Decision-Making; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Methotrexate; Psoriasis; Severity of Illness Index; Time Factors; Treatment Outcome | 2019 |
Lichen planus: a comprehensive evidence-based analysis of medical treatment.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Antifungal Agents; Calcineurin Inhibitors; Calcitriol; Cyclosporine; Dapsone; Dermatologic Agents; Enoxaparin; Evidence-Based Medicine; Humans; Hydroxychloroquine; Lichen Planus; Methotrexate; Mycophenolic Acid; Retinoids; Tacrolimus; Ultraviolet Therapy | 2019 |
Comparison of Tacrolimus and Cyclosporine Combined With Methotrexate for Graft Versus Host Disease Prophylaxis After Allogeneic Hematopoietic Cell Transplantation.
Topics: Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Global Health; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Methotrexate; Randomized Controlled Trials as Topic; Survival Rate; Tacrolimus; Transplantation, Homologous; Unrelated Donors | 2020 |
Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis.
Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Mycophenolic Acid; Network Meta-Analysis; Odds Ratio; Recurrence; Remission Induction; Rituximab; Tacrolimus | 2020 |
Efficacy of methotrexate in management of peripheral psoriatic arthritis - a systematic review.
Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Treatment Outcome; Tumor Necrosis Factor-alpha | 2019 |
Comparative efficacy of 20 graft-versus-host disease prophylaxis therapies for patients after hematopoietic stem-cell transplantation: A multiple-treatments network meta-analysis.
Topics: Antilymphocyte Serum; Bortezomib; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Network Meta-Analysis; Randomized Controlled Trials as Topic; Sirolimus; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2020 |
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunologic Factors; Methotrexate; Network Meta-Analysis; Pruritus; Quality of Life; Severity of Illness Index; Treatment Outcome | 2020 |
Tapering and discontinuation of systemic medications in psoriasis patients with low disease activity.
Topics: Cyclosporine; Dermatologic Agents; Humans; Methotrexate; Psoriasis; Quality of Life; Severity of Illness Index | 2020 |
Anti-CD6 mAbs for the treatment of psoriasis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Autoimmune Diseases; Cell Differentiation; Cyclosporine; Humans; Methotrexate; Psoriasis; Tumor Necrosis Factor-alpha | 2020 |
Efficacy and Safety of Systemic Treatments for Skin and Joint Manifestations in Patients With Psoriasis.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Humans; Methotrexate; Psoriasis | 2020 |
Inflammatory Bowel Disease - Non-biological treatment.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Digestive System Surgical Procedures; Gastrointestinal Agents; Humans; Mesalamine; Methotrexate; Tacrolimus; Treatment Outcome | 2020 |
An Update on Biologic Agents During Pregnancy.
Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Autoimmune Diseases; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Female; Fetal Growth Retardation; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Premature Birth; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.
Topics: Age Factors; Allografts; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Methotrexate; Risk Factors; Transplantation Conditioning; Unrelated Donors; Vidarabine | 2021 |
Vitiligo: an update on systemic treatments.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; alpha-MSH; Anti-Bacterial Agents; Calcineurin Inhibitors; Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Humans; Janus Kinase Inhibitors; Methotrexate; Minocycline; Neoadjuvant Therapy; Outcome Assessment, Health Care; Phototherapy; Psychology; Vitiligo | 2021 |
Interventions for cutaneous disease in systemic lupus erythematosus.
Topics: Age of Onset; Azathioprine; Bias; Biological Factors; Chloroquine; Cosmetic Techniques; Cyclosporine; Dermatologic Agents; Exanthema; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Medicine, Chinese Traditional; Methotrexate; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Skin Diseases; Symptom Flare Up | 2021 |
Translating the 2020 AAD-NPF Guidelines of Care for the Management of Psoriasis With Systemic Nonbiologics to Clinical Practice.
Topics: Acitretin; Adult; Cyclosporine; Humans; Methotrexate; Psoriasis; United States | 2021 |
Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.
Topics: Administration, Cutaneous; Animals; Cyclosporine; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Liposomes; Methotrexate; Nanocapsules; Psoriasis; Salicylic Acid | 2021 |
Treatment strategies for Sjögren's syndrome with childhood onset: a systematic review of the literature.
Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Rituximab; Sjogren's Syndrome | 2022 |
Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review.
Topics: Chronic Disease; Cyclosporine; Humans; Interleukin-17; Interleukin-23; Methotrexate; Psoriasis; Recurrence; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor Inhibitors | 2022 |
Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults.
Topics: Adult; Antirheumatic Agents; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammation; Macular Edema; Methotrexate; Mycophenolic Acid; Panuveitis; Steroids; Tacrolimus | 2022 |
Expert consensus on the systemic treatment of atopic dermatitis in special populations.
Topics: Aged; Asthma; Cyclosporine; Dermatitis, Atopic; Female; Humans; Methotrexate; Mycophenolic Acid | 2023 |
Current management of generalized pustular psoriasis.
Topics: Acute Disease; CARD Signaling Adaptor Proteins; Chronic Disease; Cyclosporine; Female; Guanylate Cyclase; Humans; Interleukins; Membrane Proteins; Methotrexate; Psoriasis; Retinoids; Skin Diseases, Vesiculobullous | 2023 |
Comparing four immunosuppressive agents for chronic spontaneous urticaria-A network meta-analysis.
Topics: Anti-Allergic Agents; Azathioprine; Chronic Disease; Chronic Urticaria; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Glycosides; Histamine Antagonists; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Methotrexate; Network Meta-Analysis; Omalizumab; Randomized Controlled Trials as Topic; Treatment Outcome; Urticaria | 2023 |
176 trial(s) available for methotrexate and cyclosporine
| Article | Year |
|---|---|
Fractionated TBI and methotrexate-cyclosporin do not seem to increase relapses in BMT for first chronic phase CML patients: results of a single centre study.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Pulmonary Fibrosis; Recurrence; Whole-Body Irradiation | 1992 |
Autologous and allogeneic bone marrow transplantation for childhood acute nonlymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Child; Cyclophosphamide; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Melphalan; Methotrexate; Transplantation, Autologous; Transplantation, Homologous | 1992 |
Long-term follow-up of three controlled trials comparing cyclosporine versus methotrexate for graft-versus-host disease prevention in patients given marrow grafts for leukemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Leukemia; Methotrexate | 1992 |
Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Topics: Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Time Factors | 1992 |
A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Family; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prednisolone; Prospective Studies; Survival Analysis; Treatment Outcome | 1991 |
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Daunorubicin; Etoposide; Follow-Up Studies; Graft vs Host Disease; Humans; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Time Factors; Transplantation, Homologous; Vincristine; Whole-Body Irradiation | 1991 |
Phase II study of glycosylated recombinant human granulocyte colony-stimulating factor after HLA-identical sibling bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glycosylation; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Histocompatibility; HLA Antigens; Humans; Injections, Subcutaneous; Leukocyte Count; Male; Methotrexate; Middle Aged; Neutrophils; Recombinant Proteins; Tissue Donors | 1994 |
Combined transplantation of allogeneic bone marrow and CD34+ blood cells.
Topics: Adult; Antigens, CD; Antigens, CD34; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Whole-Body Irradiation | 1995 |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporine; Female; Flushing; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Middle Aged; Nausea; Prednisolone; Tacrolimus; Treatment Outcome | 1995 |
Graft-versus-host-disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Histocompatibility; Humans; Incidence; Infections; Male; Methotrexate; Methylprednisolone; Survival Rate | 1995 |
Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: preliminary results.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Aspergillosis; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporine; Female; Fungemia; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Male; Methotrexate; Polymorphism, Restriction Fragment Length | 1995 |
In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: comparison with cyclosporin/methotrexate.
Topics: Acute Disease; Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus Infections; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome | 1995 |
Bone marrow transplantation for Fanconi anemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Male; Methotrexate; Survival Rate | 1995 |
Drug combination therapy of systemic lupus erythematosus.
Topics: Adult; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunoglobulin G; Interleukin-2; Kidney Function Tests; Lupus Erythematosus, Systemic; Male; Methotrexate; Receptors, Interleukin-2 | 1994 |
Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Activation; Male; Methotrexate; Middle Aged; Prospective Studies; Receptors, Interleukin-2; T-Lymphocytes | 1995 |
Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group.
Topics: Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Severity of Illness Index; Treatment Outcome | 1995 |
Combination therapy of cyclosporine with methotrexate and gold in rheumatoid arthritis (2 pilot studies).
Topics: Adult; Arthritis, Rheumatoid; Blood Pressure; Blood Urea Nitrogen; Creatinine; Cyclosporine; Drug Therapy, Combination; Female; Gold; Humans; Liver Function Tests; Male; Methotrexate; Middle Aged; Pilot Projects | 1994 |
Intensified conditioning regimen with busulfan followed by allogeneic BMT in children with myelodysplastic syndromes.
Topics: Anemia, Refractory; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Cytarabine; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Methotrexate; Myelodysplastic Syndromes; Transplantation, Homologous; Whole-Body Irradiation | 1994 |
Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO).
Topics: Adolescent; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Leukemia, Myeloid, Acute; Leukocytes; Male; Methotrexate; Multivariate Analysis; Recurrence; Remission Induction; Risk Factors; Transplantation, Homologous; Whole-Body Irradiation | 1994 |
Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; T-Lymphocytes | 1994 |
Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; HLA Antigens; Humans; Leukemia; Male; Methotrexate; Middle Aged; Regression Analysis; Retrospective Studies; Risk Factors | 1994 |
Use of cyclosporine in the treatment of autoimmune disorders.
Topics: Adult; Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence | 1994 |
Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Topics: Adult; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Methotrexate; Recurrence; Survival Analysis; T-Lymphocytes; Time Factors | 1994 |
[A comparative evaluation of the treatment results with cyclosporin A, methotrexate and azathioprine in rheumatoid arthritis patients (a preliminary report)].
Topics: Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Remission Induction; Time Factors | 1993 |
Cyclosporine-induced alterations in renal function are not associated with lipid peroxidation.
Topics: Arthritis, Rheumatoid; Creatinine; Cyclosporine; Double-Blind Method; Female; Humans; Kidney; Lipid Peroxidation; Male; Methotrexate; Middle Aged | 1994 |
Fractionated total-body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 94 patients with chronic myelogenous leukemia in chronic phase.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cause of Death; Child; Chromosome Aberrations; Chromosome Disorders; Cyclosporine; Cytogenetics; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Methylprednisolone; Middle Aged; Recurrence; Survival Rate; Whole-Body Irradiation | 1994 |
Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis. A pilot study.
Topics: Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged | 1994 |
Influence of the conditioning regimens on the incidence of mixed chimerism in thalassemic transplanted patients.
Topics: Adolescent; Adult; Antilymphocyte Serum; beta-Thalassemia; Bone Marrow; Bone Marrow Purging; Bone Marrow Transplantation; Busulfan; Cell Survival; Child; Child, Preschool; Chimera; Cyclophosphamide; Cyclosporine; DNA; Graft Survival; Hematopoietic Stem Cells; Humans; Methotrexate; Polymorphism, Restriction Fragment Length | 1993 |
Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Methotrexate; Prospective Studies | 1994 |
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Prednisolone; Transplantation, Homologous | 1994 |
Combined cyclosporin A-steroid-MTX treatment in endogenous non-infectious uveitis.
Topics: Adolescent; Adult; Autoimmune Diseases; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Fluocortolone; Humans; Male; Methotrexate; Middle Aged; Uveitis; Visual Acuity | 1993 |
Cyclosporine combined with methylprednisolone or methotrexate in prophylaxis of moderate to severe acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index | 1993 |
Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Edema; Female; Graft vs Host Disease; Histocompatibility; Humans; Immunotoxins; Infant; Male; Methotrexate; Prednisolone; Ricin; Tissue Donors; Weight Gain | 1993 |
Outcome of BMT during first complete remission of AML: a comparison of two sequential studies by the Children's Cancer Group.
Topics: Adult; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid, Acute; Male; Methotrexate; Prognosis | 1993 |
A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Cytomegalovirus Infections; Double-Blind Method; Fever; Graft vs Host Disease; Humans; Methotrexate; Middle Aged; Pentoxifylline; Placebos; Probability; Recurrence; Survival Analysis; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Graft vs Host Disease; Humans; Infant; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Regression Analysis; Treatment Outcome | 1993 |
Decreased transplant-related complications and improved leukemia-free survival in adults receiving methotrexate combined with cyclosporin compared with either agent alone for prevention of graft-versus-host disease. Advisory Committee of the International
Topics: Adult; Bone Marrow Transplantation; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Probability; Proportional Hazards Models; Regression Analysis | 1993 |
Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Analysis; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infections; Karyotyping; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Prognosis; Recurrence; Regression Analysis; Survival Rate; Treatment Outcome; Whole-Body Irradiation | 1996 |
Transplantation of allogeneic CD34+ blood cells.
Topics: Acute Disease; Adult; Antigens, CD34; Bone Marrow; Cell Division; Cyclosporine; Erythropoietin; Female; Filgrastim; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukapheresis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Platelet Transfusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; T-Lymphocytes; Transplantation, Homologous | 1996 |
Combination therapy of cyclosporine A with methotrexate or hydroxychloroquine in refractory rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Treatment Outcome | 1996 |
Do changes in clinical improvement in rheumatoid arthritis patients treated with immunosuppressive drugs reflect the changes in acute phase proteins?
Topics: Acute-Phase Proteins; Adult; alpha 1-Antichymotrypsin; alpha 1-Antitrypsin; Arthritis, Rheumatoid; C-Reactive Protein; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Humans; Immunoelectrophoresis; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Orosomucoid | 1995 |
Combination therapy with cyclosporin in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Forecasting; Humans; Methotrexate; Rheumatology | 1996 |
Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
Topics: Adult; Aged; Antigens, CD34; Blood Cells; Cell Count; Cell Separation; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosorbent Techniques; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisone; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 1996 |
Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Fusion Proteins, bcr-abl; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Prognosis; T-Lymphocytes; Time Factors; Transcription, Genetic; Transplantation Chimera | 1997 |
Variability in determination of body weight used for dosing busulphan and cyclophosphamide in adult patients: results of an international survey.
Topics: Adult; Body Weight; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Graft vs Host Disease; Humans; Immunosuppressive Agents; Methotrexate; Transplantation Conditioning | 1997 |
Effect of combination therapy with cyclosporine and methotrexate on liver function test results in rheumatoid arthritis.
Topics: Alkaline Phosphatase; Antirheumatic Agents; Arthritis, Rheumatoid; Bilirubin; Chemical and Drug Induced Liver Injury; Cyclosporine; Drug Therapy, Combination; Humans; Liver; Liver Diseases; Liver Function Tests; Methotrexate | 1997 |
Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty-eight weeks: an open-label extension study. The Methotrexate-Cyclosporine Combination Study Group.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Time Factors; Treatment Outcome | 1997 |
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Humans; Karnofsky Performance Status; Methotrexate; Multivariate Analysis; Recurrence; Risk Factors; Time Factors; Transplantation Conditioning; Treatment Failure | 1997 |
Allogeneic peripheral blood stem cell transplantation: is there an increased risk of graft vs host disease in leukemia patients?
Topics: Adult; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukapheresis; Leukemia; Male; Methotrexate; Middle Aged; Nuclear Family; Tissue Donors; Transplantation, Homologous | 1997 |
Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions.
Topics: Adolescent; Anemia, Sickle Cell; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Graft Rejection; Graft vs Host Disease; Humans; Methotrexate; Transplantation Chimera; Transplantation Conditioning | 1997 |
Low transplant mortality in allogeneic bone marrow transplantation for acute myeloid leukemia: a randomized study of low-dose cyclosporin versus low-dose cyclosporin and low-dose methotrexate.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Recurrence; Survival Analysis; Time Factors | 1998 |
Soluble interleukin-2 receptor and interleukin-6 levels: evaluation during cyclosporin A and methotrexate treatment in psoriatic arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Female; Humans; Interleukin-6; Male; Methotrexate; Middle Aged; Receptors, Interleukin-2; Solubility; Treatment Outcome | 1998 |
Cord blood transplantation (CBT) in hemoglobinopathies. Eurocord.
Topics: Anemia, Sickle Cell; Antineoplastic Agents, Alkylating; beta-Thalassemia; Child; Child, Preschool; Cyclosporine; Female; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Prospective Studies; Thiotepa; Treatment Outcome | 1998 |
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Humans; Hyperglycemia; Hypertension; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Nuclear Family; Recurrence; Survival Analysis; Tacrolimus; Tissue Donors; Transplantation, Homologous; Treatment Outcome | 1998 |
Long-term followup of patients receiving combined therapy with cyclosporine and methotrexate.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Severity of Illness Index; Treatment Outcome | 1998 |
Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphocyte Depletion; Methotrexate; Multivariate Analysis; Prognosis; Time Factors; Transplantation Conditioning; Treatment Outcome | 1998 |
Comparative study of the clinical efficacy of four DMARDs (leflunomide, methotrexate, cyclosporine, and levamisole) in patients with rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Female; Humans; Isoxazoles; Leflunomide; Levamisole; Male; Methotrexate; Middle Aged | 1998 |
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Time Factors; Transplantation, Homologous | 1997 |
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.
Topics: Adolescent; Adult; Anti-Infective Agents; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Diseases; Histocompatibility Testing; Humans; Immunoglobulin A; Immunoglobulin M; Immunosuppressive Agents; Infant; Male; Methotrexate; Metronidazole; Middle Aged; Transplantation, Homologous; Treatment Outcome | 1999 |
The safety and efficacy of cyclosporine (Neoral) in rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome | 1999 |
Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Chronic Disease; Communicable Diseases; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Transplantation, Homologous | 1999 |
A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.
Topics: Acute Disease; Adenoviridae Infections; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antiviral Agents; Bone Marrow Transplantation; Cyclosporine; Cystitis; Cytomegalovirus Infections; Female; Fungemia; Ganciclovir; Graft vs Host Disease; Histocompatibility; Humans; Immunomagnetic Separation; Immunosuppressive Agents; Leukemia; Lung Diseases, Interstitial; Lymphocyte Depletion; Male; Methotrexate; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1999 |
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Drug Combinations; Female; Glucocorticoids; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pilot Projects; Prednisolone; Safety; Survival Rate; Tissue Donors | 2000 |
Influence of cyclosporin A on radiological progression in early rheumatoid arthritis patients: a 42-month prospective study.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Female; Hand; Humans; Hypertension; Male; Methotrexate; Nausea; Prospective Studies; Radiography; Time Factors; Wrist | 2000 |
Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis.
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Outcome Assessment, Health Care; Polymyositis | 2000 |
A randomised study of allogeneic transplantation with stem cells from blood or bone marrow.
Topics: Adolescent; Adult; Bone Marrow Cells; Cyclosporine; Family; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Leukocyte Count; Living Donors; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Platelet Count; Primary Myelofibrosis; Survival Analysis; Transplantation, Homologous | 2000 |
Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Double-Blind Method; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2000 |
Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Cyclosporine; Drug Therapy, Combination; Humans; Injections, Intra-Articular; Methotrexate; Patient Dropouts; Prognosis; Regression Analysis; Sulfasalazine; Therapeutic Equivalency; Treatment Outcome | 2000 |
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Nuclear Family; Survival Analysis; Time Factors; Transplantation, Homologous; Treatment Outcome | 2000 |
Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukapheresis; Male; Melphalan; Methotrexate; Middle Aged; Neoplasms; Prospective Studies; Survival Analysis; T-Lymphocytes; Transplantation Chimera; Transplantation Conditioning; Transplantation Tolerance; Vidarabine | 2000 |
Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methotrexate; Middle Aged; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2000 |
Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study.
Topics: Acute Disease; Adolescent; Adult; Blood Transfusion; Bone and Bones; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Hospitalization; Humans; Infections; Male; Methotrexate; Methylprednisolone; Middle Aged; Necrosis; Nuclear Family; Prospective Studies; Recurrence; Survival Rate | 2000 |
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation.
Topics: Adolescent; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Melphalan; Methotrexate; Microsatellite Repeats; Middle Aged; Nuclear Family; Polymerase Chain Reaction; Recurrence; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2000 |
Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cyclosporine; Cytarabine; Etoposide; Female; Graft vs Tumor Effect; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Pilot Projects; Risk Factors; Survival Rate; Transplantation Chimera; Vidarabine | 2000 |
Treatment with cyclosporin switching to hydroxychloroquine in patients with rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Hydroxychloroquine; Hypertension; Hypertrichosis; Linear Models; Male; Methotrexate; Middle Aged; Pilot Projects; Treatment Outcome | 2001 |
Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunoglobulin G; Male; Methotrexate; Middle Aged; Patient Compliance; Receptors, Tumor Necrosis Factor; Treatment Outcome | 2001 |
Etanercept therapy in children with treatment-resistant uveitis.
Topics: Administration, Topical; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Cyclosporine; Etanercept; Female; Glucocorticoids; Humans; Immunoglobulin G; Injections, Subcutaneous; Male; Methotrexate; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Treatment Outcome; Uveitis, Anterior; Vision Disorders; Visual Acuity | 2001 |
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Infections; Leukemia; Lymphocyte Depletion; Lymphoma; Male; Methotrexate; Middle Aged; Survival Analysis; Time Factors; Tissue Donors; Transplantation, Homologous | 2001 |
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).
Topics: Adolescent; Adult; Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Infection Control; Italy; Life Tables; Male; Methotrexate; Middle Aged; Rabbits; Survival Analysis; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous | 2001 |
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate as acute GVHD prophylaxis after unrelated donor allogeneic bone marrow transplantation].
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Mycophenolic Acid; Transplantation, Heterologous; Young Adult | 2001 |
[A clinical study of haploidentical transplantation using granulocyte colony-stimulating factor stimulating donor bone marrow].
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Haploidy; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Sibling Relations; Stem Cells; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation | 2001 |
Step-down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Joints; Male; Methotrexate; Middle Aged | 2002 |
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
Topics: Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; HLA-DR1 Antigen; Humans; Male; Methotrexate; Middle Aged; Pain; Sulfasalazine | 2002 |
Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infliximab; Male; Methotrexate; Middle Aged; Remission Induction; Treatment Outcome | 2002 |
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.
Topics: Adolescent; Adult; Analgesics; Cause of Death; Costs and Cost Analysis; Cyclosporine; Drug Utilization; Erythrocyte Transfusion; Female; Fever; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Home Nursing; Hospitalization; Humans; Immunosuppressive Agents; Infection Control; Male; Methotrexate; Middle Aged; Pancytopenia; Parenteral Nutrition, Total; Patient Care Team; Patient Isolation; Prednisolone; Quality of Life; Recurrence; Survival Rate; Sweden; Transplantation Conditioning; Treatment Outcome | 2002 |
Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Longitudinal Studies; Male; Methotrexate; Mycoses; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2002 |
Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-gamma and IL-4 expression in psoriatic skin in situ.
Topics: Adult; Aged; Cyclosporine; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; Interferon-gamma; Interleukin-4; Lymphocyte Count; Male; Methotrexate; Middle Aged; Prospective Studies; Psoriasis; T-Lymphocytes | 2003 |
Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Radiography; Severity of Illness Index; Treatment Outcome | 2003 |
Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Radiography; Single-Blind Method; Treatment Outcome | 2003 |
Efficacy and safety of cyclosporine versus methotrexate in severe psoriasis: a study from north India.
Topics: Adult; Cyclosporine; Dermatologic Agents; Drug Administration Schedule; Female; Humans; India; Male; Methotrexate; Middle Aged; Prospective Studies; Psoriasis; Treatment Outcome | 2003 |
Methotrexate vs Cyclosporin A as a single agent for graft-versus-host disease prophylaxis in pediatric patients with hematological malignancies undergoing allogeneic bone marrow transplantation from HLA-identical siblings: a single-center analysis in Japa
Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility Testing; Humans; Infant; Japan; Male; Methotrexate; Siblings; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2003 |
Addition of a low fixed number of CD3+ cells to CD34-enriched allografts: effects on engraftment, graft-versus-host disease, and survival after related and unrelated peripheral stem cell transplantation.
Topics: Adult; Antigens, CD; Antigens, CD34; CD3 Complex; Cell Separation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Stem Cell Transplantation; Survival Analysis; Time Factors; Transplantation, Homologous | 2003 |
Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
Topics: Adult; Chronic Disease; Cyclosporine; Dermatologic Agents; Female; Humans; Male; Methotrexate; Psoriasis; Quality of Life; Severity of Illness Index | 2003 |
An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pain Measurement; Severity of Illness Index; Treatment Outcome | 2005 |
Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors.
Topics: Acute Disease; Adolescent; Area Under Curve; Bayes Theorem; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Histocompatibility; Humans; Incidence; Infant; Male; Methotrexate; Risk Factors; Tissue Donors | 2003 |
Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors.
Topics: Adult; Blood Donors; Cyclosporine; Cytomegalovirus; Graft vs Host Disease; Hematologic Neoplasms; Humans; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Virus Activation | 2004 |
A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Pentostatin; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2004 |
Systemic treatment with either cyclosporin A or methotrexate does not influence the T helper 1/T helper 2 balance in psoriatic patients.
Topics: Adult; CD4 Lymphocyte Count; Cyclosporine; Cytokines; Female; Humans; Interferon-gamma; Interleukin-4; Male; Methotrexate; Middle Aged; Psoriasis; Severity of Illness Index; Th1 Cells; Th2 Cells | 2004 |
Costs of treatment in patients with moderate to severe plaque psoriasis: economic analysis in a randomized controlled comparison of methotrexate and cyclosporine.
Topics: Administration, Oral; Adult; Cost of Illness; Cost-Benefit Analysis; Cyclosporine; Dermatology; Drug Administration Schedule; Drug Costs; Female; Health Care Costs; Hospital Costs; Humans; Immunosuppressive Agents; Male; Methotrexate; Netherlands; Outpatient Clinics, Hospital; Psoriasis; Severity of Illness Index; Treatment Outcome | 2004 |
Cyclosporine alone vs cyclosporine plus methotrexate for post-transplant immunosuppression after HLA-identical sibling bone marrow transplantation: a randomized prospective study.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prospective Studies; Recurrence; Siblings; Survival Rate; Tissue Donors | 2004 |
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation.
Topics: Adult; Antineoplastic Agents, Alkylating; Bone Marrow Transplantation; Busulfan; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Methotrexate; Middle Aged; Mycophenolic Acid; Prospective Studies; Survival Rate; Transplantation, Homologous; Treatment Outcome | 2004 |
A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Quality of Life; Severity of Illness Index; Treatment Outcome | 2005 |
Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate | 2005 |
An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab.
Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Infliximab; Lymphocyte Activation; Male; Methotrexate; Middle Aged; Pilot Projects; Receptors, Interleukin-2; Severity of Illness Index; Treatment Failure; Treatment Outcome; Tumor Necrosis Factor-alpha | 2006 |
Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Topics: Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia; Methotrexate; Premedication; Prevalence; Survival Analysis | 2005 |
Outcome of pediatric hematopoietic stem cell transplantations from Thai unrelated donors matched with high-resolution HLA typing.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; DNA Fingerprinting; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Middle Aged; Premedication; Risk Factors; Survival Analysis; Thailand; Tissue Donors; Treatment Failure; Treatment Outcome | 2005 |
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Forced Expiratory Volume; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Karnofsky Performance Status; Leukemia; Life Tables; Lung Diseases; Male; Methotrexate; Middle Aged; Neural Tube Defects; Premedication; Prospective Studies; Recurrence; Survival Analysis; T-Lymphocytes; Transplantation, Homologous; Treatment Outcome; Vital Capacity | 2006 |
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, par
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Betamethasone; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intra-Articular; Male; Methotrexate; Middle Aged | 2006 |
Low-dose cyclosporin A with short-term methotrexate for graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation from human leukocyte antigen-identical siblings: a prospective phase II study in Japanese patients.
Topics: Adolescent; Adult; Asian People; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; HLA Antigens; Humans; Immunosuppressive Agents; Japan; Male; Methotrexate; Middle Aged; Prospective Studies; Recurrence; Siblings; Transplantation, Homologous | 2006 |
Approaches to discontinuing efalizumab: an open-label study of therapies for managing inflammatory recurrence.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pilot Projects; Prospective Studies; Psoriasis; Recurrence; Retinoids; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Withholding Treatment | 2006 |
Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults.
Topics: Adolescent; Adult; Aged; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Survival Rate; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2007 |
Social support, optimism, and self-efficacy predict physical and emotional well-being after bone marrow transplantation.
Topics: Adolescent; Adult; Affect; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Physical Fitness; Psychology; Self Efficacy; Social Support | 2007 |
[Peripheral blood stem cell transplantation for 53 patients with malignant hematologic diseases].
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2007 |
Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
Topics: Adult; Aged; Busulfan; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphocyte Count; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Postoperative Complications; Prospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2007 |
Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Foot Joints; Glucocorticoids; Hand Joints; Humans; Logistic Models; Male; Methotrexate; Middle Aged; Prednisolone; Quality of Life; Radiography; Treatment Outcome | 2008 |
The added therapeutic efficacy and safety of alefacept in combination with other (systemic) anti-psoriatics in refractory psoriasis.
Topics: Acitretin; Adult; Aged; Alefacept; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Recombinant Fusion Proteins; Treatment Outcome | 2006 |
Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphocyte Depletion; Lymphocyte Transfusion; Male; Melphalan; Methotrexate; Middle Aged; Multivariate Analysis; Myeloablative Agonists; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2007 |
Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Betamethasone; Combined Modality Therapy; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Injections, Intra-Articular; Male; Methotrexate; Middle Aged; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2008 |
Methotrexate vs. ciclosporin in psoriasis: effectiveness, quality of life and safety. A randomized controlled trial.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome | 2008 |
Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host
Topics: Adolescent; Adult; Aspergillosis; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Lymphocyte Depletion; Male; Methotrexate; Opportunistic Infections; Retrospective Studies; Survival Analysis; Transplantation, Homologous | 2007 |
Achievement of target cyclosporine concentrations as a predictor of severe acute graft versus host disease in children undergoing hematopoietic stem cell transplantation and receiving cyclosporine and methotrexate prophylaxis.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Logistic Models; Male; Methotrexate; Multivariate Analysis; Retrospective Studies; Risk Factors | 2007 |
Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants.
Topics: Adolescent; Adult; Bone Density; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 2008 |
Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Survival Rate; Transplantation Conditioning | 2008 |
A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis.
Topics: Adult; Alefacept; CD4 Lymphocyte Count; Cyclosporine; Dermatologic Agents; Drug Administration Routes; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Infections; Lymphopenia; Male; Methotrexate; Middle Aged; Neoplasms; Psoriasis; Recombinant Fusion Proteins; Retinoids; Retreatment; Treatment Outcome; Ultraviolet Therapy | 2008 |
Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2008 |
Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Prognosis; Treatment Outcome | 2009 |
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Topics: Adolescent; Adult; Antilymphocyte Serum; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prospective Studies; Regression Analysis; Survival Analysis; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous | 2009 |
Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus.
Topics: Adolescent; Blood Glucose; Child; Cyclosporine; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Male; Methotrexate; Pilot Projects; Remission Induction | 2010 |
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Biomarkers; Bone Marrow Diseases; Cyclosporine; Disease Progression; Drug Therapy, Combination; Edema; Epidemiologic Methods; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Prognosis; Radiography; Remission Induction | 2010 |
The effect of anti-TNF treatment on the immunogenicity and safety of the 7-valent conjugate pneumococcal vaccine in children with juvenile idiopathic arthritis.
Topics: Adolescent; Antibodies, Bacterial; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Cyclosporine; Female; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Male; Methotrexate; Pneumococcal Vaccines; Prednisone; Tumor Necrosis Factor-alpha; Vaccines, Conjugate | 2010 |
Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study.
Topics: Administration, Oral; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Female; Humans; Injections, Subcutaneous; Male; Methotrexate; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2010 |
Etanercept plus ciclosporin versus etanercept plus methotrexate for maintaining clinical control over psoriatic arthritis: a randomised pilot study.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Male; Methotrexate; Middle Aged; Pilot Projects; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Treatment Outcome | 2011 |
Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study.
Topics: Cyclosporine; Humans; Methotrexate; Nail Diseases; Psoriasis; Single-Blind Method | 2011 |
Allogeneic hematopoietic stem cell transplantation for childhood aplastic anemia: prospective trial in China.
Topics: Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Cell Survival; Child; Child, Preschool; China; Combined Modality Therapy; Cyclosporine; Female; Filgrastim; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Histocompatibility Testing; Humans; Immunosuppressive Agents; Living Donors; Male; Methotrexate; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Siblings; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2011 |
A global approach to psoriatic patients through PASI score and Skindex-29.
Topics: Acitretin; Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatologic Agents; Diagnostic Self Evaluation; Emotions; Etanercept; Female; Folic Acid; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Interpersonal Relations; Male; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Quality of Life; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2011 |
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Methotrexate; Middle Aged; Pilot Projects; Sirolimus; Tacrolimus; Transplantation, Homologous; Young Adult | 2011 |
Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt.
Topics: Administration, Oral; Adolescent; Child; Cyclosporine; Dermatitis, Atopic; Drug Administration Schedule; Egypt; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Severity of Illness Index; Treatment Outcome | 2013 |
Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies.
Topics: Adult; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Prospective Studies; Risk; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Whole-Body Irradiation | 2013 |
Standard pentostatin dose reductions in renal insufficiency are not adequate: selected patients with steroid-refractory acute graft-versus-host disease.
Topics: Adenosine Deaminase Inhibitors; Adult; Antibodies, Monoclonal; Area Under Curve; Blood Transfusion, Autologous; Creatinine; Cyclosporine; Drug Resistance; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infliximab; Lymphocyte Transfusion; Male; Methotrexate; Methylprednisolone; Middle Aged; Pentostatin; Renal Insufficiency; Stem Cell Transplantation; Tacrolimus; Young Adult | 2013 |
Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
Topics: Adult; Aged; Alendronate; Antirheumatic Agents; Arthritis, Rheumatoid; Betamethasone; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Cyclosporine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intra-Articular; Lumbar Vertebrae; Male; Methotrexate; Middle Aged; Radiography; Treatment Outcome; Young Adult | 2014 |
Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation.
Topics: Adult; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prospective Studies; Siblings; Tissue Donors; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2013 |
Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
Topics: Adult; Aged; Antibodies, Anti-Idiotypic; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; CD4-Positive T-Lymphocytes; Chemokine CCL19; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Methotrexate; Middle Aged; Monocytes; Peptides, Cyclic; Radiography; Receptors, CCR7; Severity of Illness Index; Treatment Outcome; Up-Regulation | 2014 |
Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis.
Topics: Aged; Antibodies, Anti-Idiotypic; Arthritis, Rheumatoid; Betamethasone; Biomarkers; Case-Control Studies; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interleukins; Longitudinal Studies; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Programmed Cell Death 1 Receptor; Radiography; Rheumatoid Factor; Severity of Illness Index | 2014 |
ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; Cyclosporine; Disease Progression; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Prednisolone; Quality of Life | 2014 |
Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG).
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Combinations; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Risk Factors; Transplantation Conditioning; Young Adult | 2014 |
Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis.
Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Risk Factors; Sulfasalazine; Time Factors; Treatment Outcome | 2014 |
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lymphocyte Count; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Single-Blind Method; Surveys and Questionnaires; T-Lymphocytes, Regulatory; Tacrolimus; Th17 Cells; Treatment Outcome | 2015 |
Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Certolizumab Pegol; Cholesterol; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Lipid Metabolism; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Sulfasalazine; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha | 2014 |
Second-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids.
Topics: Adrenal Cortex Hormones; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Myositis; Treatment Outcome | 2015 |
Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study.
Topics: Adult; Aged; Allografts; Anti-Inflammatory Agents; Cannabidiol; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Prospective Studies; Young Adult | 2015 |
Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation.
Topics: Acute Disease; Adolescent; Adult; Allografts; Child; Child, Preschool; Cyclosporine; Europe; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Incidence; Male; Methotrexate; Middle East; Neutropenia; Retrospective Studies; Societies, Medical; Unrelated Donors | 2015 |
Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical Trials.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Biological Products; Cyclosporine; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Severity of Illness Index; Treatment Outcome | 2016 |
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.
Topics: Adolescent; Analysis of Variance; Anti-Inflammatory Agents; Child; Child, Preschool; Cyclosporine; Dermatologic Agents; Dermatomyositis; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Prednisone; Treatment Outcome | 2016 |
A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Methotrexate; Middle Aged; Neutrophils; Platelet Count; Premedication; Sirolimus; Tacrolimus; Transplantation, Homologous; Treatment Outcome; Young Adult | 2016 |
Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis:
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Betamethasone; Bone Diseases; Cyclosporine; Double-Blind Method; Drug Administration Routes; Drug Delivery Systems; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Patient Acuity; Synovitis; Tendinopathy; Treatment Outcome | 2017 |
The objective Psoriasis Area and Severity Index: a randomized controlled pilot study comparing the effectiveness of ciclosporin and methotrexate.
Topics: Cyclosporine; Dermatologic Agents; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Pilot Projects; Psoriasis; Treatment Outcome | 2017 |
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.
Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Prospective Studies; Recurrence; Remission Induction; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Haploidentical; Unrelated Donors; Vidarabine | 2017 |
Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins; Male; Methotrexate; Middle Aged; T-Lymphocytes; Time Factors; Treatment Outcome; Young Adult | 2017 |
A randomized study of cyclosporine and methotrexate with or without methylprednisolone for the prevention of graft-versus-host disease: Improved long-term survival with triple prophylaxis.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Transplantation, Homologous; Young Adult | 2018 |
A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT).
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cost-Benefit Analysis; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Female; Filaggrin Proteins; Humans; Intermediate Filament Proteins; Male; Methotrexate; Multicenter Studies as Topic; Pragmatic Clinical Trials as Topic; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2018 |
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
Topics: Analysis of Variance; Anti-Inflammatory Agents; Child; Child, Preschool; Cyclosporine; Dermatologic Agents; Dermatomyositis; Drug Substitution; Drug Therapy, Combination; Humans; Methotrexate; Prednisone; Single-Blind Method | 2019 |
Effects of Interleukin 17A Inhibition on Myocardial Deformation and Vascular Function in Psoriasis.
Topics: Antibodies, Monoclonal, Humanized; Biomarkers; Brachial Artery; Cyclosporine; Echocardiography; Female; Heart Ventricles; Humans; Immunosuppressive Agents; Interleukin-17; Male; Methotrexate; Middle Aged; Prognosis; Psoriasis; Pulse Wave Analysis; Vascular Stiffness; Ventricular Function, Left | 2020 |
Methotrexate pharmacokinetic is influenced by co-administration of cyclosporin in rheumatoid arthritis patients. Results from a randomized clinical trial.
Topics: Adult; Aged; Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Early Diagnosis; Erythrocytes; Female; Glomerular Filtration Rate; Humans; Male; Methotrexate; Middle Aged; Treatment Outcome | 2020 |
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Patient Reported Outcome Measures; Peripheral Blood Stem Cell Transplantation; T-Lymphocytes; Tacrolimus; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Young Adult | 2020 |
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Topics: Adult; Allografts; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Pentostatin; Photopheresis; Tacrolimus; Transplantation Conditioning; Whole-Body Irradiation | 2020 |
Cyclosporine or methotrexate, which one is more promising in the treatment of lichen planopilaris?; A comparative clinical trial.
Topics: Adult; Alopecia; Cyclosporine; Female; Humans; Iran; Lichen Planus; Male; Methotrexate; Middle Aged; Treatment Outcome | 2020 |
Combination of Low-Dose, Short-Course Mycophenolate Mofetil With Cyclosporine and Methotrexate for Graft-Versus-Host Disease Prophylaxis in Allogeneic Stem Cell Transplant.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Methotrexate; Mycophenolic Acid; Prospective Studies; Stem Cell Transplantation; Treatment Outcome | 2021 |
Efficacy of folinic acid rescue following MTX GVHD prophylaxis: results of a double-blind, randomized, controlled study.
Topics: Cyclosporine; Double-Blind Method; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leucovorin; Methotrexate | 2020 |
Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Sirolimus; Stomatitis; Tacrolimus | 2021 |
Safety and efficacy profile of oral cyclosporine vs oral methotrexate vs oral acitretin in palmoplantar psoriasis: A hospital based prospective investigator blind randomized controlled comparative study.
Topics: Acitretin; Cyclosporine; Hospitals; Humans; Methotrexate; Prospective Studies; Psoriasis; Quality of Life; Severity of Illness Index; Treatment Outcome | 2021 |
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Cyclosporine; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Placebo Effect; Transplantation, Homologous; Treatment Outcome | 2021 |
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial.
Topics: Adolescent; Child; Cyclosporine; Dermatitis, Atopic; Double-Blind Method; Filaggrin Proteins; Humans; Methotrexate; Odds Ratio; Severity of Illness Index; Treatment Outcome | 2023 |
638 other study(ies) available for methotrexate and cyclosporine
| Article | Year |
|---|---|
Highly predictive and interpretable models for PAMPA permeability.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Humans; Models, Biological; Organic Chemicals; Regression Analysis; Support Vector Machine | 2017 |
Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
Topics: Animals; Computer Simulation; Databases, Factual; Drug Discovery; High-Throughput Screening Assays; Liver; Machine Learning; Male; Microsomes, Liver; National Center for Advancing Translational Sciences (U.S.); Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Retrospective Studies; United States | 2020 |
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |
Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport.
Topics: 3T3 Cells; Animals; ATP-Binding Cassette Transporters; Biological Transport; Drug Resistance, Multiple; Folic Acid; Humans; Leucovorin; Methotrexate; Mice; Multidrug Resistance-Associated Proteins; Osmolar Concentration; Polyglutamic Acid; Tritium | 2001 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Characterization of the transport properties of human multidrug resistance protein 7 (MRP7, ABCC10).
Topics: Biological Transport; Cells, Cultured; Cyclosporine; Estradiol; Glycocholic Acid; Humans; Kinetics; Leukotriene Antagonists; Leukotriene C4; Multidrug Resistance-Associated Proteins; Osmotic Pressure; Propionates; Quinolines; Recombinant Proteins; Transfection | 2003 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide.
Topics: Animals; Evolution, Molecular; Glycosylation; Gonadal Steroid Hormones; HEK293 Cells; Humans; Ion Transport; Organic Anion Transporters; Protein Multimerization; Zebrafish; Zebrafish Proteins | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Discovery of a Novel Potent and Selective Calcium Release-Activated Calcium Channel Inhibitor: 2,6-Difluoro-
Topics: Administration, Oral; Animals; Area Under Curve; Arthritis, Rheumatoid; Calcium; Calcium Channel Blockers; Calcium Release Activated Calcium Channels; Clinical Trials, Phase I as Topic; Drug Discovery; Humans; Jurkat Cells; Male; Mice; Mice, Inbred BALB C; Rats; Rats, Inbred Lew; Structure-Activity Relationship | 2021 |
Allogeneic bone marrow transplantation: the Huddinge experience.
Topics: Adult; Anemia; Bone Marrow Transplantation; Candidiasis; Child; Cyclosporine; Cytomegalovirus Infections; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia; Male; Methotrexate; Neoplasms; Retrospective Studies; Risk Factors; Sweden; Transplantation, Homologous | 1992 |
Strong donor mononuclear cell reactivity for herpes simplex virus antigen in immune donor/recipient pairs is associated with acute graft-versus-host disease.
Topics: Acute Disease; Adult; Antigens, Viral; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukocytes, Mononuclear; Lymphocyte Depletion; Male; Methotrexate; Simplexvirus | 1992 |
Inclusion body myositis: analysis of 32 cases.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Biopsy; Cyclosporine; Demography; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Inclusion Bodies; Male; Methotrexate; Middle Aged; Muscles; Myositis; Prednisone; Retrospective Studies; Time Factors | 1992 |
Prevention and therapy of graft-versus-host disease. Report from a work-shop.
Topics: Bone Marrow Transplantation; Clinical Trials as Topic; Cyclosporine; Graft vs Host Disease; Humans; Lymphocyte Depletion; Methotrexate; T-Lymphocytes | 1992 |
Possible role of histamine in pathogenesis of autoimmune diseases: implications for immunotherapy with histamine-2 receptor antagonists.
Topics: Autoimmune Diseases; Autoimmunity; Cyclosporine; Histamine; Histamine H2 Antagonists; Humans; Immunity, Cellular; Immunotherapy; Major Histocompatibility Complex; Methotrexate; Models, Biological; Psoriasis; T-Lymphocytes | 1992 |
[Bone marrow transplantation for therapy of leukemia].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Leukemia; Male; Methotrexate; Middle Aged; Pulmonary Fibrosis; Survival Rate | 1992 |
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; DNA, Neoplasm; Drug Therapy, Combination; Female; Fusion Proteins, bcr-abl; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Prognosis; Recurrence; RNA, Messenger; Transcription, Genetic | 1992 |
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Leukemia; Lymphoma; Male; Methotrexate; Multivariate Analysis; Retrospective Studies; Risk Factors; Sex Factors; Survival Analysis; Tissue Donors; Transplantation, Homologous; Whole-Body Irradiation | 1992 |
Pneumocystis carinii pneumonia following cyclosporine A and methotrexate treated rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Methotrexate; Pneumonia, Pneumocystis | 1992 |
Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation.
Topics: Adolescent; Adult; Aged; Bacteria, Anaerobic; Bone Marrow Transplantation; Child; Cyclosporine; Family; Female; Graft vs Host Disease; Humans; Intestines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Tissue Donors | 1992 |
How to improve the risk-benefit ratio of cyclosporin therapy for psoriasis.
Topics: Cyclosporine; Drug Therapy, Combination; Humans; Kidney Diseases; Methotrexate; Psoriasis; PUVA Therapy; Retinoids | 1992 |
Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle Osseuse.
Topics: Acute Disease; Adolescent; Analysis of Variance; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Humans; Infant; Leukemia, Myeloid; Male; Methotrexate; Regression Analysis; Retrospective Studies; Transplantation, Homologous; Treatment Outcome | 1992 |
Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Leukemia; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Recurrence | 1992 |
Oral and nutritional status in allogeneic marrow recipients treated with T-cell depletion or cyclosporine combined with methotrexate to prevent graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Candidiasis, Oral; Chi-Square Distribution; Cyclosporine; Facial Pain; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Mouth Diseases; Mouth Mucosa; Nutritional Status; Oral Hemorrhage; Random Allocation; Stomatitis, Herpetic | 1992 |
Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; HLA Antigens; Humans; Infant; Male; Methotrexate; Middle Aged; Neoplasms; Survival Rate | 1992 |
Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.
Topics: ABO Blood-Group System; Adult; Anemia, Aplastic; Antibodies; Blood Component Transfusion; Blood Group Incompatibility; Bone Marrow Transplantation; Coombs Test; Cyclosporine; Hemolysis; Humans; Immunosuppression Therapy; Leukemia; Methotrexate; Middle Aged; Myelodysplastic Syndromes | 1992 |
Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Infant; Male; Methotrexate; Whole-Body Irradiation | 1992 |
An effective acute graft-vs.-host disease prophylaxis with minidose methotrexate, cyclosporine, and single-dose methylprednisolone.
Topics: Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Graft vs Host Disease; Humans; Leukemia; Methotrexate; Methylprednisolone; Multiple Myeloma; Myelodysplastic Syndromes | 1991 |
[The analysis of leukemic relapse after allogeneic bone marrow transplantation].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Postoperative Complications; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Rate; Transplantation, Homologous | 1991 |
Suppression of collagen-induced arthritis by combination cyclosporin A and methotrexate therapy.
Topics: Animals; Antibodies; Arthritis; Collagen; Cyclosporine; Drug Therapy, Combination; Female; Hypersensitivity, Delayed; Methotrexate; Radiography; Rats | 1991 |
Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: long-term follow-up.
Topics: Abdomen; Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Male; Methotrexate; Middle Aged; Multivariate Analysis; Thorax | 1991 |
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate | 1995 |
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate | 1995 |
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate | 1995 |
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Topics: Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate | 1995 |
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lymphoma; Methotrexate | 1995 |
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate | 1995 |
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hemolysis; Humans; Hypertension; Immunosuppressive Agents; L-Lactate Dehydrogenase; Male; Methotrexate; Methylprednisolone; Middle Aged; Nervous System Diseases; Plasmapheresis; Platelet Count; Retrospective Studies; Syndrome; Transplantation, Homologous; Vascular Diseases | 1995 |
Re: Severe interaction between methotrexate and a macrolide-like antibiotic.
Topics: Bone Marrow Transplantation; Cyclosporine; Drug Administration Schedule; Drug Interactions; Humans; Immunosuppressive Agents; Methotrexate; Tacrolimus | 1995 |
Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Male; Melphalan; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Whole-Body Irradiation | 1995 |
Treatment of recalcitrant cardiac allograft rejection with methotrexate. Cardiac Transplant Team.
Topics: Administration, Oral; Azathioprine; Bacterial Infections; Case-Control Studies; Combined Modality Therapy; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Leukocyte Count; Lymphatic Irradiation; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Transplantation, Homologous | 1995 |
In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Lymphocyte Depletion; Lymphocytosis; Male; Methotrexate; Middle Aged; Pneumonia, Viral; T-Lymphocytes; Transplantation, Homologous | 1995 |
Whether methotrexate administration in graft-versus-host disease prophylaxis significantly delays the engraftment in allogeneic peripheral blood progenitor cell transplantation.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Cyclosporine; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Methotrexate; Middle Aged | 1995 |
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Histocompatibility; Humans; Leukemia; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis | 1995 |
Antithymocyte globulin and methotrexate therapy of severe or persistent cardiac allograft rejection.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Evaluation Studies as Topic; Female; Graft Rejection; Heart Transplantation; Humans; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Treatment Outcome | 1995 |
Hematopoietic growth factors in rheumatoid arthritis: a critical approach to their use in view of possible adverse effects.
Topics: Adult; Arthritis, Rheumatoid; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leucovorin; Leukemia, Myeloid, Acute; Methotrexate; Neutropenia; Prednisolone | 1993 |
Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Male; Methotrexate; Middle Aged; Tumor Virus Infections | 1995 |
[Psoriasis: diagnosis and therapy].
Topics: Combined Modality Therapy; Cyclosporine; Dermatologic Agents; Humans; Methotrexate; Psoriasis; Psychotherapy; PUVA Therapy; Retinoids | 1995 |
New perspectives on treating rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Drug Therapy, Combination; Humans; Methotrexate; Prednisolone | 1995 |
Therapeutic trials in primary biliary cirrhosis.
Topics: Bilirubin; Clinical Trials as Topic; Colchicine; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Humans; Liver; Liver Cirrhosis, Biliary; Methotrexate; Prognosis; Ursodeoxycholic Acid | 1994 |
Ultrasound imaging of psoriatic skin: a noninvasive technique to evaluate treatment of psoriasis.
Topics: Adult; Aged; Cell Division; Cyclosporine; Drug Combinations; Epidermis; Female; Follow-Up Studies; Glucosamine; Humans; Male; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Skin; Sulfasalazine; Ultrasonography | 1994 |
Reusable influence diagrams.
Topics: Acute Disease; Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Artificial Intelligence; Bayes Theorem; Bone Marrow Transplantation; Child; Cyclosporine; Decision Support Techniques; Expert Systems; Graft vs Host Disease; Humans; Leukemia, Myeloid; Methotrexate; Models, Biological; Neural Networks, Computer; Patient Care Planning; Prognosis; Sex Factors; Systems Integration | 1994 |
Prolonged survival of cardiac xenografts between widely divergent species: bird to mammal.
Topics: Animals; Chickens; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Graft Rejection; Graft Survival; Guinea Pigs; Heart Transplantation; Immunosuppression Therapy; Methotrexate; Rats; Rats, Inbred ACI; Species Specificity; Time Factors; Transplantation, Heterologous | 1995 |
Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
Topics: Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Daunorubicin; Drug Resistance; Flow Cytometry; Gene Expression; Humans; Leukemia, Erythroblastic, Acute; Membrane Glycoproteins; Methotrexate; Neoplasm Proteins; Tumor Cells, Cultured; Verapamil; Vinblastine | 1993 |
Primary biliary cirrhosis: how should we evaluate new treatments?
Topics: Clinical Trials as Topic; Colchicine; Cyclosporine; Humans; Liver Cirrhosis, Biliary; Methotrexate; Prognosis; Survival Analysis; Ursodeoxycholic Acid | 1994 |
Bone marrow transplantation in Hong Kong.
Topics: Bone Marrow Transplantation; Cyclosporine; Family Health; Graft vs Host Disease; Histocompatibility; Hong Kong; Humans; Methotrexate; Middle Aged; National Health Programs; Tissue Donors; Transplantation, Autologous; Transplantation, Homologous | 1994 |
Addition of low-dose folinic acid to a methotrexate/cyclosporin A regimen for prevention of acute graft-versus-host disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Humans; Leucovorin; Leukemia; Male; Methotrexate; Middle Aged; Transplantation, Homologous | 1994 |
Bone marrow transplantation for primary refractory acute leukaemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Remission Induction; Survival Rate | 1994 |
Prolongation of survival of heterotopic heart xenografts by antibody and complement suppression in primates.
Topics: Animals; Antibody Formation; Chlorocebus aethiops; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Methotrexate; Papio; Transplantation, Heterologous; Transplantation, Heterotopic | 1994 |
Graft adaptation in hamster-to-rat cardiac xenografts.
Topics: Animals; Cricetinae; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Mesocricetus; Methotrexate; Rats; Rats, Inbred Strains; Time Factors; Transplantation, Heterologous | 1994 |
Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients.
Topics: Adolescent; Adult; Age Factors; Analysis of Variance; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Graft vs Host Disease; Herpesviridae Infections; Histocompatibility Testing; Humans; Infant; Leukemia; Lymphocyte Depletion; Methotrexate; Middle Aged; Multivariate Analysis; Regression Analysis; Risk Factors; Transplantation, Homologous | 1994 |
Prevention of graft-versus-host disease on an individual basis.
Topics: Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Leukemia; Methotrexate; Retrospective Studies; Risk Factors | 1994 |
Diminished cytotoxic gene expression in rat cardiac transplants with low-dose cyclosporine/methotrexate combination therapy.
Topics: Animals; Blotting, Northern; Cells, Cultured; Cyclosporine; Cytokines; Cytotoxicity, Immunologic; DNA Probes; Drug Therapy, Combination; Female; Gene Expression; Graft Rejection; Heart Transplantation; Male; Methotrexate; Myocardium; Pregnancy; Rats; Rats, Inbred BN; Rats, Inbred Lew; RNA, Messenger; Serine Endopeptidases; Transplantation, Homologous | 1994 |
Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Neoplasm; Bone Marrow Transplantation; CD52 Antigen; Complement System Proteins; Cyclosporine; Female; Glycoproteins; Graft Rejection; Graft vs Host Disease; Humans; Leukemia; Lymphocyte Depletion; Male; Methotrexate; T-Lymphocytes | 1994 |
Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Topics: Adolescent; Adult; Age Factors; Aged; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies; Risk Factors; Survival Rate | 1994 |
Successful bone marrow transplant for a patient with T-lymphoblastic lymphoma in second remission preconditioned by total-body irradiation plus melphalan and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Etoposide; Graft vs Host Disease; Humans; Male; Melphalan; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Whole-Body Irradiation | 1994 |
Bone marrow transplantation in Thailand.
Topics: Anemia, Aplastic; Blood Transfusion; Bone Marrow Transplantation; Cyclosporine; Fetal Blood; Graft vs Host Disease; Histocompatibility Testing; Humans; Incidence; Leukemia; Methotrexate; Thailand; Thalassemia; Transplantation, Homologous | 1994 |
Immunoblastic lymphadenopathy in a five-month-old girl: successful treatment with immunosuppressants.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunoblastic Lymphadenopathy; Immunosuppressive Agents; Infant; Interferon-alpha; Lymph Nodes; Mercaptopurine; Methotrexate; Recurrence; Remission Induction | 1994 |
Use of low-dose cyclosporine A/methotrexate to prolong rat cardiac allograft survival.
Topics: Animals; Cyclosporine; Ear; Graft Rejection; Graft Survival; Heart Rate; Heart Transplantation; Interleukin-2; Male; Methotrexate; Rats; Rats, Inbred BN; Rats, Inbred Lew; Transplantation, Heterotopic | 1993 |
Adjusted-dose continuous-infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Amphotericin B; Bone Marrow Transplantation; Creatinine; Cyclosporine; Drug Combinations; Female; Graft vs Host Disease; Humans; Infusion Pumps; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Postoperative Care; Transplantation, Homologous | 1994 |
Immunosuppression: preliminary results of alternative maintenance therapy for familial hemophagocytic lymphohistocytosis (FHL).
Topics: Cyclosporine; Drug Therapy, Combination; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Prednisone | 1994 |
Pulmonary arterial hypertension responsive to immunosuppressive therapy in systemic lupus erythematosus.
Topics: Adult; Blood Pressure; Cyclosporine; Dexamethasone; Drug Therapy, Combination; Echocardiography, Doppler; Female; Fluocortolone; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Pulmonary Artery | 1993 |
Cytotoxic T lymphocyte precursor frequency does not correlate with either the incidence or severity of graft-versus-host disease after matched unrelated donor bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclosporine; Graft Survival; Graft vs Host Disease; Humans; Incidence; Methotrexate; Prednisone; Prospective Studies; PUVA Therapy; Retrospective Studies; Severity of Illness Index; Stem Cells; T-Lymphocytes, Cytotoxic; Tissue Donors | 1994 |
Cyclosporine monitoring improves graft-versus-host disease prophylaxis after bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Chromatography, High Pressure Liquid; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Humans; Male; Methotrexate; Retrospective Studies; Time Factors | 1994 |
Cold agglutinin disease following allogeneic bone marrow transplantation.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Incidence; Male; Methotrexate; Prednisolone; Transplantation, Homologous | 1994 |
Elevated levels of TNF in the joints of adjuvant arthritic rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Biological Assay; Cells, Cultured; Cyclosporine; Edema; Freund's Adjuvant; Ibuprofen; Isoxazoles; Joints; L Cells; Leflunomide; Macrophages, Peritoneal; Male; Methotrexate; Mice; Mycobacterium tuberculosis; Rabbits; Rats; Rats, Inbred Lew; Tumor Necrosis Factor-alpha | 1993 |
Bone marrow transplantation for chronic myeloid leukemia: long-term results. Chronic Leukemia Working Party of the European Group for Bone Marrow Transplantation.
Topics: Adult; Age Factors; Bone Marrow Transplantation; Cohort Studies; Cyclosporine; Family Health; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Retrospective Studies; Surveys and Questionnaires; Survival Rate; Time Factors; Tissue Donors | 1993 |
Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease.
Topics: Adolescent; Adult; Bone Marrow Cells; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppression Therapy; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Retrospective Studies | 1993 |
Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
Topics: Adolescent; Adult; Attitude of Health Personnel; Azathioprine; Child; Colitis; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Gastroenterology; Health Surveys; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methotrexate; Pediatrics; Remission Induction; Retrospective Studies; Societies, Medical; Surveys and Questionnaires | 1993 |
Rate of marrow engraftment does not appear to be adversely affected by early marrow infusion after total body irradiation.
Topics: Bone Marrow; Bone Marrow Cells; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Humans; Methotrexate; Time Factors; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation | 1993 |
Acute graft-versus-host disease prophylaxis with methotrexate and cyclosporine after busulfan and cyclophosphamide in patients with hematologic malignancies.
Topics: Adult; Busulfan; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Time Factors | 1993 |
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Infant; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1993 |
Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures.
Topics: Animals; Antineoplastic Agents; Azathioprine; Colchicine; Cyclophosphamide; Cyclosporine; Cytarabine; Daunorubicin; Erythropoietin; Humans; Ifosfamide; Immunosuppressive Agents; L-Lactate Dehydrogenase; Liver Neoplasms, Experimental; Methotrexate; Organoplatinum Compounds; Tetrazolium Salts; Tumor Cells, Cultured; Vincristine | 1993 |
Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate.
Topics: Animals; Antibodies, Anti-Idiotypic; Antibody Formation; Cricetinae; Cyclophosphamide; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppression Therapy; Mesocricetus; Methotrexate; Rats; Rats, Inbred Strains; Transplantation, Heterologous; Transplantation, Heterotopic | 1993 |
Cutaneous malignancy related to cyclosporin A therapy.
Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Humans; Male; Methotrexate; Psoriasis; Skin Neoplasms | 1993 |
Influence of HLA-DPB1 disparity on the development of acute graft-versus-host disease following unrelated donor marrow transplantation.
Topics: Alleles; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; HLA-DP Antigens; HLA-DP beta-Chains; Humans; Leukemia; Methotrexate; Transplantation, Homologous | 1993 |
The annual cost of psoriasis.
Topics: Adult; Cyclosporine; Etretinate; Female; Health Care Costs; Humans; Hydroxyurea; Male; Methotrexate; Middle Aged; Phototherapy; Psoriasis; PUVA Therapy; Retrospective Studies; Ultraviolet Therapy | 1993 |
Bone marrow transplantation from unrelated donors: the Italian experience. GITMO, AIEOP and IBMDR.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Graft vs Host Disease; Histocompatibility; HLA Antigens; Humans; Infant; Italy; Leukemia; Methotrexate; Middle Aged; Tissue Donors; Transplantation, Homologous | 1993 |
[Red cell fragmentation syndrome after bone marrow transplantation presumed to be caused by cyclosporin A].
Topics: Adult; Anemia, Hemolytic; Bone Marrow Transplantation; Cyclosporine; Erythrocytes; Female; Humans; Methotrexate; Syndrome | 1993 |
[Therapy of Wegener's granulomatosis. Experiences with conventional and stage-adjusted treatment in 111 patients over 24 years].
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisolone; Quality of Life; Retrospective Studies; Survival Rate; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
Predictors and the rate of medical treatment failure in ulcerative colitis.
Topics: Adult; Aminosalicylic Acids; Colitis, Ulcerative; Cyclosporine; Discriminant Analysis; Female; Humans; Male; Mesalamine; Methotrexate; Prognosis; Risk Factors; Steroids; Treatment Failure | 1993 |
Risk factors for acute graft-versus-host disease associated with cyclosporine and methotrexate prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Graft vs Host Disease; Humans; Methotrexate; Middle Aged; Risk Factors | 1993 |
Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Histocompatibility; Humans; Leukemia, Myeloid; Life Tables; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Remission Induction; Salvage Therapy; Survival Rate; Transplantation, Homologous; Whole-Body Irradiation | 1996 |
Allogeneic bone marrow transplatation in a patient with Shwachman-Diamond syndrome.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Exocrine Pancreatic Insufficiency; Fatal Outcome; Female; Graft vs Host Disease; Humans; Leukemia, Myelomonocytic, Acute; Male; Methotrexate; Pregnancy; Syndrome | 1996 |
Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Apoptosis; Cycloheximide; Cyclosporine; Dose-Response Relationship, Drug; Doxorubicin; Fas Ligand Protein; fas Receptor; Humans; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Methotrexate; Protein Synthesis Inhibitors; Tumor Cells, Cultured | 1996 |
Cardiac xenotransplantation into complement 5-deficient mice.
Topics: Animals; Complement C5; Cricetinae; Cyclophosphamide; Cyclosporine; Heart Transplantation; Immunosuppressive Agents; Mesocricetus; Methotrexate; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Species Specificity; Transplantation, Heterologous | 1996 |
Histological findings in heart grafts after orthotopic pig to baboon cardiac transplantation.
Topics: Animals; Animals, Newborn; Cyclosporine; Edema; Female; Graft Rejection; Graft Survival; Guanidines; Heart Transplantation; Hemorrhage; Immunosuppressive Agents; Male; Methotrexate; Necrosis; Papio; Splenectomy; Swine; Tacrolimus; Time Factors; Transplantation, Heterologous | 1996 |
Study of hematopoietic progenitor cells in thalassemia after bone marrow transplantation.
Topics: beta-Thalassemia; Bone Marrow; Bone Marrow Transplantation; Busulfan; Cells, Cultured; Child; Child, Preschool; Colony-Forming Units Assay; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cells; Hemoglobin E; Hemoglobinuria; Homozygote; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Reference Values | 1995 |
Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine.
Topics: Anti-Infective Agents; Antirheumatic Agents; Arthritis, Juvenile; Bone Marrow; Child; Cyclosporine; Humans; Macrophage Activation; Male; Methotrexate; Phagocytes; Pneumonia, Pneumocystis; Sulfamethoxazole; Trimethoprim | 1996 |
Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994.
Topics: Administration, Cutaneous; Anti-Bacterial Agents; Cyclosporine; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Humans; Immunosuppressive Agents; Methotrexate; Photochemotherapy; Psoriasis; PUVA Therapy; Retinoids | 1996 |
Cytokine network in peripheral blood mononuclear cells after allogeneic bone marrow transplantation.
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Cytokines; Etoposide; Gene Expression; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Interleukins; Lymphocytes; Methotrexate; Polymerase Chain Reaction; RNA, Messenger; Transplantation, Homologous; Whole-Body Irradiation | 1996 |
Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.
Topics: Adolescent; Adult; Blood Donors; Busulfan; Child; Child, Preschool; Cyclosporine; Erythropoietin; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Leukemia; Lymphoma; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prednisolone; Whole-Body Irradiation | 1996 |
Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
Topics: Actuarial Analysis; Acute Disease; Adult; Anti-Infective Agents; Bone Marrow Transplantation; Busulfan; Cause of Death; Critical Care; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hepatic Veno-Occlusive Disease; Histocompatibility; HLA-DR Antigens; Humans; Immunosuppressive Agents; Infections; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Risk; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 1996 |
[Therapeutic management of psoriasis].
Topics: Adrenal Cortex Hormones; Calcitriol; Cyclosporine; Dermatologic Agents; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Psoriasis; PUVA Therapy; Retinoids | 1996 |
Reversible MRI lesions.
Topics: Cyclosporine; Humans; Magnetic Resonance Imaging; Methotrexate; Seizures | 1996 |
Epstein-Barr virus associated Burkitt lymphoma in a heart transplant recipient.
Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Cyclosporine; Cytarabine; Doxorubicin; Etoposide; Heart Transplantation; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Postoperative Complications; Prednisolone; Remission Induction; T-Lymphocytes, Cytotoxic; Tumor Virus Infections; Vincristine | 1996 |
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group.
Topics: Actuarial Analysis; Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Bone Marrow; Catheterization, Central Venous; Child; Cyclosporine; Female; Filgrastim; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Lenograstim; Leukapheresis; Leukocyte Count; Male; Methotrexate; Middle Aged; Neutrophils; Platelet Count; Recombinant Proteins; Retreatment; Retrospective Studies; Safety; Transplantation, Homologous; Treatment Outcome | 1996 |
Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy.
Topics: Acute-Phase Proteins; Arthritis, Rheumatoid; Bone Density; C-Reactive Protein; Cyclosporine; Dehydroepiandrosterone Sulfate; Drug Resistance; Female; Humans; Insulin-Like Growth Factor I; Joints; Male; Methotrexate; Middle Aged; Osteocalcin; Retreatment | 1996 |
Radioreceptor assay for sirolimus.
Topics: Carrier Proteins; Chromatography, High Pressure Liquid; Cyclosporine; DNA-Binding Proteins; Heat-Shock Proteins; Humans; Immunosuppressive Agents; Methanol; Methotrexate; Polyenes; Radioligand Assay; Reproducibility of Results; Sensitivity and Specificity; Sirolimus; Tacrolimus Binding Proteins | 1996 |
Evaluation of the efficacy and toxicity of the cyclosporine A-flucortolone-methotrexate combination in the treatment of sarcoidosis.
Topics: Adult; Aged; Biopsy; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluocortolone; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Methotrexate; Middle Aged; Peptidyl-Dipeptidase A; Radioimmunoassay; Remission Induction; Sarcoidosis, Pulmonary; Treatment Outcome | 1996 |
Successful treatment of lymphomatoid granulomatosis using cyclosporin-A after failure of intensive chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Doxorubicin; Etoposide; Humans; Immunosuppressive Agents; Lung Diseases; Lymphomatoid Granulomatosis; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Salvage Therapy; Vincristine | 1996 |
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantatio
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Leukemia; Methotrexate; Middle Aged; Recurrence; Transplantation, Homologous; Treatment Outcome | 1996 |
Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Infections; Interleukin-12; Male; Methotrexate; Middle Aged; Transplantation, Autologous; Transplantation, Homologous | 1996 |
Cyclosporin A down-regulates the LTA4 hydrolase level in human keratinocyte cultures.
Topics: 8,11,14-Eicosatrienoic Acid; Anti-Inflammatory Agents; Antineoplastic Agents; Calcitriol; Cells, Cultured; Cyclosporine; Dexamethasone; Down-Regulation; Epoxide Hydrolases; Humans; Interferon-gamma; Keratinocytes; Leukotriene B4; Methotrexate; Psoriasis; Thiophenes; Tretinoin | 1996 |
Plasma endothelin in psoriasis: possible relations to therapy and toxicity.
Topics: Acitretin; Cyclosporine; Endothelins; Humans; Hydroxyurea; Keratolytic Agents; Methotrexate; Psoriasis; Ranitidine | 1996 |
The effects of cyclosporin A, dexamethasone and other immunomodulatory drugs on induced expression of IL-3, IL-4 and IL-8 mRNA in a human mast cell line.
Topics: Adjuvants, Immunologic; Cell Line; Cyclosporine; Cytokines; Dexamethasone; Gene Expression; Humans; Immunosuppressive Agents; Interleukin-3; Interleukin-4; Interleukin-8; Interleukins; Mast Cells; Methotrexate; Polymerase Chain Reaction; Progesterone; RNA, Messenger; Transcription, Genetic | 1997 |
Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.
Topics: Adenosine; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chymases; Cyclosporine; Diclofenac; Histamine Release; Humans; Immunoglobulin E; Immunosuppressive Agents; Leukotriene C4; Mast Cells; Methotrexate; Middle Aged; Polyenes; Prostaglandins D; Rheumatic Diseases; Serine Endopeptidases; Sirolimus; Substance P; Sulfonamides; Synovial Membrane; Tacrolimus; Tryptases | 1997 |
Effects of cyclosporine A and methotrexate on induction of tumour necrosis factor-alpha in rat cardiac allografts.
Topics: Animals; Cyclosporine; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Graft Survival; Heart Transplantation; Macrophages; Male; Methotrexate; Polymerase Chain Reaction; Rats; Rats, Inbred BN; Rats, Inbred Lew; RNA-Directed DNA Polymerase; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 1997 |
Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A or methotrexate: comment on the article by Pasero et al.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Humans; Joint Diseases; Methotrexate | 1997 |
A survey of the prophylaxis and treatment of acute GVHD in Europe: a report of the European Group for Blood and Marrow, Transplantation (EBMT). Chronic Leukaemia Working Party of the EBMT.
Topics: Acute Disease; Adrenal Cortex Hormones; Bone Marrow Transplantation; Clinical Protocols; Cyclosporine; Europe; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Surveys and Questionnaires; Transplantation, Homologous | 1997 |
Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation.
Topics: Adrenal Cortex Hormones; Bone Marrow Transplantation; Child, Preschool; Combined Modality Therapy; Cyclosporine; Etoposide; Female; Graft vs Host Disease; Histiocytosis, Non-Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Injections, Spinal; Killer Cells, Natural; Male; Methotrexate; Remission Induction; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 1997 |
[Rheumatoid arthritis. Begin early aggressive therapy].
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate | 1997 |
Busulfan/cyclophosphamide in volunteer unrelated donor (VUD) BMT: excellent feasibility and low incidence of treatment-related toxicity.
Topics: Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; T-Lymphocytes; Transplantation Conditioning | 1997 |
Factors influencing haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis. A single-centre experience.
Topics: Adolescent; Adult; Blood Platelets; Bone Marrow Transplantation; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Neutrophils; Recombinant Proteins; Retrospective Studies; Statistics, Nonparametric; Transplantation, Homologous | 1997 |
Successful bone marrow transplantation in sensitized aplastic anemia patients using total lymphoid irradiation for conditioning: long-term follow-up.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Purging; Bone Marrow Transplantation; Child; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphoid Tissue; Male; Methotrexate; Middle Aged; Risk Factors; Survival Rate; Transplantation Conditioning | 1996 |
Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy.
Topics: Acute Disease; Animals; Cyclophosphamide; Cyclosporine; Elapid Venoms; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Myocardium; Papio; Splenectomy; Swine; Transplantation, Heterologous | 1997 |
[Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
Topics: Anemia, Hemolytic, Autoimmune; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Chlorambucil; Cyclophosphamide; Cyclosporine; Doxorubicin; Humans; Hydrocortisone; Interferon-alpha; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Red-Cell Aplasia, Pure; Vidarabine; Vincristine | 1997 |
Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis.
Topics: Adolescent; Age of Onset; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Cyclosporine; Dermatomyositis; Female; Humans; Male; Methotrexate; Prednisone; Retrospective Studies | 1997 |
Linear chronic cutaneous graft-versus-host disease.
Topics: Adult; Basement Membrane; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Cytarabine; E-Selectin; Epidermis; Graft vs Host Disease; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Keratosis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lichenoid Eruptions; Male; Methotrexate; Platelet Endothelial Cell Adhesion Molecule-1; Transplantation, Homologous; Whole-Body Irradiation | 1997 |
Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Topics: Adult; Bone Marrow Cells; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Female; Flow Cytometry; Graft Rejection; Graft vs Host Disease; Humans; Immunoglobulins, Intravenous; Immunomagnetic Separation; Immunophenotyping; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Pilot Projects; T-Lymphocyte Subsets; Transplantation Conditioning; Transplantation, Homologous | 1997 |
Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis.
Topics: Abdominal Pain; Acute Disease; Adult; Amylases; Bile; Biomarkers; Bone Marrow Transplantation; Cause of Death; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Gallbladder; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Neoplasms; Pancreatitis; Prednisone; Prevalence; Risk Factors; Transplantation Conditioning; Whole-Body Irradiation | 1997 |
Immunomodulator therapy of inflammatory bowel disease.
Topics: Antimetabolites, Antineoplastic; Azathioprine; Blood Component Removal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytokines; Folic Acid Antagonists; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate | 1997 |
Multidrug resistance modulation in rhabdomyosarcoma and neuroblastoma cell lines.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cell Survival; Cisplatin; Cyclophosphamide; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Etoposide; Humans; Kinetics; Lung Neoplasms; Methotrexate; Neuroblastoma; Rhabdomyosarcoma; Time Factors; Tumor Cells, Cultured; Verapamil; Vincristine | 1998 |
[Severe hepatic veno-occlusive disease (VOD) which was successfully treated with supportive therapy, but subsequently developed late-recurrence].
Topics: Adult; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Recurrence; Respiratory Distress Syndrome; Tacrolimus | 1998 |
[Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination].
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Data Interpretation, Statistical; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Methotrexate; Methylprednisolone; Time Factors | 1998 |
[Sandimmun Optoral now approved in Germany. Treatment of rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Approval; Drug Combinations; Germany; Humans; Methotrexate | 1998 |
Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model.
Topics: Animals; Cyclosporine; Cytokines; Graft Rejection; Graft Survival; Heart Transplantation; Immunoglobulins; Immunohistochemistry; Immunosuppressive Agents; Killer Cells, Natural; Lymphatic Irradiation; Macrophages; Methotrexate; Myocardium; Papio; Swine; T-Lymphocytes; Transplantation, Heterologous | 1998 |
Combined chronic administration of methotrexate and cyclosporine A following cardiac ongoing rejection.
Topics: Adult; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Leukocyte Count; Liver Function Tests; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies | 1998 |
Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Chronic-Phase; Male; Methotrexate; Middle Aged; Prognosis; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 1998 |
Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, s
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cells, Cultured; Cyclosporine; Cytokines; Dexamethasone; DNA-Binding Proteins; Fibroblasts; Fluorescent Antibody Technique, Direct; Heat Shock Transcription Factors; HSP70 Heat-Shock Proteins; Humans; Methotrexate; Physical Stimulation; Synovial Membrane; Transcription Factors | 1998 |
[Peripheral neuropathy investigation in the early stage of bone marrow transplantation].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Busulfan; Child; Cross-Sectional Studies; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Neural Conduction; Peripheral Nervous System Diseases; Postoperative Period; Prospective Studies; Risk Factors; Time Factors | 1998 |
The development of chronic graft-versus-host disease: an analysis of screening studies and the impact of corticosteroid use at 100 days after transplantation.
Topics: Adrenal Cortex Hormones; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Mass Screening; Methotrexate; Multivariate Analysis; Risk Factors; Transplantation, Homologous | 1998 |
Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Risk Factors; Transplantation Conditioning; Treatment Outcome | 1998 |
Twelve years of cyclosporine in pediatric heart transplantation: what is the future?
Topics: Adolescent; Azathioprine; Cardiomyopathies; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Heart Defects, Congenital; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Infant, Newborn; Kidney Failure, Chronic; Kidney Transplantation; Methotrexate; Reoperation; Retrospective Studies; Steroids; Survival Rate; Time Factors | 1998 |
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multiple Myeloma; Transplantation, Homologous; Treatment Outcome | 1998 |
Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Recurrence; Tissue Donors; Transplantation, Homologous | 1998 |
Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis).
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Infections; Life Tables; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Retrospective Studies; Survival Analysis; Survival Rate; Transplantation, Homologous | 1998 |
Methotrexate regulates ICAM-1 expression in recipients of rat cardiac allografts.
Topics: Animals; Blotting, Northern; Cyclosporine; Dose-Response Relationship, Drug; Gene Expression; Graft Rejection; Heart Transplantation; Immunohistochemistry; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Lymphoid Tissue; Male; Methotrexate; Myocardium; Rats; Rats, Inbred BN; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 1998 |
Effects of cyclosporine A and methotrexate on CD18 expression in recipients of rat cardiac allografts.
Topics: Animals; CD18 Antigens; Cyclosporine; Gene Expression; Graft Rejection; Heart Transplantation; Immunohistochemistry; Immunosuppressive Agents; Leukocytes; Methotrexate; Myocardium; Rats; Rats, Inbred BN; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterotopic | 1998 |
[Basic therapeutics in the management of various forms of arthritis].
Topics: Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Humans; Methotrexate; Polymyalgia Rheumatica; Remission Induction; Spondylitis; Spondylitis, Ankylosing; Sulfasalazine | 1998 |
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
Topics: Adolescent; Adult; Age Factors; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Middle Aged; Neoplasms; Retrospective Studies; Risk Factors; Sex Factors; Transplantation, Homologous | 1998 |
Drug-combination therapy of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Fluocortolone; Glucocorticoids; Humans; Kidney; Longitudinal Studies; Male; Methotrexate; Middle Aged | 1998 |
Experience with allogeneic and syngeneic blood stem cell transplantation in patients with hematological malignancies.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Transplantation Conditioning; Transplantation, Homologous | 1998 |
Transplantation of allogeneic peripheral blood progenitor cells--a single centre experience.
Topics: Adult; Cyclosporine; Czech Republic; Female; Graft vs Host Disease; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Treatment Outcome | 1998 |
Allogeneic and autologous bone marrow transplantation in single centre experience.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Transplantation, Autologous; Transplantation, Homologous | 1998 |
Cyclosporin A therapy in refractory non-infectious childhood uveitis.
Topics: Adolescent; Arthritis, Juvenile; Azathioprine; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisolone; Retrospective Studies; Treatment Outcome; Uveitis; Visual Acuity | 1998 |
Low dose cyclosporin A and methotrexate in the treatment of psoriasis.
Topics: Adult; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Methotrexate; Psoriasis; Treatment Outcome | 1999 |
Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts.
Topics: Adolescent; Adult; Antigens, CD19; Antigens, CD34; B-Lymphocyte Subsets; CD4 Antigens; CD8 Antigens; Cell Separation; Chimera; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Infections; Killer Cells, Natural; Kinetics; Leukapheresis; Leukocyte Common Antigens; Lymphocyte Count; Lymphocyte Depletion; Lymphocyte Subsets; Male; Methotrexate; Methylprednisolone; Middle Aged; Prospective Studies; T-Lymphocyte Subsets; Time Factors; Transplantation Conditioning; Whole-Body Irradiation | 1999 |
Validity of area-under-the-curve analysis to summarize effect in rheumatoid arthritis clinical trials.
Topics: Antirheumatic Agents; Area Under Curve; Arthritis, Rheumatoid; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Evaluation Studies as Topic; Humans; Methotrexate; Prednisone; Randomized Controlled Trials as Topic; Reproducibility of Results; Rheumatology; Sulfasalazine; Treatment Outcome | 1999 |
Treatments of generalized pustular psoriasis: a multicenter study in Japan.
Topics: Adult; Cyclosporine; Data Collection; Etretinate; Female; Glucocorticoids; Humans; Japan; Male; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Tonsillectomy | 1999 |
Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries.
Topics: Adolescent; Bone Marrow Transplantation; Case-Control Studies; Child; Child, Preschool; Cyclosporine; Female; Finland; Graft vs Host Disease; Humans; Iceland; Infant; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Scandinavian and Nordic Countries; Time Factors; Treatment Outcome | 1999 |
Combination therapy in rheumatoid arthritis: a comment.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome | 1999 |
Interactions of HIV protease inhibitors with ATP-dependent drug export proteins.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cyclosporine; Fluoresceins; HIV Protease Inhibitors; Killifishes; Methotrexate; Mitochondrial Proteins; Ribosomal Proteins; Ritonavir; Saccharomyces cerevisiae Proteins; Saquinavir | 1999 |
Ganciclovir-induced encephalopathy in a bone marrow transplant recipient.
Topics: Antilymphocyte Serum; Antiviral Agents; Bone Marrow Transplantation; Brain Diseases; Child; Cyclosporine; Ganciclovir; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Prednisolone; Transplantation, Homologous; Whole-Body Irradiation | 1999 |
Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis.
Topics: Adult; Chronic Disease; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Retrospective Studies | 1999 |
Continuous infusion cyclosporine and nifedipine to day +100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Calcium Channel Blockers; Cause of Death; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Infant; Life Tables; Male; Methotrexate; Methylprednisolone; Middle Aged; Nifedipine; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Wiskott-Aldrich Syndrome | 1999 |
Severe hepatitis and pure red cell aplasia in adult Still's disease: good response to immunosuppressive therapy.
Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Female; Hepatitis; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Prednisone; Red-Cell Aplasia, Pure; Still's Disease, Adult-Onset | 1999 |
[Successful combination chemotherapy with low-dose methotrexate and steroids for dermatomyositis complicated by interstitial pneumonitis].
Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Prednisolone; Pulse Therapy, Drug; Treatment Outcome | 1999 |
Treatment considerations in early rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Patient Selection; Risk; Sulfasalazine; Time Factors; Treatment Outcome | 1997 |
Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome.
Topics: Adolescent; Antibodies, Monoclonal; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Histocompatibility Testing; HLA-C Antigens; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Living Donors; Lymphocyte Depletion; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sex Factors; Survival Analysis; T-Lymphocytes; Time Factors; Transplantation, Homologous; Treatment Failure; Treatment Outcome | 1999 |
Immune recovery after bone marrow and peripheral blood stem cells transplantation.
Topics: Adult; Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunophenotyping; Immunosuppressive Agents; Leukemia; Lymphoma, Non-Hodgkin; Methotrexate; Middle Aged; Multiple Myeloma; T-Lymphocytes; Transplantation, Autologous; Transplantation, Homologous | 1999 |
Combination therapy in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Humans; Methotrexate | 1999 |
Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Alleles; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; Histocompatibility Testing; HLA-A2 Antigen; Humans; Immunosuppressive Agents; Incidence; Infant; Male; Methotrexate; Middle Aged; Minor Histocompatibility Antigens; Nuclear Family; Oligopeptides; Parity; Retrospective Studies; Risk; Severity of Illness Index; Transplantation Conditioning; Whole-Body Irradiation | 1999 |
High-dose peripheral blood stem cell transplant for multitransfused severe aplastic anaemia patients without antithymocyte globulin in the conditioning regimen.
Topics: Acute Disease; Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Blood Transfusion; Cyclophosphamide; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate | 1999 |
[Hairy cell leukemia during treatment of psoriatic polyarthritis with methotrexate].
Topics: Arthritis, Psoriatic; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Male; Methotrexate; Middle Aged | 1999 |
Endothelin B receptor-mediated regulation of ATP-driven drug secretion in renal proximal tubule.
Topics: Adenosine Triphosphate; Animals; Anion Transport Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carrier Proteins; Cyclosporine; Endothelins; Fluoresceins; Iohexol; Kidney Tubules, Proximal; Killifishes; Methotrexate; Protein Kinase C; Receptor, Endothelin B; Receptors, Endothelin | 2000 |
Effect of short-term interferon therapy on the outcome of subsequent HLA-identical sibling bone marrow transplantation for chronic myelogenous leukemia: an analysis from the international bone marrow transplant registry.
Topics: Actuarial Analysis; Adolescent; Adult; Bone Marrow Transplantation; Child; Cyclosporine; Disease-Free Survival; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Living Donors; Male; Methotrexate; Middle Aged; Multivariate Analysis; Nuclear Family; Registries; Survival Analysis; Transplantation, Homologous | 2000 |
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Colectomy; Colon; Cyclosporine; Female; Flow Cytometry; Genes, MDR; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Lymphocytes; Male; Mesalamine; Methotrexate; Middle Aged; Reference Values; Treatment Failure | 2000 |
IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases.
Topics: Azathioprine; Cyclosporine; Europe; Female; Gastroenterology; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Internal Medicine; Male; Mercaptopurine; Methotrexate; North America; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications; Surveys and Questionnaires | 2000 |
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged | 1999 |
Epstein-Barr virus-associated Hodgkin's lymphoma and legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cyclosporine A.
Topics: Arthritis, Rheumatoid; Cyclosporine; Epstein-Barr Virus Infections; Fatal Outcome; Female; Hodgkin Disease; Humans; Immunosuppressive Agents; Infant; Legionnaires' Disease; Methotrexate | 2000 |
Cytotoxic T lymphocyte antigen 4-immunoglobulin fusion protein combined with methotrexate/cyclosporine as graft-versus-host disease prevention in a canine dog leukocyte antigen-nonidentical marrow transplant model.
Topics: Abatacept; Animals; Antigens, CD; Antigens, Differentiation; Bone Marrow Transplantation; CTLA-4 Antigen; Cyclosporine; Dogs; Graft vs Host Disease; Histocompatibility Testing; Immunoconjugates; Immunoglobulin Fc Fragments; Immunosuppressive Agents; Methotrexate; Recombinant Fusion Proteins; Transplantation Immunology; Transplantation, Homologous | 2000 |
Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Brain Diseases; Cerebral Cortex; Cyclosporine; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Necrosis; Tacrolimus; Tomography, X-Ray Computed; Vincristine | 2000 |
[Pharmacotherapy of patients with (early) rheumatoid arthritis].
Topics: Agranulocytosis; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Humans; Methotrexate; Sulfasalazine | 2000 |
[Effects of anti-inflammatory drugs on adhesion and migration of lymphocytes].
Topics: Adult; Anti-Inflammatory Agents; Antigens, CD; Aspirin; Cell Adhesion; Cell Movement; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Lymphocytes; Male; Methotrexate; Reference Values; Transforming Growth Factor beta | 1999 |
Complications of systemic chemotherapy as treatment of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclosporine; Cytarabine; Etoposide; Female; Fever; Humans; Infant; Male; Methotrexate; Neutropenia; Organophosphorus Compounds; Retinal Neoplasms; Retinoblastoma; Thrombocytopenia; Vincristine | 2000 |
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Podophyllotoxin; Transplantation Conditioning; Transplantation, Homologous | 2000 |
Combined use of cyclosporine A and methotrexate in refractory polymyositis.
Topics: Antirheumatic Agents; Creatine Kinase; Cyclosporine; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Muscle Weakness; Polymyositis; Treatment Outcome | 2000 |
Further evidence for genetic heterogeneity in familial hemophagocytic lymphohistiocytosis (FHLH).
Topics: Adolescent; Adrenal Cortex Hormones; Bone Marrow; Bone Marrow Transplantation; Child; Chromosome Mapping; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 19; Chromosomes, Human, Pair 9; Cyclosporine; Female; Genetic Markers; Histiocytosis, Non-Langerhans-Cell; Humans; Male; Methotrexate; Newfoundland and Labrador; Nova Scotia; Pedigree | 2000 |
Immunomodulatory therapy for chronic tubulointerstitial nephritis-associated uveitis.
Topics: Adolescent; Adult; Azathioprine; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Nephritis, Interstitial; Panuveitis; Retrospective Studies; Secondary Prevention; Uveitis, Anterior; Visual Acuity | 2000 |
Probable failure of chimerism induction in orthotopically transplanted monkey hearts in baboons.
Topics: Animals; Antilymphocyte Serum; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Graft Survival; Heart Transplantation; Immunosuppression Therapy; Macaca mulatta; Methotrexate; Papio; Time Factors; Transplantation Chimera; Transplantation, Heterologous; Whole-Body Irradiation | 2000 |
Delayed cardiac xenograft rejection in a pig-to-baboon model treated with a tolerance-inducing regimen and donor bone marrow infusion.
Topics: Animals; Antibody Formation; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Papio; Swine; Time Factors; Transplantation, Heterologous; Whole-Body Irradiation | 2000 |
Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cyclosporine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Immunoblastic Lymphadenopathy; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Prednisone; Remission Induction; Vincristine | 2000 |
Pediatric utilization of rapamycin for severe cardiac allograft rejection.
Topics: Acute Disease; Adult; Animals; Antilymphocyte Serum; Child; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Mycophenolic Acid; Platelet Count; Prednisone; Rabbits; Safety; Sirolimus; T-Lymphocytes; Tacrolimus | 2000 |
Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children.
Topics: Adolescent; Adrenal Cortex Hormones; Antibodies; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclosporine; Data Collection; Global Health; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infant; Infant, Newborn; International Agencies; Lymphocyte Depletion; Methotrexate; Practice Guidelines as Topic; T-Lymphocytes; Transplantation, Homologous | 2000 |
Cyclosporin A inhibits CD69 expression induced on synovial fluid and peripheral blood lymphocytes by interleukin 15.
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Arthritis, Rheumatoid; Cells, Cultured; Chemokines; Cyclosporine; Cytokines; Dose-Response Relationship, Drug; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunosuppressive Agents; Interleukin-15; Lectins, C-Type; Lymphocyte Activation; Lymphocytes; Methotrexate; Synovial Fluid; Up-Regulation | 2000 |
[Clinical manifestations and therapeutic approach in neurosarcoidosis].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Brain; Brain Diseases; Cyclophosphamide; Cyclosporine; Electromyography; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Retrospective Studies; Sarcoidosis; Severity of Illness Index; Steroids; Treatment Outcome | 2000 |
Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
Topics: Acyclovir; Adolescent; Adult; Antifungal Agents; Antiviral Agents; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Fluconazole; Foscarnet; Humans; Leukemia; Lymphoma; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Postoperative Period; Prospective Studies; Risk; Survival Rate; Time Factors; Tissue Donors; Transplantation, Homologous | 2000 |
De novo chronic graft-versus-host disease in marrow graft recipients given methotrexate and cyclosporine: risk factors and survival.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Homologous | 2000 |
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease.
Topics: Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Recurrence; Treatment Outcome | 2000 |
Remitting asymmetrical pitting oedema in systemic lupus erythematosus: two cases studied with magnetic resonance imaging.
Topics: Adult; Ankle; Cyclosporine; Disease Progression; Drug Therapy, Combination; Edema; Female; Functional Laterality; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methotrexate; Prednisone; Remission, Spontaneous; Treatment Outcome; Wrist | 2000 |
Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.
Topics: Adolescent; Adult; Ambulatory Care; Busulfan; Child; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Neural Tube Defects; Program Evaluation; Recurrence; Survival Analysis; Thalassemia; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2001 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chlorambucil; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferons; Levamisole; Male; Methotrexate; Pentoxifylline; Recombinant Proteins; Recurrence; Sulfasalazine; Thalidomide | 2001 |
Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.
Topics: Acute Disease; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Isoantibodies; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Tacrolimus; Transplantation, Homologous | 2001 |
Mycophenolate Mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: four years of experience.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nuclear Family; Recurrence; Retrospective Studies; Survival Rate; Whole-Body Irradiation | 2001 |
Conventional DMARD options for patients with a suboptimal response to methotrexate.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2001 |
Acquired pure red cell aplasia associated with lymphoproliferative disease of granular T lymphocytes.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia, T-Cell; Male; Methotrexate; Middle Aged; Neutropenia; Prednisone; Recurrence; Red-Cell Aplasia, Pure; Remission Induction; T-Lymphocytes, Cytotoxic | 2001 |
Amelioration of steroid-resistant chronic graft-versus-host-mediated liver disease via tacrolimus treatment.
Topics: Adolescent; Adult; Cholestasis, Intrahepatic; Cyclosporine; Drug Evaluation; Drug Resistance; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Liver Function Tests; Male; Methotrexate; Prednisone; Tacrolimus; Transplantation, Homologous; Treatment Outcome | 2001 |
Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study.
Topics: Adult; Blood Sedimentation; Cyclosporine; Female; Humans; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Pilot Projects; Retrospective Studies | 2001 |
Do corticosteroids add any benefit to standard GVHD prophylaxis in allogeneic BMT?
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cause of Death; Cyclosporine; Female; Gastrointestinal Hemorrhage; Graft vs Host Disease; Hematologic Neoplasms; Humans; Hypertension; Infections; Male; Methotrexate; Middle Aged; Musculoskeletal Diseases; Prednisone; Retrospective Studies; Survival Analysis; Therapeutic Equivalency; Transplantation, Homologous | 2001 |
Treatment of psoriasis in the Nordic countries: a questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life Study.
Topics: Administration, Topical; Analysis of Variance; Anthralin; Anti-Inflammatory Agents; Calcitriol; Complementary Therapies; Cyclosporine; Dermatologic Agents; Europe; Female; Health Care Surveys; Humans; Male; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Steroids; Surveys and Questionnaires | 2001 |
Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease.
Topics: Adolescent; Adult; Cause of Death; Child; Child, Preschool; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Middle Aged; Odds Ratio; Prednisone; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2001 |
Severe oral manifestations of chronic graft-vs.-host disease.
Topics: Adult; Anemia, Aplastic; Anti-Inflammatory Agents; Betamethasone; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Methotrexate; Mouth Diseases; Mouthwashes; Mycophenolic Acid; Oral Hygiene; Prednisone; Transplantation Conditioning; Transplantation, Homologous | 2001 |
[Conservative therapy in endocrine orbitopathy: "State of the art"].
Topics: Cyclosporine; Graves Disease; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Pentoxifylline; Phosphodiesterase Inhibitors | 2001 |
[Regression of Epstein-Barr virus associated lymphoma after methotrexate and cyclosporine A withdrawal in a patient with rheumathoid arthritis].
Topics: Arthritis, Rheumatoid; Cyclosporine; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged | 2001 |
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies.
Topics: Adult; Aged; Anemia, Refractory, with Excess of Blasts; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Transfusion; Lymphoma, Mantle-Cell; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Polymerase Chain Reaction; Recurrence; Remission Induction; Survival Rate; Thiotepa; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2002 |
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Combined Modality Therapy; Cyclosporine; Cytarabine; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Herpes Genitalis; Herpes Simplex; Humans; Hydroxyurea; Immunocompromised Host; Immunosuppressive Agents; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Transplantation Conditioning; Whole-Body Irradiation | 2001 |
Effective treatment of early rheumatoid arthritis with a combination of methotrexate, prednisolone and cyclosporin.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Prednisolone; Probability; Prognosis; Severity of Illness Index; Treatment Outcome | 2002 |
Cost-effectiveness comparison of therapy for psoriasis with a methotrexate-based regimen versus a rotation regimen of modified cyclosporine and methotrexate.
Topics: Cost-Benefit Analysis; Cyclosporine; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Health Care Costs; Humans; Male; Methotrexate; Models, Economic; Psoriasis; Severity of Illness Index; Treatment Outcome; United States | 2002 |
Multifocal choroiditis and panuveitis: immunomodulatory therapy.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Choroiditis; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Panuveitis; Retrospective Studies; Steroids; Treatment Outcome; Visual Acuity | 2002 |
CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation, Isogeneic; Treatment Outcome | 2002 |
Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections.
Topics: Adolescent; Adult; Aged; Antibodies, Anticardiolipin; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Child; Child, Preschool; Chloroquine; Cyclosporine; Drug Combinations; Etanercept; Humans; Immunoglobulin G; Immunoglobulin M; Infant; Infant, Newborn; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Staphylococcal Infections; Staphylococcus aureus | 2002 |
Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cells, Cultured; Chemokine CXCL1; Chemokines, CXC; Chemotactic Factors; Cyclosporine; Fibroblasts; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-17; Interleukin-8; Kinetics; MAP Kinase Signaling System; Methotrexate; NF-kappa B; Receptors, Interleukin; Receptors, Interleukin-17; Recombinant Proteins; RNA, Messenger; Signal Transduction; Synovial Membrane; Transcription, Genetic; U937 Cells | 2002 |
Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs.
Topics: Apoptosis; Cyclophosphamide; Cyclosporine; Dexamethasone; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Activation; Methotrexate; Mycophenolic Acid; Sirolimus; T-Lymphocytes; Tacrolimus; Tumor Cells, Cultured | 2002 |
Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry.
Topics: Adult; Age Factors; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Middle Aged; Multivariate Analysis; Registries; Retrospective Studies; Risk Factors; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2002 |
[Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation by mycophenolate mofetil in a murine model].
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Dose-Response Relationship, Drug; Drug Synergism; Female; Graft Survival; Graft vs Host Disease; Immunosuppressive Agents; Methotrexate; Mice; Mice, Inbred C57BL; Models, Animal; Mycophenolic Acid; Time Factors; Transplantation, Homologous | 2002 |
[Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
Topics: Acute Disease; Adult; Anemia, Aplastic; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Mouth Mucosa; Mycophenolic Acid; Neutrophils; Transplantation, Homologous; Treatment Outcome | 2002 |
[Hyperacute graft versus host disease after allo-stem cell transplantation, analysis of 118 cases].
Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2002 |
Severe cardiac involvement in children with systemic sclerosis and myositis.
Topics: Adolescent; Cardiomyopathies; Child; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Methotrexate; Polymyositis; Prednisone; Scleroderma, Systemic; Survival Rate; Treatment Outcome | 2002 |
[Tubulointerstitial nephritis and uveitis (TINU syndrome) - comorbidity and complications in four patients].
Topics: Adolescent; Arthritis, Rheumatoid; Autoimmune Diseases; Child; Cyclosporine; Female; Follow-Up Studies; Humans; Male; Methotrexate; Mycophenolic Acid; Nephritis, Interstitial; Patient Care Team; Syndrome; Thyroiditis, Autoimmune; Treatment Outcome; Uveitis | 2002 |
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infections; Life Tables; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Spain; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; United Kingdom; Vidarabine | 2002 |
Remission of lymphoma after drug withdrawal in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Buttocks; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Muscle Neoplasms; Muscle, Skeletal; Remission, Spontaneous | 2002 |
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease.
Topics: Acute Disease; Anemia, Sickle Cell; Blood Platelets; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Neutrophils; Survival Rate; Thalassemia; Transplantation, Homologous; Treatment Outcome | 2003 |
The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.
Topics: Acute Disease; Aged; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Clinical Protocols; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Organogold Compounds; Penicillamine; Sulfasalazine; Treatment Outcome | 2002 |
G-CSF-primed haploidentical marrow transplantation without ex vivo T cell depletion: an excellent alternative for high-risk leukemia.
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow; Cell Lineage; Child; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Haplotypes; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Lenograstim; Leukemia; Life Tables; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Recurrence; Risk Factors; Survival Analysis; T-Lymphocytes; Treatment Outcome | 2002 |
Psychological factors and survival after bone marrow transplantation in patients with leukemia.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Male; Methotrexate; Middle Aged; Mood Disorders; Sex Distribution | 2003 |
Baboons undergoing orthotopic concordant cardiac xenotransplantation surviving more than 300 days: effect of immunosuppressive regimen.
Topics: Actuarial Analysis; Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Macaca mulatta; Methotrexate; Papio; Splenectomy; Tacrolimus; Time Factors; Transplantation, Heterologous | 2003 |
Successful combination therapy of cyclosporine and methotrexate for refractory polymyositis with anti-Jo-1 antibody: a case report.
Topics: Adult; Antibodies, Antinuclear; Autoantigens; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Histidine-tRNA Ligase; Humans; Immunosuppressive Agents; Methotrexate; Polymyositis | 2003 |
[Evidence-based treatment of methotrexate-resistant rheumatoid arthritis. Combinations of conventional disease-modifying antirheumatic agents].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Chloroquine; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Placebos; Prednisolone; Randomized Controlled Trials as Topic; Sulfasalazine; Time Factors | 2003 |
Reduced-intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first-donor origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Myelodysplastic Syndromes; Recurrence; Remission Induction; Tissue Donors; Transplantation Chimera; Transplantation Conditioning | 2003 |
Sulfate conjugating and transport functions of MDCK distal tubular cells.
Topics: Animals; Biological Transport; Buthionine Sulfoximine; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclosporine; Glutathione; Harmine; Humans; Immunosuppressive Agents; Kidney Tubules, Distal; Leukotriene Antagonists; Liver; Membrane Transport Proteins; Methotrexate; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Organic Anion Transport Protein 1; Probenecid; Propionates; Quinolines; Radiation-Protective Agents; Radiation-Sensitizing Agents; Sulfates; Uricosuric Agents | 2003 |
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
Topics: Aged; Bone Marrow Transplantation; Busulfan; Cause of Death; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Intestines; Life Tables; Liver; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Organ Specificity; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Severity of Illness Index; Skin; Survival Analysis; Time Factors; Tissue Donors; Transplantation Conditioning; Vidarabine; Washington; Whole-Body Irradiation | 2003 |
[Study on graft-versus-host disease in the allogeneic peripheral blood stem cell transplantation for the treatment of leukemia].
Topics: Adolescent; Adult; Cyclosporine; Drug Therapy, Combination; Enzyme Inhibitors; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2003 |
Inducing remission in inflammatory bowel disease.
Topics: Antibodies, Monoclonal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Remission Induction | 2003 |
Position statement: immunomodulator therapy for inflammatory Bowel disease.
Topics: Adjuvants, Immunologic; Azathioprine; Clinical Trials as Topic; Contraindications; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Safety; Tumor Necrosis Factor-alpha | 2003 |
Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
Topics: Administration, Oral; Adult; Aged; Arthritis, Rheumatoid; Cyclosporine; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged | 2003 |
Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: a single institution experience.
Topics: Adolescent; Adult; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Erythrocyte Transfusion; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Male; Methotrexate; Middle Aged; Neoplasms; Peripheral Blood Stem Cell Transplantation; Platelet Transfusion; Prospective Studies; Recombinant Proteins; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2003 |
Prognostic value of cyclic GMP in patients undergoing allogeneic bone marrow transplantation after conditioning with total body irradiation.
Topics: Adolescent; Adult; Biomarkers; Blast Crisis; Bone Marrow Transplantation; Cyclic GMP; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Methotrexate; Methylprednisolone; Monitoring, Physiologic; Myelodysplastic Syndromes; Neoplasm Staging; Nitric Oxide; Prognosis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2003 |
Allogeneic PBPC transplantation in children.
Topics: Adolescent; Anemia; Antigens, CD34; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Methylprednisolone; Peripheral Blood Stem Cell Transplantation; Stem Cells; Transplantation, Homologous | 1999 |
[Indication and effect of immunosuppression in patients with scleritis].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Scleritis; Treatment Outcome | 2003 |
Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Topics: Aged; Cyclosporine; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Psoriasis; Remission Induction; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2003 |
[Human leukocyte antigen mismatched hemopietic stem cell transplants for the treatment of leukemia].
Topics: Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Histocompatibility Antigens Class II; HLA Antigens; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Methotrexate; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous | 2003 |
Cytomegalovirus infection in a patient with rheumatoid arthritis.
Topics: Anemia, Aplastic; Antiviral Agents; Arthritis, Rheumatoid; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotrexate; Middle Aged; Pneumonia, Viral; RNA, Viral; Treatment Outcome | 2003 |
Effect of immunostimulatory ribomunyl on the preventive treatment of rat adjuvant arthritis with cyclosporine and methotrexate.
Topics: Administration, Oral; Animals; Antigens, Bacterial; Arthritis, Experimental; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Immunosuppressive Agents; Inflammation Mediators; Male; Methotrexate; Random Allocation; Rats; Rats, Inbred Lew; Reference Values; Sensitivity and Specificity; Treatment Outcome | 2003 |
Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicity.
Topics: Adult; Bone Marrow Diseases; Bone Marrow Transplantation; Brain; Calcineurin Inhibitors; Central Nervous System Diseases; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Tacrolimus; Transplantation, Homologous | 2003 |
[Idiopathic hypereosinophilic syndrome associated with rheumatoid arthritis. A case report].
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Cyclosporine; Female; Glucocorticoids; Humans; Hypereosinophilic Syndrome; Immunosuppressive Agents; Methotrexate; Middle Aged; Sulfasalazine | 2003 |
CD34 positive selection as prophylaxis against graft versus host disease in allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Antigens, CD34; Cyclophosphamide; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Immunomagnetic Separation; Immunophenotyping; Immunosuppressive Agents; Leucovorin; Leukemia, Myeloid; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; T-Lymphocytes, Cytotoxic; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2003 |
Cyclosporin A in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate | 2003 |
Cyclosporin and methotrexate therapy.
Topics: Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Sulfasalazine | 2003 |
[Adult onset Still's disease (AOSD) treated with a combination of prednisolone, cyclosporin A, and methotrexate].
Topics: Anti-Inflammatory Agents; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Prednisolone; Treatment Outcome | 2003 |
[Quadruple therapy with CsA, MTX, MMF and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic stem cell transplantation].
Topics: Adolescent; Adult; Antilymphocyte Serum; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mycophenolic Acid | 2003 |
Reversal of marrow fibrosis in agnogenic myeloid metaplasia by allogeneic peripheral blood stem cell transplantation.
Topics: Busulfan; Cyclophosphamide; Cyclosporine; Female; Granulocyte Colony-Stimulating Factor; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Primary Myelofibrosis; Transplantation, Homologous | 2003 |
Effect of a drug combination treatment on ocular perfusion in recurrent idiopathic intermediate uveitis.
Topics: Adult; Blood Flow Velocity; Ciliary Arteries; Cortisone; Cyclosporine; Drug Therapy, Combination; Eye; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Ophthalmic Artery; Perfusion; Prospective Studies; Recurrence; Regional Blood Flow; Retinal Artery; Ultrasonography, Doppler, Color; Uveitis, Intermediate; Visual Acuity | 2003 |
Behçet's disease with relapsing cutaneous polyarteritis-nodosa-like lesions, responsive to oral cyclosporine therapy.
Topics: Adolescent; Anticoagulants; Azathioprine; Behcet Syndrome; Colchicine; Cyclosporine; Heparin; Humans; Immunosuppressive Agents; Male; Methotrexate; Polyarteritis Nodosa; Prednisone; Thrombophlebitis; Warfarin | 2003 |
A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
Topics: Adolescent; Adult; Cyclosporine; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Multicenter Studies as Topic; Netherlands; Psoriasis; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2004 |
Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.
Topics: Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Leukemia Effect; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Recurrence | 2004 |
Ten-year radiographic outcome in patients with rheumatoid factor positive rheumatoid arthritis treated with aggressive immunosuppressive combination therapy.
Topics: Administration, Oral; Adolescent; Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Prospective Studies; Pulse Therapy, Drug; Radiography; Remission Induction; Rheumatoid Factor; Treatment Outcome | 2004 |
Cogan syndrome in children: early diagnosis and treatment is critical to prognosis.
Topics: Amblyopia; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Autoimmune Diseases; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Fludrocortisone; Hearing Loss, Sensorineural; Humans; Immunosuppressive Agents; Keratitis; Male; Methotrexate; Prognosis; Syndrome; Vasculitis; Vision, Low | 2004 |
Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus.
Topics: Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Chronic Disease; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Living Donors; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Population Surveillance; Postoperative Care; Retrospective Studies; Risk Assessment; Severity of Illness Index; Siblings; Stem Cell Transplantation | 2004 |
Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation.
Topics: Adult; Blood Cells; Bone Marrow Transplantation; Chronic Disease; Cohort Studies; Cyclosporine; Drug Therapy, Combination; fas Receptor; Female; Genetic Predisposition to Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interleukins; Male; Methotrexate; Middle Aged; Polymorphism, Genetic; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 2004 |
[Reduced intensity stem cell transplantation for metastatic renal cell carcinoma].
Topics: Adult; Busulfan; Carcinoma, Renal Cell; Cyclosporine; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Salvage Therapy; Stem Cell Transplantation; Transplantation Chimera; Transplantation Conditioning; Vidarabine | 2004 |
Macrophage activation syndrome due to methotrexate in a 12-year-old boy with dermatomyositis.
Topics: Child; Cyclosporine; Dermatomyositis; Glucocorticoids; Humans; Immunosuppressive Agents; Macrophage Activation; Macrophages; Male; Methotrexate; Syndrome; Treatment Outcome; Withholding Treatment | 2004 |
Use of infliximab in the treatment of psoriasis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Male; Methotrexate; Middle Aged; Psoriasis; Remission Induction; Time Factors | 2004 |
Joint lavage for treating recurrent knee involvement in patients with juvenile idiopathic arthritis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Azathioprine; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intra-Articular; Knee Joint; Male; Methotrexate; Recurrence; Retrospective Studies; Therapeutic Irrigation; Treatment Outcome | 2004 |
Use of immunomodulary agents is difficult in treating autoimmune hepatitis patients.
Topics: Anti-Inflammatory Agents; Budesonide; Cyclophosphamide; Cyclosporine; Hepatitis, Autoimmune; Humans; Immunologic Factors; Immunosuppressive Agents; Interleukins; Methotrexate; Mycophenolic Acid; Prednisolone; Tacrolimus; Treatment Outcome | 2004 |
Combined donor leucocyte administration and immunosuppressive drug treatment for survival of rat heart allografts.
Topics: Adoptive Transfer; Animals; Combined Modality Therapy; Cyclosporine; Cytokines; Gene Expression; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Indolizines; Leukocyte Transfusion; Male; Methotrexate; Postoperative Care; Rats; Rats, Inbred Strains; RNA, Messenger; Skin Transplantation; Tissue Donors; Transplantation, Homologous | 2004 |
[Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian working group on IBD].
Topics: Administration, Oral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Injections, Intramuscular; Male; Mercaptopurine; Methotrexate; Placebos; Pregnancy; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Safety; Time Factors | 2004 |
[Mismatched hematopoietic stem cell transplantation using GIAC protocol: report of 100 cases].
Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation, Homologous | 2004 |
Long-term relief for RA? Potential therapy targets cells that, in rheumatoid arthritis, short circuit and attack the body.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; B-Lymphocytes; Combined Modality Therapy; Cyclosporine; Humans; Methotrexate; Rituximab | 2004 |
Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing.
Topics: Acitretin; Cyclosporine; Female; Ficusin; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Methotrexate; Middle Aged; Patient Satisfaction; Photosensitizing Agents; Psoriasis; PUVA Therapy; Treatment Outcome | 2005 |
Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Blood Transfusion; Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; T-Lymphocytes; Time Factors; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2005 |
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Busulfan; Cohort Studies; Comorbidity; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Patient Selection; Postoperative Complications; Recurrence; Renal Dialysis; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2005 |
Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey.
Topics: Acitretin; Adult; Aged; Cyclosporine; Dermatologic Agents; Female; Ficusin; Health Surveys; Humans; Male; Methotrexate; Middle Aged; Patient Satisfaction; Psoriasis; PUVA Therapy; Treatment Outcome; United States | 2005 |
Reversing myocardial microvascular disease in a patient with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cardiovascular Diseases; Coronary Angiography; Coronary Circulation; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Microcirculation; Middle Aged; Prednisolone; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2005 |
Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; CD3 Complex; Child; Chimerism; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cells; Humans; Leukemia; Leukocytes; Lymphocytes; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Recurrence; Risk; Stem Cell Transplantation; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings.
Topics: Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Recurrence; Retrospective Studies; Siblings; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.
Topics: Adolescent; beta-Thalassemia; Blood Transfusion; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Neutrophils; Time Factors; Transfusion Reaction; Transplantation, Homologous; Treatment Outcome | 2005 |
Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
Topics: Adolescent; Adult; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Glucocorticoids; Humans; Immunoglobulin G; Infant; Male; Methotrexate; Prednisone; Receptors, Tumor Necrosis Factor; Surveys and Questionnaires; Tumor Necrosis Factor-alpha | 2005 |
[When to begin rheumatism treatment? Initial combination therapy helps fastest].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Hydroxychloroquine; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Prednisolone; Randomized Controlled Trials as Topic; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
[Three joints swollen, blood sedimentation increased. Methotrexate to be given immediately?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Sedimentation; C-Reactive Protein; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
Topics: Acitretin; Adult; Costs and Cost Analysis; Cyclosporine; Dermatologic Agents; Female; Health Care Costs; Humans; Male; Managed Care Programs; Methotrexate; Middle Aged; New England; Phototherapy; Psoriasis; PUVA Therapy; Treatment Failure; United States | 2005 |
Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria.
Topics: Basophils; Calcineurin Inhibitors; Cells, Cultured; Chronic Disease; Complement C5a; Cyclosporine; Diphenhydramine; Dose-Response Relationship, Immunologic; Histamine H1 Antagonists; Histamine Release; Humans; Hydroxyzine; Immunoglobulin G; Immunosuppressive Agents; Leukocytes; Methotrexate; Recurrence; Tacrolimus; Urticaria | 2005 |
Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclosporine; Dexamethasone; Disease-Free Survival; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Non-Langerhans-Cell; Humans; Immunophenotyping; Infant; Male; Methotrexate; Odds Ratio; Regression Analysis; Reoperation; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Choroid Diseases; Cyclosporine; Daclizumab; Disease Progression; Drug Therapy, Combination; Electroretinography; Female; Follow-Up Studies; HLA-A Antigens; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retinal Diseases; Retrospective Studies; Treatment Outcome; Visual Acuity | 2005 |
Tolerability of cyclosphosphamide and methotrexate induction immunosuppression in nonhuman primates.
Topics: Animals; Cyclophosphamide; Cyclosporine; Drug Synergism; Everolimus; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Leukocyte Count; Macaca fascicularis; Male; Methotrexate; Mycophenolic Acid; Organ Transplantation; Papio; Propylene Glycols; Sirolimus; Sphingosine | 2005 |
[Graft-versus-ATLL effect induced by abrupt discontinuation of immunosuppression following allogeneic bone marrow transplantation].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Cyclosporine; DNA, Viral; Doxorubicin; Graft vs Leukemia Effect; Human T-lymphotropic virus 1; Humans; Immunosuppression Therapy; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Prednisone; Remission Induction; Vincristine | 2005 |
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Premedication; Retrospective Studies; Statistics, Nonparametric; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Karnofsky Performance Status; Male; Methotrexate; Middle Aged; Multivariate Analysis; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2005 |
Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antigens, CD34; Cell Count; Cohort Studies; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Male; Methotrexate; Middle Aged; Multivariate Analysis; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Risk Factors; Transplantation, Homologous | 2006 |
Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow.
Topics: Adult; Bone Marrow; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2006 |
Etanercept therapy improves symptoms and allows tapering of other medications in children and adolescents with moderate to severe psoriasis.
Topics: Adolescent; Arthritis, Psoriatic; Child; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Psoriasis; Treatment Outcome | 2006 |
American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Cyclosporine; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid | 2006 |
Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders.
Topics: Adolescent; Adult; Aged; B-Lymphocytes; Cyclosporine; Female; Filgrastim; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Recombinant Proteins; Remission Induction; Transplantation, Homologous | 2006 |
The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis.
Topics: Antimalarials; Azathioprine; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisolone; Middle Aged; Panniculitis, Lupus Erythematosus; Pulse Therapy, Drug; Tacrolimus; Treatment Failure | 2007 |
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Contraindications; Cyclosporine; Disease Progression; Disease Susceptibility; DNA, Neoplasm; Etanercept; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Gene Rearrangement, B-Lymphocyte, Light Chain; Genes, Immunoglobulin; Humans; Immunocompromised Host; Immunoglobulin G; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Neoplasm Proteins; Receptors, Tumor Necrosis Factor; Rituximab; Tumor Necrosis Factor-alpha | 2006 |
Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A.
Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Infusions, Parenteral; Male; Methotrexate; Receptors, Tumor Necrosis Factor; Suppositories | 2006 |
Polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes: not always a POEMS syndrome.
Topics: Cyclosporine; Diagnostic Errors; Eosinophilia; Fasciitis; Hepatomegaly; Humans; Hyperpigmentation; Immunoglobulin G; Immunoglobulin lambda-Chains; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Paresthesia; Peripheral Nervous System Diseases; POEMS Syndrome; Prednisone; Reflex, Abnormal; Skin; Vascular Endothelial Growth Factor A | 2006 |
Methotrexate and ciclosporin combination for the treatment of severe psoriasis.
Topics: Adult; Aged; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Psoriasis; Treatment Outcome | 2006 |
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.
Topics: Adult; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Fibrosis; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Myeloablative Agonists; Scleroderma, Systemic; Skin; Transplantation Conditioning; Transplantation, Homologous | 2006 |
Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infe
Topics: Acute Disease; Child, Preschool; Cyclosporine; Female; Follow-Up Studies; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Antigens Class II; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Incidence; Infant; Male; Methotrexate; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Isogeneic; Treatment Outcome; Virus Diseases | 2006 |
Methotrexate, azathioprine, cyclosporine, and risk of fracture.
Topics: Adult; Aged; Azathioprine; Case-Control Studies; Cyclosporine; Enzyme Inhibitors; Female; Fractures, Bone; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Registries; Risk | 2006 |
[Clinical study of unrelated umbilical cord blood transplantation in 32 children patients].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclosporine; Graft vs Host Disease; Hematologic Neoplasms; Humans; Methotrexate; Survival Rate; Transplantation Conditioning | 2006 |
Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin.
Topics: Adolescent; Animals; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Rabbits; Transplantation, Homologous | 2006 |
Adverse events from systemic therapies for psoriasis are common in clinical practice.
Topics: Adult; Aged; Biological Products; Cyclosporine; Dermatologic Agents; Female; Humans; Hydroxyurea; Male; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Retinoids; Retrospective Studies | 2006 |
Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia.
Topics: Adolescent; Alemtuzumab; Anemia, Aplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppressive Agents; Infant; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Retrospective Studies; Siblings; Survival Analysis; T-Lymphocyte Subsets; Tacrolimus; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2006 |
The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Randomized Controlled Trials as Topic; Siblings; Transplantation Chimera; Transplantation, Homologous | 2007 |
Interactions of cyclosporin a with breast cancer resistance protein.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line; Cell Membrane; Cell Membrane Permeability; Cyclosporine; Daunorubicin; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Estrone; Female; Humans; Immunosuppressive Agents; Methotrexate; Mutation; Neoplasm Proteins; Transfection | 2007 |
Changes in circulating lymphocyte subpopulations following administration of the leucocyte function-associated antigen-3 (LFA-3)/IgG1 fusion protein alefacept.
Topics: Adult; Aged; Alefacept; CD2 Antigens; CD4-Positive T-Lymphocytes; Cyclosporine; Dermatologic Agents; Drug Administration Schedule; Flow Cytometry; Humans; Immunologic Memory; Immunosuppressive Agents; Killer Cells, Natural; Lymphocyte Count; Methotrexate; Middle Aged; Psoriasis; Recombinant Fusion Proteins; Severity of Illness Index; T-Lymphocyte Subsets; Treatment Outcome | 2007 |
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; beta-Thalassemia; Blood Group Incompatibility; Busulfan; Child, Preschool; Cyclosporine; Epstein-Barr Virus Infections; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasma Exchange; Red-Cell Aplasia, Pure; Remission, Spontaneous; Retrospective Studies; Risk Factors; Rituximab; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2007 |
[Cyclosporine combined with another basic drug for the management of rheumatoid arthritis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2006 |
[Coexistence of hypothyroidism with polymyositis or dermatomyositis].
Topics: Adult; Cyclophosphamide; Cyclosporine; Dermatomyositis; Female; Humans; Hypothyroidism; Male; Methotrexate; Middle Aged; Muscle Weakness; Polymyositis; Thyroid Hormones | 2006 |
Allogeneic bone marrow transplantation with total body irradiation-based conditioning in acute lymphoblastic leukemia patient with Cochlear implant.
Topics: Adolescent; Antimetabolites, Antineoplastic; Bone Marrow Transplantation; Cochlear Implantation; Cyclosporine; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Radiotherapy Dosage; Time Factors; Transplantation, Homologous; Treatment Outcome; Whole-Body Irradiation | 2006 |
Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection.
Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Etanercept; Hepatitis C; HIV Infections; Humans; Immunoglobulin G; Male; Methotrexate; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2007 |
Patients with moderate-to-severe plaque psoriasis preferred oral therapies to phototherapies: a preference assessment based on clinical scenarios with trade-off questions.
Topics: Acitretin; Administration, Oral; Adult; Cyclosporine; Dermatologic Agents; Female; Humans; Keratolytic Agents; Male; Methotrexate; Patient Satisfaction; Psoriasis; PUVA Therapy; Surveys and Questionnaires; Treatment Outcome; Ultraviolet Therapy | 2007 |
Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Antineoplastic Agents; Busulfan; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2007 |
[Treatment of thyroid ophthalmopathy--a clinical case].
Topics: Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Nicergoline; Optic Nerve Diseases; Risk Factors; Smoking; Treatment Outcome; Vasodilator Agents; Visual Field Tests; Vitamin B Complex | 2007 |
Amyopathic dermatomyositis--an uncommon presentation of dermatomyositis.
Topics: Adult; Arthralgia; Cyclosporine; Dermatologic Agents; Dermatomyositis; Exanthema; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Prednisone | 2007 |
Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cryptogenic Organizing Pneumonia; Cyclophosphamide; Cyclosporine; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Methotrexate; Neoplasm Recurrence, Local; Palatal Neoplasms; Remission Induction; Salvage Therapy; Transplantation, Homologous; Vincristine | 2007 |
Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients.
Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Immunotherapy; Infections; Injections, Spinal; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Methotrexate; Methylprednisolone; Recurrence; Retrospective Studies; Treatment Outcome | 2007 |
Adult onset Still's disease: a study of 14 cases.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Contraindications; Cyclosporine; Diagnosis, Differential; Exanthema; Female; Fever; Fever of Unknown Origin; Follow-Up Studies; Glucocorticoids; Humans; Joint Diseases; Male; Methotrexate; Middle Aged; Retrospective Studies; Still's Disease, Adult-Onset; Sulfasalazine; Treatment Outcome | 2008 |
Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Prednisolone; Survival Rate; Transplantation, Homologous; Treatment Outcome | 2007 |
Risk factors for acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: retrospective analysis of 73 patients who received cyclosporin A.
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Drug Monitoring; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Premedication; Retrospective Studies; Risk Factors | 2007 |
Conventional therapies for psoriasis.
Topics: Acitretin; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Humans; Italy; Keratolytic Agents; Methotrexate; Psoriasis; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
Disseminated cryptococcal infection in a patient with severe psoriasis treated with efalizumab, methotrexate and ciclosporin.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cryptococcosis; Cryptococcus neoformans; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Methotrexate; Psoriasis | 2007 |
Decreased incidence of acute graft-versus-host disease by continuous infusion of cyclosporine with a higher target blood level.
Topics: Acute Disease; Adult; Antineoplastic Agents; Chronic Disease; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Living Donors; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Whole-Body Irradiation | 2008 |
[Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it].
Topics: Adrenal Cortex Hormones; Anthralin; Arthritis, Psoriatic; Biological Products; Cyclosporine; Dermatologic Agents; Female; Fumarates; Humans; Male; Methotrexate; Phototherapy; Psoriasis; PUVA Therapy; Retinoids; Sex Factors | 2007 |
Atypical acute graft-versus-host disease.
Topics: Acute Disease; Adult; Bone Marrow Transplantation; Cyclosporine; Erythema; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Necrosis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin Diseases; Treatment Outcome | 2007 |
Methylenetetrahydrofolate reductase C677T genotypes and clinical outcome following hematopoietic cell transplant.
Topics: Adolescent; Adult; Cohort Studies; Cyclosporine; Female; Genotype; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Treatment Outcome | 2007 |
[Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous | 2007 |
Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Topics: Acute Disease; Adolescent; beta-Thalassemia; Blood Platelets; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Methotrexate; Myeloablative Agonists; Neutrophils; Peripheral Blood Stem Cell Transplantation; Recovery of Function; Retrospective Studies; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2008 |
Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia--feasibility and safety study.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Feasibility Studies; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Tissue Donors | 2008 |
Methotrexate and cyclosporine treatments modify the activities of dipeptidyl peptidase IV and prolyl oligopeptidase in murine macrophages.
Topics: Animals; Cyclosporine; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Drug Therapy, Combination; Enzyme Inhibitors; Immunosuppressive Agents; Inflammation; Macrophages, Peritoneal; Male; Methotrexate; Mice; Pain; Prolyl Oligopeptidases; Serine Endopeptidases | 2008 |
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.
Topics: Cyclosporine; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Sirolimus; Tacrolimus | 2008 |
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Topics: Acitretin; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Cardiovascular Diseases; Cyclosporine; Depression; Etanercept; Humans; Immunoglobulin G; Interleukin-12; Interleukin-23; Lymphoma; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Smoking; Tumor Necrosis Factor-alpha | 2008 |
Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease.
Topics: Acute Disease; Animals; Antibodies; CD3 Complex; Chronic Disease; Colitis; Cyclosporine; Dextran Sulfate; Disease Models, Animal; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-12 Subunit p40; Methotrexate; Mice; Mice, Inbred C57BL | 2008 |
Beta-thalassaemia major: bone marrow versus peripheral blood stem cell transplantation.
Topics: Adolescent; beta-Thalassemia; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Risk Factors; Treatment Outcome | 2008 |
Unexpected complication after varicella: aplastic anemia.
Topics: Anemia, Aplastic; Biopsy, Needle; Blood Cell Count; Bone Marrow; Chickenpox; Child; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Female; Flow Cytometry; Follow-Up Studies; Humans; Immunosuppressive Agents; Methotrexate; Stem Cell Transplantation | 2008 |
Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis.
Topics: Adolescent; Adrenal Cortex Hormones; Arthritis, Juvenile; Child; Child, Preschool; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Retrospective Studies; Uveitis | 2009 |
Acrodermatitis continua resistant to etanercept: therapeutic challenge and unfortunate outcome.
Topics: Acrodermatitis; Cyclosporine; Drug Resistance; Etanercept; Humans; Immunoglobulin G; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Treatment Outcome | 2009 |
Clinical and radiological features of brain neurotoxicity caused by antitumor and immunosuppressant treatments.
Topics: Adult; Aged; Antineoplastic Agents; Asparaginase; Brain; Cerebral Veins; Child; Cyclosporine; Diagnosis, Differential; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Transplantation; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Neoplasms; Neurotoxicity Syndromes; Paraneoplastic Syndromes, Nervous System; Radiotherapy; Risk Factors; Venous Thrombosis | 2008 |
Systemic and light therapies for the management of childhood psoriasis: part II.
Topics: Biological Products; Child; Cyclosporine; Dermatologic Agents; Humans; Methotrexate; Phototherapy; Psoriasis; Retinoids | 2008 |
Persistent clinical response of infliximab therapy in patients with refractory rheumatoid arthritis, over a 3-year period.
Topics: Antibodies, Monoclonal; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Infliximab; Magnetic Resonance Imaging; Methotrexate; Tumor Necrosis Factor-alpha | 2006 |
Combination of CsA, MTX and low-dose, short-course mycophenolate mofetil for GVHD prophylaxis.
Topics: Adolescent; Adult; Cohort Studies; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mucositis; Mycophenolic Acid; Prospective Studies; Transplantation Conditioning; Young Adult | 2009 |
Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Treatment Outcome | 2008 |
Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Behcet Syndrome; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Methotrexate; Prednisone; Recurrence; Retinal Vasculitis; Retrospective Studies; Treatment Outcome; Visual Acuity; Young Adult | 2008 |
Increased insulin-like growth factor binding protein-3 expression level in psoriatic tissue before and after systemic treatment with cyclosporine A and methotrexate.
Topics: Adult; Cyclosporine; Dermatologic Agents; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; Insulin-Like Growth Factor Binding Protein 3; Male; Methotrexate; Middle Aged; Psoriasis; Skin; Young Adult | 2008 |
Generalized pustulosis induced by adalimumab in a patient with rheumatoid arthritis - a therapeutic challenge.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Cyclosporine; Drug Eruptions; Drug Therapy, Combination; Epidermis; Female; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Prednisolone | 2008 |
Fluctuation of circulating plasmacytoid dendritic cells in a patient with psoriatic arthritis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Psoriatic; Cyclosporine; Dendritic Cells; Humans; Immunophenotyping; Male; Methotrexate | 2008 |
What the first 10,000 patients with chronic urticaria have taught me: a personal journey.
Topics: Allergens; Autoantibodies; Autoimmunity; Chronic Disease; Cyclosporine; Guidelines as Topic; Histamine Antagonists; Humans; Hydroxyzine; Immunosuppressive Agents; Methotrexate; Urticaria | 2009 |
Economic evaluation of systemic therapies for moderate to severe psoriasis.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cost-Benefit Analysis; Cyclosporine; Dermatologic Agents; Etanercept; Humans; Immunoglobulin G; Infliximab; Methotrexate; Psoriasis; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Statistics as Topic; Time Factors; Treatment Outcome | 2009 |
Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Cyclosporine; Female; Glomerular Filtration Rate; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Melphalan; Methotrexate; Middle Aged; Mycophenolic Acid; Premedication; Risk Factors; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation; Young Adult | 2009 |
Sterile corneal melt after descemet stripping endothelial keratoplasty in patients with previously undiagnosed Sjogren syndrome.
Topics: Aged, 80 and over; Corneal Diseases; Corneal Transplantation; Cyclosporine; Descemet Membrane; Drug Therapy, Combination; Endothelium, Corneal; Fuchs' Endothelial Dystrophy; Humans; Male; Methotrexate; Postoperative Complications; Prednisone; Sjogren's Syndrome | 2009 |
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Topics: Acute Disease; Clinical Trials, Phase III as Topic; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Diseases; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Liver Diseases; Methotrexate; Organ Specificity; Postoperative Complications; Randomized Controlled Trials as Topic; Retrospective Studies; Skin Diseases; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous | 2009 |
Long-term efficacy of mycophenolate mofetil in a case of refractory antisynthetase syndrome.
Topics: Adult; C-Reactive Protein; Cyclosporine; Diabetes Mellitus, Type 1; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Mycophenolic Acid; Protoporphyria, Erythropoietic; Raynaud Disease | 2009 |
A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients.
Topics: Adolescent; Adult; Aged; Child; Cyclosporine; Female; Humans; Keratoderma, Palmoplantar; Male; Methotrexate; Middle Aged; Photochemotherapy; Psoriasis; Retinoids; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
European S3-guidelines on the systemic treatment of psoriasis vulgaris.
Topics: Adalimumab; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatologic Agents; Etanercept; Humans; Immunoglobulin G; Infliximab; Methotrexate; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Retinoids | 2009 |
Ocular findings after allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Child; Cyclosporine; Eye Diseases; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Intraocular Pressure; Male; Methotrexate; Middle Aged; Ophthalmoscopy; Retrospective Studies; Transplantation, Homologous; Visual Acuity | 2009 |
The effects of drug transporter inhibitors on the pharmacokinetics and tissue distribution of methotrexate in normal and tumor-bearing mice: a microdialysis study.
Topics: Animals; ATP-Binding Cassette Transporters; Cell Line, Tumor; Cyclosporine; Drug Delivery Systems; Drug Interactions; Female; Humans; Methotrexate; Mice; Mice, Nude; Microdialysis; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neoplasms; Probenecid; Tissue Distribution; Xenograft Model Antitumor Assays | 2010 |
Microscopic colitis and endoscopy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Azathioprine; Cholestyramine Resin; Colitis, Collagenous; Colitis, Lymphocytic; Colonoscopy; Cyclosporine; Gastric Mucosa; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Methotrexate; Proton Pump Inhibitors | 2009 |
[Hepatotoxicity induced by new immunosuppressants].
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Tumor Necrosis Factor-alpha | 2010 |
Tacrolimus/Methotrexate versus cyclosporine/methotrexate as graft-versus-host disease prophylaxis in patients with severe aplastic anemia who received bone marrow transplantation from unrelated donors: results of matched pair analysis.
Topics: Anemia, Aplastic; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Matched-Pair Analysis; Methotrexate; Survival Rate; Tacrolimus; Tissue Donors | 2009 |
Influence of lymphocyte recovery on outcome of haploidentical transplantation for hematologic malignancies.
Topics: Adolescent; Adult; Child; Cyclosporine; Female; Graft vs Host Disease; Haplotypes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Immunosuppressive Agents; Lymphocyte Count; Male; Methotrexate; Middle Aged; Transplantation, Homologous; Treatment Outcome; Young Adult | 2009 |
Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease.
Topics: Acute Disease; Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cohort Studies; Cyclosporine; Dry Eye Syndromes; Eye Diseases; Female; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Steroids; Treatment Outcome | 2010 |
GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplants.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Siblings; Survival Rate; Transplantation, Homologous | 2010 |
Childhood psoriasis: often favorable outcome.
Topics: Acitretin; Administration, Topical; Anthralin; Calcitriol; Child; Cyclosporine; Dermatologic Agents; Emollients; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Nicotinic Acids; Plant Extracts; Psoriasis; Receptors, Tumor Necrosis Factor; Salicylates; Steroids; Tars; Treatment Outcome; Ultraviolet Therapy | 2009 |
Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTX.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etoposide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Male; Methotrexate; Middle Aged; Mucositis; Retrospective Studies; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation; Young Adult | 2010 |
High prevalence of potential drug-drug interactions for psoriasis patients prescribed methotrexate or cyclosporine for psoriasis: associated clinical and economic outcomes in real-world practice.
Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Drug Interactions; Female; Humans; Immunosuppressive Agents; Male; Managed Care Programs; Methotrexate; Middle Aged; Prevalence; Psoriasis; Retinoids | 2010 |
MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings.
Topics: Adolescent; Adult; Aged; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Siblings; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2010 |
Comparison of peripheral blood stem cell transplant with bone marrow transplant in class 3 thalassemic patients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Survival Rate; Thalassemia; Treatment Outcome; Young Adult | 2010 |
Large granular lymphocyte leukemia: natural history and response to treatment.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Male; Methotrexate; Middle Aged; Pentostatin; Survival Rate; Treatment Outcome | 2010 |
[Prophylactic effect of CsA, MTX, MMF combined with ATG on GVHD in patients underwent unrelated peripheral blood hematopoietic stem cell transplantation].
Topics: Adolescent; Adult; Antilymphocyte Serum; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Young Adult | 2010 |
Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
Topics: Adult; Antineoplastic Agents; Asparaginase; Combined Modality Therapy; Cyclosporine; Drug Resistance, Neoplasm; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma, T-Cell; Male; Methotrexate; Natural Killer T-Cells; Neoplasm Recurrence, Local; Nose Neoplasms; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Transplantation, Homologous; Treatment Outcome; Young Adult | 2010 |
Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors.
Topics: Adalimumab; Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Cytokines; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Patch Tests; Prospective Studies; Tacrolimus; Treatment Outcome | 2010 |
Evaluation of posttransplant methotrexate to facilitate engraftment in the canine major histocompatibility complex-haploidentical nonmyeloablative transplant model.
Topics: Animals; Antibodies, Monoclonal; Cyclosporine; Dogs; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hyaluronan Receptors; Immunosuppressive Agents; Major Histocompatibility Complex; Methotrexate; Models, Animal; Mycophenolic Acid; Transplantation Conditioning | 2010 |
Langerhans cell histiocytosis in a child with non-Hodgkin lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Cytarabine; Female; Histiocytosis, Langerhans-Cell; Humans; Lymphoma, Non-Hodgkin; Mercaptopurine; Methotrexate; Prednisolone; Prednisone; Vinblastine; Vincristine | 2010 |
Successful treatment of hand and foot psoriasis with infliximab.
Topics: Adult; Antibodies, Monoclonal; Cyclosporine; Dermatologic Agents; DiGeorge Syndrome; Fatty Liver, Alcoholic; Female; Foot Dermatoses; Hand Dermatoses; Hepatitis C, Chronic; Humans; Infliximab; Male; Methotrexate; Middle Aged; Psoriasis; Retinoids; Retrospective Studies; Treatment Outcome | 2010 |
Development of a dot-blot assay for screening monoclonal antibodies to low-molecular-mass drugs.
Topics: Acridines; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Anticonvulsants; Carbamazepine; Collodion; Cyclosporine; Gentamicins; Hydrocortisone; Immunoblotting; Immunosuppressive Agents; Methotrexate; Pharmaceutical Preparations; Reproducibility of Results; Sirolimus; Tacrolimus | 2010 |
Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia.
Topics: Adolescent; Adult; Anemia, Aplastic; Antineoplastic Agents; Blood Platelets; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Female; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Neutrophils; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Young Adult | 2011 |
Dose-dependent inhibition of transporter-mediated hepatic uptake and biliary excretion of methotrexate by cyclosporine A in an isolated perfused rat liver model.
Topics: Animals; Bile; Biliary Tract; Biological Transport; Cyclosporine; Dose-Response Relationship, Drug; Liver; Male; Membrane Transport Proteins; Metabolic Detoxication, Phase II; Methotrexate; Perfusion; Rats; Rats, Sprague-Dawley | 2010 |
Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
Topics: Adult; Antilymphocyte Serum; Calcineurin Inhibitors; Cyclosporine; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sirolimus; Survival Analysis; Tacrolimus; Thrombotic Microangiopathies; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2011 |
Sudden onset of an aggressive cutaneous lymphoma in a young patient with psoriasis: role of immunosuppressants.
Topics: Adult; Antibiotics, Antineoplastic; Biopsy; Cyclosporine; Doxorubicin; Etanercept; Fatal Outcome; Humans; Immunoglobulin G; Immunosuppressive Agents; Leg; Lymphoma, T-Cell, Cutaneous; Male; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Polyethylene Glycols; Psoriasis; Receptors, Tumor Necrosis Factor; Skin Neoplasms; Treatment Failure | 2010 |
Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A: modulation of P-glycoprotein function.
Topics: Adult; Arthritis, Psoriatic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Sedimentation; C-Reactive Protein; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Joints; Male; Methotrexate; Middle Aged; Rhodamine 123; Sulfasalazine; T-Lymphocytes; Treatment Outcome; Verapamil | 2011 |
Treatment of psoriasis in patients with hepatitis C virus infection.
Topics: Acitretin; Antiviral Agents; Cyclosporine; Drug Eruptions; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon-alpha; Methotrexate; Psoriasis; Ribavirin | 2011 |
Immunoglobulins during different treatment regimes in Schnitzler's syndrome.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azathioprine; Biomarkers; C-Reactive Protein; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Immunoglobulin M; Interleukin 1 Receptor Antagonist Protein; Male; Methotrexate; Pain Measurement; Prednisone; Receptors, Tumor Necrosis Factor; Schnitzler Syndrome | 2011 |
How I treat LGL leukemia.
Topics: Anemia; Arthritis, Rheumatoid; Cyclosporine; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Methotrexate; Neutropenia | 2011 |
Effective continuous systemic therapy of severe plaque-type psoriasis is accompanied by amelioration of biomarkers of cardiovascular risk: results of a prospective longitudinal observational study.
Topics: Adalimumab; Adipokines; Adult; Aged; Antibodies, Monoclonal, Humanized; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cyclosporine; Etanercept; Female; Fumarates; Humans; Immunoglobulin G; Longitudinal Studies; Male; Methotrexate; Middle Aged; Prospective Studies; Psoriasis; Receptors, Tumor Necrosis Factor; Resistin; Risk Factors; Severity of Illness Index; Treatment Outcome; Vascular Endothelial Growth Factor A | 2011 |
Cyclosporin combined with methotrexate in two patients with recalcitrant subacute cutaneous lupus erythematosus.
Topics: Adult; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Lupus Erythematosus, Cutaneous; Methotrexate; Middle Aged; Treatment Outcome | 2011 |
Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia.
Topics: Adult; Benzamides; Blast Crisis; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Piperazines; Pyrimidines; Remission Induction; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2011 |
[Active psoriatic arthritis during pregnancy: challenges and limitations of pharmacotherapy].
Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Contraindications; Cyclosporine; Female; Humans; Isoxazoles; Leflunomide; Methotrexate; Prednisolone; Prednisone; Pregnancy; Pregnancy Complications; Sulfasalazine | 2010 |
[Adverse effects of cyclosporin a observed in rheumatoid arthritis and psoriatic arthritis].
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Creatinine; Cyclosporine; Diarrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feeding and Eating Disorders; Female; Follow-Up Studies; Hirsutism; Humans; Hypertension; Male; Methotrexate; Middle Aged; Peripheral Nervous System Diseases; Tremor | 2010 |
[Nodular changes in lungs in a patient with rheumatoid arthritis. Diagnostic and therapeutic difficulties. Case report].
Topics: Aged; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; Humans; Lung; Lung Neoplasms; Male; Methotrexate; Rheumatoid Nodule | 2010 |
Use of conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists.
Topics: Cyclosporine; Dermatology; Humans; Methotrexate; Practice Patterns, Physicians'; Psoriasis; Retinoids | 2011 |
[Meetings of the Psoriasis Experts: recommendations for daily practice].
Topics: Consensus Development Conferences as Topic; Cyclosporine; Delphi Technique; Evidence-Based Medicine; Expert Testimony; Humans; Methotrexate; Practice Guidelines as Topic; Professional Practice; Psoriasis; Retinoids | 2011 |
A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.
Topics: Adolescent; Adult; Aged; Calcineurin Inhibitors; Child; Child, Preschool; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Proportional Hazards Models; Retrospective Studies; Severity of Illness Index; Standard of Care; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2011 |
Double trouble: therapeutic challenges in patients with both juvenile dermatomyositis and psoriasis.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Dermatologic Agents; Dermatomyositis; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Methotrexate; Methylprednisolone; Mycophenolic Acid; Phototherapy; Prednisone; Psoriasis; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Products; Cyclosporine; Dermatologic Agents; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Safety-Based Drug Withdrawals; Severity of Illness Index; Treatment Outcome; Withholding Treatment; Young Adult | 2011 |
Ustekinumab treats psoriasis refractory to seven conventional and biologic therapies.
Topics: Acitretin; Adalimumab; Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Calcitriol; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor; Tacrolimus; Treatment Outcome; Ustekinumab | 2011 |
Haemophagocytic lymphohistiocytosis: a case series from Mumbai.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclosporine; Dexamethasone; Etoposide; Female; Humans; India; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Methotrexate; Retrospective Studies | 2011 |
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Cyclosporine; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Remission Induction; Severity of Illness Index; Sex Factors; Tacrolimus | 2011 |
Systemic treatment with corticosteroids in psoriasis--health care provision far beyond the S3-guidelines.
Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Cyclosporine; Drug Utilization; Female; Fumarates; General Practice; Germany; Guideline Adherence; Humans; Internal Medicine; Male; Methotrexate; Off-Label Use; Psoriasis; Retinoids | 2011 |
T-cell depletion in GVHD: less is more?
Topics: Adolescent; Adult; Antilymphocyte Serum; Chronic Disease; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Time Factors; Transplantation Conditioning; Transplantation, Homologous | 2011 |
[Update on psoriasis at the Dermatology Day conference, Paris 2010].
Topics: Comorbidity; Creatinine; Cyclosporine; Dermatologic Agents; Dose-Response Relationship, Drug; Humans; Kidney Diseases; Liver Cirrhosis; Methotrexate; Psoriasis; Risk Factors; Severity of Illness Index | 2011 |
[News on psoriasis from the 2010 Dermatology Days in Paris].
Topics: Acitretin; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Cyclosporine; Dermatologic Agents; Dermatology; Drug Therapy, Combination; Etanercept; Evidence-Based Medicine; Humans; Immunoglobulin G; Methotrexate; Practice Guidelines as Topic; Psoriasis; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Treatment Outcome; Ustekinumab | 2011 |
Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Immunosuppressive Agents; Injections, Subcutaneous; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Methotrexate; Prednisolone; Pulse Therapy, Drug; Receptors, Tumor Necrosis Factor; Remission Induction; Treatment Failure | 2012 |
Superimposed linear psoriasis: low effectiveness of biologic therapy.
Topics: Acitretin; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Biological Therapy; Cyclosporine; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Loss of Heterozygosity; Male; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor | 2011 |
Medication neurotoxicity in children.
Topics: Adolescent; Angiogenesis Inhibitors; Anti-Infective Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infant; Magnetic Resonance Imaging; Male; Methotrexate; Metronidazole; Neurotoxicity Syndromes; Posterior Leukoencephalopathy Syndrome; Tacrolimus; Young Adult | 2011 |
[Biological therapy in sympathetic ophthalmia refractory to combined immunosuppressive treatment].
Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Biological Therapy; Combined Modality Therapy; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Methotrexate; Ophthalmia, Sympathetic; Postoperative Complications; Prednisone; Retinal Detachment; Tumor Necrosis Factor-alpha | 2011 |
Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Axons; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Drug Resistance; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon-alpha; Interferon-beta; Italy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasmapheresis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Remission Induction; Retrospective Studies; Rituximab; Severity of Illness Index; Treatment Outcome; Young Adult | 2011 |
[Treatment-resistant adult atopic dermatitis].
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Dermatitis, Allergic Contact; Dermatitis, Atopic; Dermatitis, Occupational; Dietary Proteins; Drug Resistance; Facial Dermatoses; Female; Food Hypersensitivity; Hand Dermatoses; Histamine Antagonists; Humans; Immunosuppressive Agents; Methotrexate; Patch Tests; Skin Tests; Tacrolimus | 2011 |
Survey of expert practice and perceptions of the supporting clinical evidence for the management of uveitis-related cataract and cystoid macular oedema.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Azathioprine; Cataract; Cataract Extraction; Cyclosporine; Expert Testimony; Female; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Macular Edema; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Ophthalmologic Surgical Procedures; Surveys and Questionnaires; Uveitis; Young Adult | 2011 |
Quality of life of patients after allogeneic hematopoietic stem cell transplantation with antihuman thymocyte globulin.
Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Leukemia; Lymphocyte Depletion; Male; Methotrexate; Middle Aged; Opportunistic Infections; Quality of Life; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous | 2012 |
Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplant.
Topics: Adult; Aged; Cause of Death; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Recurrence; Siblings; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2011 |
Treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis: a report of 2 cases.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Alefacept; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Crohn Disease; Cyclosporine; Etanercept; Female; Humans; Immunoglobulin G; Methotrexate; Middle Aged; Mycophenolic Acid; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Treatment Outcome; Ustekinumab | 2011 |
Modern treatment strategies in rheumatoid arthritis.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Betamethasone; Cohort Studies; Cyclosporine; Etanercept; Female; Humans; Immunoglobulin G; Injections, Intra-Articular; Male; Methotrexate; Middle Aged; Prognosis; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Remission Induction; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2011 |
Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne.
Topics: Adolescent; Adult; Age Factors; Anal Canal; Analysis of Variance; Chi-Square Distribution; Colectomy; Colitis, Ulcerative; Constriction, Pathologic; Crohn Disease; Cyclosporine; Female; Hong Kong; Hospitalization; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Multivariate Analysis; Proportional Hazards Models; Sex Factors; Smoking; Steroids; Tumor Necrosis Factor Inhibitors; Victoria; Young Adult | 2012 |
Marrow versus blood-derived stem cell grafts for allogeneic transplantation from unrelated donors in patients with active myeloid leukemia or myelodysplasia.
Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Agents; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Female; Follow-Up Studies; Germany; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Secondary Prevention; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors | 2012 |
[Choice of therapy based on clinical setting].
Topics: Age Factors; Comorbidity; Contraindications; Cyclosporine; Decision Making; Dermatologic Agents; Female; Hepatic Insufficiency; Humans; Kidney Diseases; Latent Tuberculosis; Mental Disorders; Methotrexate; Pregnancy; Psoriasis; Risk Factors; Skin Neoplasms | 2011 |
Estimation of tissue osteopontin levels before and after different traditional therapeutic modalities in psoriatic patients.
Topics: Cyclosporine; Humans; Methotrexate; Osteopontin; Psoriasis; PUVA Therapy | 2013 |
Good response to infliximab in a patient with deep vein thrombosis associated with Behçet disease.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Recurrence; Treatment Outcome; Venous Thrombosis | 2012 |
Nodular melanoma arising in a patient treated with anti-tumor necrosis factor alpha antagonists.
Topics: Acitretin; Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatologic Agents; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Melanoma; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Skin Neoplasms; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Child; Child, Preschool; Cyclosporine; Drug Resistance; Female; Glucocorticoids; Humans; Injections, Subcutaneous; Macula Lutea; Male; Methotrexate; Off-Label Use; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Visual Acuity | 2012 |
Langerhans cell histiocytosis presenting as a multi-system disorder in an infant.
Topics: Biopsy; Bone Diseases; Cyclosporine; Femur; Glucocorticoids; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Infant; Lung Diseases; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Prednisone; Radiography; Skin; Skin Diseases, Papulosquamous | 2012 |
Folinic acid administration after MTX GVHD prophylaxis in pediatric allo-SCT.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Female; Folic Acid Antagonists; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Leucovorin; Male; Methotrexate; Mucositis; Retrospective Studies; Severity of Illness Index; Stem Cell Transplantation; Survival Analysis; Transplantation, Homologous; Vitamin B Complex | 2013 |
Unmasking of axial spondyloarthritis and oligoarthritis following discontinuation of tumour necrosis factor inhibitor therapy for psoriasis.
Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Cyclosporine; Drug Substitution; Humans; Immunosuppressive Agents; Knee Injuries; Male; Methotrexate; Osteoarthritis, Knee; Psoriasis; Spondylarthritis; Tumor Necrosis Factor-alpha; Ustekinumab; Withholding Treatment | 2014 |
Fever of unknown origin in a patient of systemic onset juvenile idiopathic arthritis.
Topics: Adolescent; Anemia; Anti-Inflammatory Agents; Arthritis, Juvenile; Cyclosporine; Dexamethasone; Fever of Unknown Origin; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Male; Methotrexate; Thrombocytopenia | 2010 |
Large granular lymphocytic leukemia: a treatable form of refractory celiac disease.
Topics: Aged; Celiac Disease; Cyclosporine; Diet, Gluten-Free; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Methotrexate; Middle Aged; Treatment Failure; Treatment Outcome | 2012 |
Combination of adalimumab with traditional systemic antipsoriatic drugs - a report of 39 cases.
Topics: Acitretin; Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Methotrexate; Middle Aged; Psoriasis; Treatment Outcome; Young Adult | 2012 |
Cyclosporine-induced haemolytic anaemia in a child with juvenile dermatomyositis.
Topics: Anemia, Hemolytic; Azathioprine; Child; Cyclosporine; Dermatomyositis; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Prednisolone; Pulse Therapy, Drug | 2012 |
Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis.
Topics: Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Arthroplasty, Replacement, Hip; Cyclosporine; Down-Regulation; Factor XIII; Factor XIII Deficiency; Fibrinogen; Hematoma; Humans; Immunosuppressive Agents; Interleukin-6; Male; Methotrexate; Methylprednisolone; Middle Aged; Postoperative Complications; Sjogren's Syndrome | 2012 |
A retrospective analysis of combination methotrexate-cyclosporine therapy in moderate-severe psoriasis.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; India; Male; Methotrexate; Middle Aged; Psoriasis; Retrospective Studies; Treatment Outcome | 2014 |
Acral erythema worsened by intravenous infusions of cyclosporin.
Topics: Adult; Antineoplastic Agents; Cyclosporine; Cytarabine; Drug Eruptions; Erythema; Graft vs Host Disease; Humans; Infusions, Intravenous; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2013 |
Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey.
Topics: Academies and Institutes; Anti-Infective Agents; Cyclosporine; Data Collection; Graft vs Host Disease; Growth Hormone; Hematopoietic Stem Cell Transplantation; Humans; Mediterranean Region; Methotrexate; Pulmonary Veno-Occlusive Disease; Transplantation, Autologous; Transplantation, Homologous; Ursodeoxycholic Acid | 2013 |
Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants.
Topics: Acute Disease; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Chronic Disease; Clinical Trials as Topic; Cyclohexanes; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydroxamic Acids; Immunosuppressive Agents; Maraviroc; Methotrexate; Pentostatin; Peripheral Blood Stem Cell Transplantation; Pyrazines; Quality of Life; Tacrolimus; Triazoles; Vorinostat | 2013 |
Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantation.
Topics: Adolescent; Adult; Child; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Morbidity; Mycophenolic Acid; Neoplasm Recurrence, Local; Prognosis; Survival Rate; Transplantation, Homologous; Unrelated Donors; Young Adult | 2013 |
Cancer-free survival of psoriasis patients treated with methotrexate and cyclosporine combination.
Topics: Adult; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Neoplasms; Psoriasis; Surveys and Questionnaires; Turkey | 2014 |
Systemic therapies for severe atopic dermatitis in children and adults.
Topics: Adult; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Male; Methotrexate; Quality of Life | 2013 |
Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Biological Products; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Psoriasis; Retinoids; Retrospective Studies; Tertiary Care Centers; Ustekinumab | 2013 |
Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant.
Topics: Adolescent; Adult; Aged; Busulfan; Chimerism; Cohort Studies; Cyclophosphamide; Cyclosporine; Cytomegalovirus Infections; DNA; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Proportional Hazards Models; Retrospective Studies; T-Lymphocytes; Tacrolimus; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Viremia; Young Adult | 2014 |
Time to recovery from proteinuria in patients with lupus nephritis receiving standard treatment.
Topics: Adolescent; Adult; Antineoplastic Agents; Cyclosporine; Databases, Factual; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Longitudinal Studies; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methotrexate; Middle Aged; Ontario; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Proteinuria; Steroids; Time Factors; Treatment Outcome; Urinalysis; Young Adult | 2014 |
Outcomes of changing immunosuppressive therapy after treatment failure in patients with noninfectious uveitis.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Cohort Studies; Cyclosporine; Drug Substitution; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisolone; Retrospective Studies; Treatment Failure; Treatment Outcome; Uveitis; Visual Acuity; Young Adult | 2014 |
[Large granular lymphocytic leukemia. A rare disease with personalized treatment options].
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Female; Humans; Immunophenotyping; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Male; Methotrexate; Middle Aged; Molecular Targeted Therapy; Neutropenia; Precision Medicine; Rare Diseases; Retrospective Studies; Sepsis; Treatment Outcome | 2014 |
The patient with acute muscular weakness.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Creatine Kinase; Cyclosporine; Dermatomyositis; Diagnosis, Differential; Humans; Immunosuppressive Agents; Male; Methotrexate; Muscle Weakness; Prednisolone; Treatment Outcome; Young Adult | 2014 |
Methotrexate vs. ciclosporin in the treatment of severe atopic dermatitis in children: a critical appraisal.
Topics: Cyclosporine; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; Methotrexate | 2014 |
Commentary: Methotrexate and ciclosporin in the treatment of severe eczema in children.
Topics: Cyclosporine; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; Methotrexate | 2014 |
On a class of optimal covariate-adjusted response adaptive designs for survival outcomes.
Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Cyclosporine; Female; Graft vs Host Disease; Humans; Infant; Male; Methotrexate; Research Design; Survival Analysis; Treatment Outcome; Young Adult | 2016 |
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry.
Topics: Acitretin; Adalimumab; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Products; Cyclosporine; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Keratolytic Agents; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Prospective Studies; Psoriasis; Receptors, Tumor Necrosis Factor; Registries; Risk Assessment; Spain; Ustekinumab | 2015 |
The effects of prednisone and steroid-sparing agents on decay accelerating factor (CD55) expression: implications in myasthenia gravis.
Topics: Animals; Azathioprine; CD55 Antigens; Cell Line; Chlorocebus aethiops; COS Cells; Cyclosporine; Glucocorticoids; Humans; Methotrexate; Mice; Myasthenia Gravis; Prednisone | 2014 |
Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.
Topics: Anti-Infective Agents; Azathioprine; Cyclosporine; Dermatitis, Atopic; Histamine Antagonists; Humans; Immunologic Factors; Interferon-gamma; Methotrexate; Mycophenolic Acid; Phototherapy | 2014 |
Steroid-sparing effects of etanercept in a patient with steroid-dependent adult-onset Still's disease.
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Antirheumatic Agents; Cyclosporine; Etanercept; Humans; Immunoglobulin G; Male; Methotrexate; Prednisolone; Receptors, Tumor Necrosis Factor; Still's Disease, Adult-Onset | 2014 |
Frequency of monoclonal gammopathy in psoriatic patients receiving anti-TNF therapy compared with patients taking conventional drugs: a cross-sectional study.
Topics: Acitretin; Adalimumab; Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cross-Sectional Studies; Cyclosporine; Etanercept; Female; Humans; Immunosuppressive Agents; Infliximab; Keratolytic Agents; Male; Methotrexate; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Prevalence; Psoriasis; Tumor Necrosis Factor-alpha | 2015 |
Clinical and serological predictors of remission in rheumatoid arthritis are dependent on treatment regimen.
Topics: Adult; Age Factors; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Prednisolone; Remission Induction; Rheumatoid Factor; Sex Factors; Treatment Outcome | 2014 |
Methotrexate and cyclosporine in psoriasis revisited.
Topics: Cyclosporine; Humans; Methotrexate; Psoriasis | 2014 |
Treatment with immunosuppressive therapy in patients with pars planitis: experience of a reference centre in Mexico.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Mexico; Middle Aged; Pars Planitis; Referral and Consultation; Retrospective Studies; Visual Acuity | 2014 |
Usefulness of tacrolimus for refractory adult-onset still's disease: Report of six cases.
Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Pregnancy; Pregnancy Complications; Still's Disease, Adult-Onset; Tacrolimus | 2016 |
Trends in systemic psoriasis treatment therapies from 1993 through 2010.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Cyclosporine; Dermatologic Agents; Dermatology; Humans; Methotrexate; Phototherapy; Psoriasis; Retinoids; Severity of Illness Index; Surveys and Questionnaires; United States | 2014 |
Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.
Topics: Acitretin; Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cross-Sectional Studies; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Infliximab; Keratolytic Agents; Male; Methotrexate; Middle Aged; Psoriasis; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Young Adult | 2014 |
Psoriatic arthritis treatment and the risk of herpes zoster.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Etanercept; Female; Glucosamine; Herpes Zoster; Humans; Hydroxychloroquine; Incidence; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Tumor Necrosis Factor-alpha | 2016 |
The risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Asian People; Cohort Studies; Cyclosporine; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Incidence; Insurance; Male; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasms; Outcome Assessment, Health Care; Proportional Hazards Models; Receptors, Tumor Necrosis Factor; Risk Factors; Taiwan; Tumor Necrosis Factor-alpha | 2014 |
Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.
Topics: Adult; Aged; Anti-Inflammatory Agents; Biological Products; Cardiovascular Diseases; Cause of Death; Climatotherapy; Cyclosporine; Denmark; Dermatologic Agents; Female; Follow-Up Studies; Humans; Incidence; Longitudinal Studies; Male; Methotrexate; Middle Aged; Myocardial Infarction; Phototherapy; Psoriasis; Registries; Retinoids; Severity of Illness Index; Stroke; Tumor Necrosis Factor-alpha; Ustekinumab | 2015 |
Comparison of continuous and twice-daily infusions of cyclosporine A for graft-versus-host-disease prophylaxis in pediatric hematopoietic stem cell transplantation.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2015 |
[Therapeutic efficacy of second allo-HSCT for aplastic anemia after failure of first allo-HSCT].
Topics: Allografts; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Mycophenolic Acid; Retrospective Studies | 2014 |
Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Platelets; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Neutrophils; Recurrence; Retrospective Studies; Siblings; Survival Analysis; Tissue Donors; Transplantation, Homologous | 2015 |
The 'switcher' patient profile in psoriasis treatment: from traditional to biological and from biological to traditional systemic drugs.
Topics: Acitretin; Adalimumab; Adult; Aged; Biological Factors; Cyclosporine; Dermatologic Agents; Drug Substitution; Etanercept; Female; Humans; Infliximab; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Psoriasis; Ustekinumab; Young Adult | 2015 |
Cyclosporine and methotrexate-related pharmacogenomic predictors of acute graft-versus-host disease.
Topics: Acute Disease; Adult; Biomarkers, Tumor; Canada; Chronic Disease; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Neoplasm Staging; Pharmacogenetics; Polymorphism, Single Nucleotide; Prognosis; Survival Rate; Young Adult | 2015 |
Superior outcome using cyclosporin A alone versus cyclosporin A plus methotrexate for post-transplant immunosuppression in children with acute leukemia undergoing sibling hematopoietic stem cell transplantation.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Germany; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Prevention; Retrospective Studies; Severity of Illness Index; Siblings; Treatment Outcome; Young Adult | 2015 |
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Humans; Inflammatory Bowel Diseases; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Odds Ratio; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Severity of Illness Index; Sex Factors; Spain; Spondylarthropathies; Sulfasalazine; Uveitis | 2015 |
[Efficacies of hematopoietic stem cell transplantation for severe aplastic anemia: a report of 43 patients].
Topics: Adolescent; Adult; Anemia, Aplastic; Child; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Siblings; Transplantation Conditioning; Vidarabine; Young Adult | 2014 |
Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Juvenile; Azathioprine; Child; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Herpes Zoster; Humans; Immunocompromised Host; Immunosuppressive Agents; Incidence; Longitudinal Studies; Male; Methotrexate; Prospective Studies; Risk Factors | 2015 |
How are we using systemic drugs to treat psoriasis in children? An insight into current clinical U.K. practice.
Topics: Acitretin; Adolescent; Child; Child, Preschool; Cyclosporine; Dapsone; Dermatologic Agents; Fumarates; Humans; Immunosuppressive Agents; Methotrexate; Practice Patterns, Physicians'; Psoriasis; United Kingdom | 2015 |
Mycophenolate-based graft versus host disease prophylaxis is not inferior to methotrexate in myeloablative-related donor stem cell transplantation.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous | 2015 |
Systemic antipsoriatic combination therapy with fumaric acid esters for plaque-type psoriasis: report on 17 cases.
Topics: Acitretin; Adult; Aged; Anti-Inflammatory Agents; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Fumarates; Germany; Humans; Infliximab; Isoxazoles; Keratolytic Agents; Leflunomide; Male; Methotrexate; Middle Aged; Prednisolone; Psoriasis; Retrospective Studies | 2015 |
Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
Topics: Academic Medical Centers; Administration, Oral; Adult; Azathioprine; Cyclosporine; Dermatitis, Atopic; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Tacrolimus; Young Adult | 2015 |
[Treatment of myelodysplastic syndrome by hematopoietic stem cell transplantation combined with Chinese medical syndrome typing: a clinical study].
Topics: Biomedical Research; Blood Platelets; Bone Marrow Transplantation; Cyclosporine; Disease-Free Survival; Drugs, Chinese Herbal; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Medicine, Chinese Traditional; Methotrexate; Myelodysplastic Syndromes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2015 |
Systemic Therapy for Psoriasis and the Risk of Herpes Zoster: A 500,000 Person-year Study.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Biological Factors; Causality; Cohort Studies; Comorbidity; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Herpes Zoster; Herpes Zoster Vaccine; Humans; Incidence; Isoxazoles; Male; Methotrexate; Middle Aged; Multivariate Analysis; Phototherapy; Psoriasis; Risk Factors; Sex Distribution; Ustekinumab | 2015 |
Chédiak-Higashi syndrome: brain MRI and MR spectroscopy manifestations.
Topics: Brain; Chediak-Higashi Syndrome; Child; Contrast Media; Cyclosporine; Dexamethasone; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Immunosuppressive Agents; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Methotrexate; Recurrence; Treatment Outcome | 2015 |
[Uveitic macular edema and the pharmacotherapy].
Topics: Acetazolamide; Adrenal Cortex Hormones; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Azathioprine; Bevacizumab; Cyclosporine; Humans; Immunosuppressive Agents; Macular Edema; Methotrexate; Mycophenolic Acid; Tumor Necrosis Factor-alpha; Uveitis; Vision Disorders | 2015 |
Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
Topics: Adalimumab; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Hepatitis C, Chronic; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Effect of cyclosporin on distribution of methotrexate into the brain of rats.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain Chemistry; Chromatography, High Pressure Liquid; Cyclosporine; Injections, Intravenous; Injections, Spinal; Male; Methotrexate; Multidrug Resistance-Associated Proteins; Rats; Rats, Sprague-Dawley | 2015 |
Chronological assessment of airway lesions in relapsing polychondritis by positron emission tomography.
Topics: Adult; Bronchoscopy; Chest Pain; Costal Cartilage; Cyclosporine; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Methotrexate; Multimodal Imaging; Polychondritis, Relapsing; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Tomography, X-Ray Computed; Trachea | 2015 |
Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT.
Topics: Adolescent; Adult; Child; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Graft vs Host Disease; Graft vs Leukemia Effect; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Transplantation, Homologous; Young Adult | 2015 |
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.
Topics: Age Factors; Anemia, Aplastic; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Living Donors; Male; Methotrexate; Proportional Hazards Models; Retrospective Studies; Tacrolimus; Transplantation Conditioning; Treatment Outcome | 2015 |
Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Atherosclerosis; Biological Products; Carotid Intima-Media Thickness; Case-Control Studies; Cyclosporine; Disease Progression; Female; Humans; Male; Methotrexate; Middle Aged; Prevalence; Severity of Illness Index | 2015 |
Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
Topics: Adalimumab; Adolescent; Adult; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Prednisone; Retreatment; Retrospective Studies; Sarcoidosis; Treatment Outcome; Tumor Necrosis Factor-alpha; Uveitis; Young Adult | 2015 |
Sarcoidosis Presenting with Cicatrizing Conjunctivitis.
Topics: Administration, Oral; Administration, Topical; Adult; Biopsy; Chronic Disease; Cicatrix; Conjunctivitis; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed | 2015 |
Isolated ocular lichen planus in a child.
Topics: Autoimmune Diseases; Child; Conjunctival Diseases; Cyclosporine; Drug Therapy, Combination; Dry Eye Syndromes; Female; Fibrinogen; Glucocorticoids; Humans; Immunosuppressive Agents; Lichen Planus; Methotrexate; Prednisolone | 2015 |
Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
Topics: Adult; Cyclosporine; Dermatomyositis; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Prednisolone; Prognosis; Retrospective Studies; Survival Rate; Time Factors | 2016 |
Essential Truths for the Care and Management of Moderate-to-Severe Psoriasis.
Topics: Acitretin; Adalimumab; Attitude of Health Personnel; Biological Products; Cyclosporine; Dermatologic Agents; Etanercept; Humans; Infliximab; Methotrexate; Perception; Practice Patterns, Physicians'; Psoriasis | 2015 |
Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
Topics: Acitretin; Adalimumab; Adolescent; Adult; Aged; Antibodies, Monoclonal; Biological Products; Certolizumab Pegol; Cyclosporine; Dermatologic Agents; Drug Prescriptions; Drug Therapy, Combination; Etanercept; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Severity of Illness Index; Ultraviolet Therapy; Ustekinumab; Young Adult | 2015 |
The Use of Methotrexate, Alone or in Combination With Other Therapies, for the Treatment of Palmoplantar Psoriasis.
Topics: Adalimumab; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Foot Dermatoses; Hand Dermatoses; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Psoriasis; Severity of Illness Index; Thalidomide; Ustekinumab; Young Adult | 2015 |
Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest.
Topics: Adalimumab; Biological Products; Biological Therapy; Cardiovascular Diseases; Cyclosporine; Dermatologic Agents; Etanercept; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Neoplasms; Psoriasis; Registries; Ustekinumab | 2015 |
A Hemophagocytic Lymphohistiocytosis Case with Newly Defined UNC13D (c.175G>C; p.Ala59Pro) Mutation and a Rare Complication.
Topics: Amino Acid Substitution; Amphotericin B; Aspergillosis; Bone Marrow Transplantation; Combined Modality Therapy; Cyclosporine; Debridement; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Humans; Immunocompromised Host; Infant; Lymphohistiocytosis, Hemophagocytic; Membrane Proteins; Methotrexate; Mutation, Missense; Nasal Septal Perforation; Opportunistic Infections; Palate, Soft; Point Mutation; Stomatitis | 2015 |
Granulocyte and Monocyte Adsorption Apheresis for Generalized Pustular Psoriasis: Therapeutic Outcomes in Three Refractory Patients.
Topics: Adult; Blood Component Removal; Cyclosporine; Drug Resistance; Female; Granulocytes; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Monocytes; Phototherapy; Psoriasis; Severity of Illness Index; Treatment Outcome | 2015 |
The anti-IL-4 receptor alpha antibody dupilumab: facing a new era in treating atopic dermatitis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Methotrexate; Quality of Life; Receptors, Interleukin-4; Treatment Outcome | 2015 |
[Prophylaxis of acute graft-versus-host disease].
Topics: Acute Disease; Allografts; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate | 2015 |
European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC.
Topics: Acitretin; Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Drug Therapy, Combination; Etanercept; Fumarates; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Psoriasis; Ustekinumab | 2015 |
Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Human C1q Deficiency: The Karolinska Experience.
Topics: Adolescent; Adult; Child; Child, Preschool; Complement C1q; Cortisone; Cyclosporine; Fatal Outcome; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Heterozygote; Humans; Infant; Iraq; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Rituximab; Sweden; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2016 |
Graft-versus-host disease (GVHD) prophylaxis by using methotrexate decreases pre-engraftment syndrome and severe acute GVHD, and accelerates engraftment after cord blood transplantation.
Topics: Adolescent; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Infant, Newborn; Male; Methotrexate; Neoplasms; Neutrophils; Retrospective Studies; Tacrolimus; Time Factors; Transplantation Conditioning; Treatment Outcome | 2016 |
[Clinical features of patients with juvenile and adult dermatomyositis].
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatomyositis; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Muscle Weakness; Recurrence; Retrospective Studies; Young Adult | 2015 |
Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis.
Topics: Acitretin; Adolescent; Adult; Aged; Algorithms; Cyclosporine; Dermatologic Agents; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2016 |
Systemic treatments in childhood psoriasis: a French multicentre study on 154 children.
Topics: Acitretin; Adolescent; Child; Child, Preschool; Cyclosporine; Dermatologic Agents; France; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Phototherapy; Psoriasis; Treatment Outcome | 2016 |
Progress in the treatment of juvenile dermatomyositis.
Topics: Anti-Inflammatory Agents; Cyclosporine; Dermatologic Agents; Dermatomyositis; Female; Humans; Male; Methotrexate; Prednisone | 2016 |
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha | 2015 |
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs.
Topics: Adalimumab; Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Immunologic Factors; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Remission Induction; Severity of Illness Index; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2016 |
[Outcomes of allogeneic hematopoietic stem cell transplantation for 18 patients with paroxysmal nocturnal haemoglobinuria].
Topics: Anemia, Aplastic; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Humans; Methotrexate; Mycophenolic Acid; Retrospective Studies; Siblings; Tacrolimus; Transplantation Conditioning; Treatment Outcome; Unrelated Donors; Vidarabine | 2015 |
A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey.
Topics: Acute Disease; Adolescent; Adult; Aged; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Tacrolimus; Young Adult | 2016 |
Retrospective analysis of the effectiveness and costs of traditional treatments for moderate-to-severe psoriasis: A single-center, Italian study.
Topics: Acitretin; Adult; Cyclosporine; Dermatologic Agents; Female; Humans; Italy; Male; Methotrexate; Middle Aged; Phototherapy; Psoriasis; Retrospective Studies; Treatment Outcome | 2016 |
Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study.
Topics: Adolescent; Adult; Aged; Azathioprine; Cyclosporine; Dermatitis, Atopic; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome | 2016 |
[Cost Effectiveness of Treatments of Psoriasis with a PASI 75 and one Period of 12 Weeks].
Topics: Acitretin; Adalimumab; Cost-Benefit Analysis; Cyclosporine; Etanercept; Health Care Costs; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Models, Economic; Psoriasis; PUVA Therapy; Severity of Illness Index; Spain; Time Factors; Treatment Outcome; Ultraviolet Therapy; Ustekinumab | 2016 |
Concomitant Presentation of Hemophagocytic Lymphohistiocytosis and Posttransplant Lymphoproliferative Disease-Like Lymphoma in a Mildly Immunosuppressed Leukemia Patient: An Unusual Association.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclosporine; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Female; Humans; Immunocompromised Host; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Mercaptopurine; Methotrexate; Multiple Organ Failure; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rituximab; Treatment Failure; Vincristine; Viral Load | 2016 |
Predominant Neurologic Manifestations Seen in a Patient With a Biallelic Perforin1 Mutation (PRF1; p.R225W).
Topics: Adult; Brain Stem; Child, Preschool; Codon; Cyclosporine; Demyelinating Diseases; Dexamethasone; Exons; Female; Ferritins; Frontal Lobe; Humans; Immunosuppressive Agents; Lymphohistiocytosis, Hemophagocytic; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Muscle Weakness; Mutation, Missense; Perforin; Recurrence; Respiratory Tract Infections | 2017 |
Generalized pustular psoriasis treated with ustekinumab.
Topics: Acitretin; Adalimumab; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Cyclosporine; Drug Resistance; Female; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Psoriasis; Skin Diseases, Vesiculobullous; Treatment Outcome; Ustekinumab | 2016 |
The PRINTO juvenile dermatomyositis trial.
Topics: Anti-Inflammatory Agents; Cyclosporine; Dermatologic Agents; Dermatomyositis; Female; Humans; Male; Methotrexate; Prednisone | 2016 |
The PRINTO juvenile dermatomyositis trial - Authors' reply.
Topics: Anti-Inflammatory Agents; Cyclosporine; Dermatologic Agents; Dermatomyositis; Female; Humans; Male; Methotrexate; Prednisone | 2016 |
Ultra-Widefield Imaging in Granulomatosis With Polyangiitis.
Topics: Adult; Autoantibodies; Choroid Diseases; Cyclosporine; Diagnostic Imaging; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Myeloblastin; Papilledema; Retinal Diseases | 2016 |
British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016.
Topics: Adult; Alcohol Drinking; Biological Products; Bone Marrow Diseases; Checklist; Chemical and Drug Induced Liver Injury; Chickenpox; Child; Counseling; Cyclosporine; Dermatologic Agents; Drug Administration Routes; Drug Administration Schedule; Drug Approval; Drug Interactions; Drug Monitoring; Drug Overdose; Evidence-Based Medicine; Female; Hepatitis, Viral, Human; HIV Infections; Humans; Intraoperative Complications; Kidney Diseases; Lung Diseases; Methotrexate; Nausea; Neoplasms; Off-Label Use; Patient Education as Topic; Patient Safety; Pregnancy; Pregnancy Complications; Retinoids; Skin Diseases; Tuberculosis; Ultraviolet Rays; Vaccination | 2016 |
Sepsis During Immunosuppression for Sight-threatening Uveitis: The Flip side.
Topics: Adult; Aged; Azathioprine; Bacteremia; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Klebsiella Infections; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pneumocystis Infections; Prednisolone; Retrospective Studies; Uveitis | 2018 |
Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry.
Topics: Adalimumab; Adult; Aged; Bacterial Infections; Biological Products; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Poisson Distribution; Psoriasis; Registries | 2017 |
Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study.
Topics: Adult; Aged; Ambulatory Care; Azathioprine; Case-Control Studies; Cyclosporine; Denmark; Dermatitis, Atopic; Eczema; Female; Follow-Up Studies; Hospitalization; Hospitals; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Myocardial Infarction; Registries; Risk Factors; Young Adult | 2016 |
Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
Topics: Adult; Azathioprine; Canada; Child; Cyclosporine; Dermatitis, Atopic; Dermatology; Drug Prescriptions; Female; Health Care Surveys; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pediatrics; Practice Patterns, Physicians'; Severity of Illness Index; United States | 2017 |
Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
Topics: Adult; Alitretinoin; Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Dermatitis, Atopic; Female; Follow-Up Studies; Humans; Leflunomide; Long-Term Care; Male; Methotrexate; Mycophenolic Acid; Prednisolone; Registries; Treatment Outcome | 2017 |
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.
Topics: Adolescent; Adult; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Incidence; Japan; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Registries; Survival Rate; Tacrolimus | 2017 |
Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study.
Topics: Acitretin; Adolescent; Child; Cohort Studies; Cyclosporine; Dermatologic Agents; Female; Humans; Male; Methotrexate; Psoriasis; Treatment Outcome | 2017 |
Graft-Versus-Host Disease in Adolescents and Young Adults (15-24 Years Old) After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia in First Complete Remission.
Topics: Acute Disease; Adolescent; Adult; Child; Chronic Disease; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Intestinal Diseases; Leukemia, Myeloid, Acute; Methotrexate; Mortality; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proportional Hazards Models; Quality of Life; Remission Induction; Severity of Illness Index; Skin Diseases; Survival Rate; Transplantation, Homologous; Young Adult | 2017 |
[Clinical Efficacy of Haploidentical Allo-HSCT of Reduced Intensity Preconditioning Combined with Induced Immune Tolerance after Transplantation for Severe Aplastic Anemia].
Topics: Anemia, Aplastic; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Fathers; Hematopoietic Stem Cell Transplantation; Hematopoietic System; Humans; Immune Tolerance; Male; Methotrexate; T-Lymphocyte Subsets; Tissue Donors; Transplantation Conditioning; Treatment Outcome; Vidarabine | 2016 |
The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors.
Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mortality; Mycophenolic Acid; Neutrophils; Premedication; Retrospective Studies; Stem Cell Transplantation; Unrelated Donors; Young Adult | 2017 |
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Cyclosporine; Drug Therapy, Combination; Evidence-Based Medicine; Female; Humans; Inflammatory Bowel Diseases; Italy; Mercaptopurine; Methotrexate; Pregnancy; Randomized Controlled Trials as Topic; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
Topics: Acitretin; Adult; Biological Products; Body Mass Index; Comorbidity; Coronary Disease; Cyclosporine; Czech Republic; Dermatologic Agents; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Keratolytic Agents; Male; Methotrexate; Middle Aged; Obesity; Phototherapy; Prevalence; Psoriasis; Quality of Life; Registries; Retreatment; Retrospective Studies; Risk Factors; Severity of Illness Index | 2017 |
Management of patients with psoriasis.
Topics: Acitretin; Administration, Cutaneous; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Cyclosporine; Dermatologic Agents; Disease Management; Emollients; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Phototherapy; Psoriasis; Thalidomide | 2017 |
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology Inter
Topics: Adolescent; Alanine Transaminase; Antirheumatic Agents; Aspartate Aminotransferases; Child; Creatine Kinase; Cyclosporine; Dermatomyositis; Europe; Fructose-Bisphosphate Aldolase; Glucocorticoids; Humans; L-Lactate Dehydrogenase; Logistic Models; Methotrexate; Muscle Strength; Outcome Assessment, Health Care; Patient Reported Outcome Measures; Prednisone; Reproducibility of Results; Rheumatology; Rituximab; Societies, Medical; Surveys and Questionnaires; Treatment Outcome; United States | 2017 |
A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents.
Topics: Animals; Cyclosporine; Cytokines; Dermatitis, Atopic; Female; Haptens; Humans; Immunoglobulin E; Inflammation; Interleukin-23; Interleukin-23 Subunit p19; Janus Kinase Inhibitors; Male; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pyrroles; Rats; Rats, Inbred BN; Skin; Thymic Stromal Lymphopoietin | 2018 |
Biologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.
Topics: Acitretin; Adalimumab; Austria; Biological Products; Combined Modality Therapy; Cyclosporine; Czech Republic; Dermatologic Agents; Drug Therapy, Combination; Etanercept; Female; Fumarates; Humans; Infliximab; Israel; Italy; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Netherlands; Psoriasis; PUVA Therapy; Registries; Severity of Illness Index; Ustekinumab | 2018 |
Treatment of lichen planopilaris: methotrexate or cyclosporine a therapy?
Topics: Adult; Aged; Cyclosporine; Dermatologic Agents; Female; Humans; Lichen Planus; Male; Methotrexate; Middle Aged; Treatment Outcome | 2018 |
Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
Topics: Acute Disease; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Off-Label Use; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity | 2018 |
[Pityriasis rubra pilaris].
Topics: Adult; Antirheumatic Agents; Child; Cyclosporine; Dermatologic Agents; Diagnosis, Differential; Humans; Incidence; Keratoderma, Palmoplantar; Keratosis; Methotrexate; Phototherapy; Pityriasis Rubra Pilaris; Retinoids | 2018 |
Cutaneous side effects caused by treatment for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporine; Drug Eruptions; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Tumor Necrosis Factor-alpha | 2016 |
Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate-cyclosporin A-hydroxychloroquine-prednisone.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Sulfonamides; Treatment Outcome | 2018 |
Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation
Topics: Adalimumab; Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chitinase-3-Like Protein 1; Cyclosporine; Disease Progression; Female; Forefoot, Human; Hand Joints; Humans; Interleukin-6; Male; Methotrexate; Middle Aged; Prognosis; Radiography; Randomized Controlled Trials as Topic; Remission Induction; Severity of Illness Index; Vascular Endothelial Growth Factor A | 2018 |
[Current and upcoming treatments of adult atopic dermatitis].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Glucocorticoids; Humans; Methotrexate; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Thalidomide; Ustekinumab | 2017 |
Drug survival and postdrug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine.
Topics: Adult; Alphavirus; Cyclosporine; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Proportional Hazards Models; Retrospective Studies; Time Factors; Young Adult | 2018 |
Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands.
Topics: Administration, Oral; Azathioprine; Cyclosporine; Databases, Factual; Dermatitis, Atopic; Drug Prescriptions; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Netherlands | 2018 |
Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Glucocorticoids; Glycosides; Humans; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Remission Induction; Treatment Outcome; Young Adult | 2018 |
[Juvenile Dermatomyositis].
Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Cyclosporine; Dermatomyositis; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Muscle, Skeletal; Polymyositis | 2018 |
Long-term aprepitant for nausea and vomiting associated with gastroparesis in hematopoietic stem cell transplantation.
Topics: Alemtuzumab; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Busulfan; Cyclosporine; Gastroparesis; Hematopoietic Stem Cell Transplantation; Humans; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Methotrexate; Nausea; Unrelated Donors; Vidarabine; Vomiting | 2018 |
'It's hard to swallow'.
Topics: Anti-Bacterial Agents; Capsules; Cyclosporine; Deglutition; Deglutition Disorders; Dermatologic Agents; Erythromycin; Humans; Isotretinoin; Lymecycline; Methotrexate; Tablets | 2018 |
Cogan's syndrome with pyoderma gangrenosum: management of two uncommon disorders with aggressive presentation in a patient.
Topics: Administration, Intravenous; Azathioprine; Biopsy; Cogan Syndrome; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Pyoderma Gangrenosum; Skin Ulcer | 2018 |
Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
Topics: Acute Disease; Adult; Aged; Area Under Curve; Biomarkers, Tumor; Calcineurin Inhibitors; Case-Control Studies; Cyclosporine; Exosomes; Female; Gene Expression Profiling; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Methotrexate; MicroRNAs; Middle Aged; Myeloablative Agonists; ROC Curve; Survival Analysis; Tacrolimus; Transplantation, Homologous | 2018 |
Generating new evidence for old medications: the TREAT trial in paediatric atopic dermatitis.
Topics: Child; Cost-Benefit Analysis; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Methotrexate | 2018 |
Compounded topical preparations in plaque psoriasis: Still a place for it in 2018?
Topics: Administration, Cutaneous; Adult; Chronic Disease; Cyclosporine; Dermatologic Agents; Drug Compounding; Drug Substitution; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Remission Induction; Skin; Time Factors; Treatment Outcome | 2019 |
Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Therapy; Comorbidity; Cyclosporine; Etanercept; Female; Hepatitis B; Hepatitis C; Humans; Infliximab; Interleukin-17; Latent Tuberculosis; Male; Methotrexate; Middle Aged; Non-alcoholic Fatty Liver Disease; Psoriasis; Ustekinumab | 2018 |
Lichen planopilaris: retrospective study on the characteristics and treatment of 291 patients.
Topics: 5-alpha Reductase Inhibitors; Adult; Cyclosporine; Female; Hair Follicle; Humans; Iran; Isotretinoin; Lichen Planus; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome | 2019 |
TNF-α inhibitor-induced psoriasis: A decade of experience at the Cleveland Clinic.
Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retrospective Studies; Risk Factors; Sex Factors; Spondylitis, Ankylosing; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2020 |
Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France.
Topics: Adult; Cyclosporine; Dermatologic Agents; Female; Folic Acid; France; Humans; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prospective Studies; Psoriasis; Treatment Outcome | 2019 |
Drug survival of conventional systemic and biologic therapies for moderate-to-severe psoriasis in clinical practice in Spain: prospective results from the SAHARA study.
Topics: Acitretin; Adalimumab; Adolescent; Adult; Age of Onset; Biological Products; Cyclosporine; Dermatologic Agents; Etanercept; Female; Humans; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Prospective Studies; Psoriasis; Spain; Ustekinumab | 2020 |
Switching to secukinumab in difficult-to-treat psoriasis recalcitrant to methotrexate, cyclosporine and leflunomide, in a tuberculosis-endemic country.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatologic Agents; Humans; Interleukin-17; Leflunomide; Male; Methotrexate; Middle Aged; Psoriasis; Treatment Failure; Tuberculosis | 2019 |
Establishment of immunity against Epstein-Barr virus infection in a patient with CHARGE/complete DiGeorge syndrome after peripheral blood lymphocyte transfusion.
Topics: CD3 Complex; Cell Proliferation; CHARGE Syndrome; Concanavalin A; Cyclosporine; Diarrhea; DiGeorge Syndrome; Epstein-Barr Virus Infections; Fatal Outcome; Graft vs Host Disease; Herpesvirus 4, Human; HLA Antigens; Humans; Infant, Newborn; Lymphocyte Transfusion; Male; Methotrexate; Mutation; Phenotype; Phytohemagglutinins; Siblings; T-Lymphocytes | 2019 |
Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology.
Topics: Adrenal Cortex Hormones; Anthralin; Antibodies, Monoclonal; Brazil; Calcineurin Inhibitors; Comorbidity; Cyclosporine; Dermatologic Agents; Dermatology; Drug Combinations; Female; Humans; Male; Methotrexate; Phototherapy; Psoriasis; Severity of Illness Index; Societies, Medical; Time Factors; Vitamin D | 2019 |
Acquired Amegakaryocytic Thrombocytopenia in Adult-onset Still's Disease: Successful Combination Therapy with Tocilizumab and Cyclosporine.
Topics: Aged; Antibodies, Monoclonal, Humanized; Bone Marrow Diseases; Combined Modality Therapy; Cyclosporine; Female; Humans; Immunosuppressive Agents; Methotrexate; Prednisolone; Purpura, Thrombocytopenic; Still's Disease, Adult-Onset; Tacrolimus | 2019 |
Mitochondrial and lysosomal protective agents ameliorate cytotoxicity and oxidative stress induced by cyclophosphamide and methotrexate in human blood lymphocytes.
Topics: Adolescent; Adult; Antineoplastic Agents; Butylated Hydroxytoluene; Cell Survival; Cells, Cultured; Chloroquine; Cyclophosphamide; Cyclosporine; Glutathione; Humans; Immunosuppressive Agents; Lymphocytes; Lysosomes; Methotrexate; Mitochondria; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Young Adult | 2019 |
Changes in serum TNF-like weak inducer of apoptosis (TWEAK) levels and Psoriasis Area Severity Index (PASI) scores in plaque psoriasis patients treated with conventional versus anti-TNF treatments.
Topics: Acitretin; Adalimumab; Adult; Anti-Inflammatory Agents; Cyclosporine; Cytokine TWEAK; Dermatologic Agents; Etanercept; Female; Humans; Infliximab; Keratolytic Agents; Male; Methotrexate; Middle Aged; Psoriasis; Severity of Illness Index; Tumor Necrosis Factor-alpha | 2020 |
Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantation.
Topics: Acetyl-CoA C-Acetyltransferase; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; HLA Antigens; Humans; Incidence; Japan; Male; Methotrexate; Middle Aged; Polymorphism, Single Nucleotide; Recurrence; Siblings; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Young Adult | 2020 |
Perinatal use and discontinuation of disease-modifying anti-rheumatic drugs and biologics in women with rheumatoid arthritis: a cohort study.
Topics: Abatacept; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Biological Products; British Columbia; Chloroquine; Cohort Studies; Cyclophosphamide; Cyclosporine; Deprescriptions; Female; Glucocorticoids; Gold Compounds; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Leflunomide; Logistic Models; Maternal Age; Methotrexate; Mycophenolic Acid; Odds Ratio; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Rheumatology; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cyclosporine; Deprescriptions; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Risk Factors; Symptom Flare Up; Time Factors | 2020 |
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients.
Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Biological Products; Calcineurin Inhibitors; Cardiovascular Diseases; Child; Child, Preschool; Coal Tar; Comorbidity; Cyclosporine; Dermatologic Agents; Dyslipidemias; Evidence-Based Medicine; Humans; Infant; Infant, Newborn; Inflammatory Bowel Diseases; Insulin Resistance; Mental Health; Metabolic Syndrome; Methotrexate; Nicotinic Acids; Obesity; Photochemotherapy; Psoriasis; Retinoids | 2020 |
Fibroblastic Rheumatism Versus Variant Disease of Multinucleate Cell Angiohistiocytoma.
Topics: Antirheumatic Agents; Cyclosporine; Diagnosis, Differential; Female; Fibroblasts; Giant Cells; Hemangioma; Histiocytoma; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Rheumatic Diseases; Skin Diseases; Skin Neoplasms | 2020 |
Characteristics and Management of Autoimmune Bullous Disease in Psoriasis Patients.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Cyclosporine; Disease Management; Enzyme Inhibitors; Female; Glucocorticoids; Humans; Hydroxyurea; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pemphigoid, Bullous; Pemphigus; Psoriasis; Retrospective Studies; Ultraviolet Therapy | 2019 |
A Long-Term Follow-up of Retinal Vasculitis - Do They Develop Systemic Disease?
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retinal Vasculitis; Retrospective Studies; Tuberculin Test; Tuberculosis, Ocular; Visual Acuity; Vitreous Hemorrhage | 2020 |
Granulomatous mural folliculitis in a dog treated with ciclosporin and methotrexate.
Topics: Alopecia; Animals; Cyclosporine; Disease Management; Dog Diseases; Dogs; Female; Folliculitis; Histological Techniques; Inflammation; Methotrexate; Skin; Skin Diseases | 2020 |
Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.
Topics: Adolescent; Anemia, Diamond-Blackfan; Antilymphocyte Serum; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Factors; Immunosuppressive Agents; Infusions, Intravenous; Male; Methotrexate; Prospective Studies; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2019 |
Adverse event monitoring in patients on oral systemic medications for inflammatory skin disease.
Topics: Azathioprine; Cross-Sectional Studies; Cyclosporine; Dermatitis, Atopic; Drug Eruptions; Drug Monitoring; Humans; Methotrexate; Mycophenolic Acid; Psoriasis; United States | 2020 |
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies.
Topics: Acitretin; Cyclosporine; Drug Monitoring; Humans; Methotrexate; Piperidines; Psoriasis; Pyrimidines; Thalidomide | 2020 |
Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry.
Topics: Adult; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Pharmaceutical Preparations; Registries | 2020 |
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine | 2020 |
Clinical outcomes in T-cell large granular lymphocytic leukaemia: prognostic factors and treatment response.
Topics: Aged; Alemtuzumab; Antineoplastic Agents; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Humans; Leukemia, Large Granular Lymphocytic; Male; Methotrexate; Middle Aged; Pentostatin; Prognosis; Retrospective Studies | 2021 |
Utility of azathioprine, methotrexate and cyclosporine as steroid-sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients.
Topics: Alopecia Areata; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Retrospective Studies | 2020 |
Carfilzomib combined with cyclosporine and methotrexate for the prevention of graft-versus-host disease after allogeneic stem-cell transplantation from unrelated donors.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Oligopeptides; Transplantation Conditioning; Unrelated Donors | 2021 |
Treatment of pityriasis rubra pilaris: a case series of 28 patients.
Topics: Acitretin; Biological Products; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Pityriasis Rubra Pilaris; Retrospective Studies; Smoking; Ustekinumab | 2020 |
Cyclosporine/methotrexate versus tacrolimus/methotrexate with or without anti-thymocyte globulin as GVHD prophylaxis in adult patients with aplastic anemia.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pre-Exposure Prophylaxis; Retrospective Studies; Survival Rate; Tacrolimus; Transplantation Conditioning; Young Adult | 2021 |
Chronic spontaneous urticaria refractory to cyclosporine add-on omalizumab successfully treated with methotrexate add-on.
Topics: Anti-Allergic Agents; Chronic Disease; Chronic Urticaria; Cyclosporine; Humans; Methotrexate; Omalizumab; Treatment Outcome; Urticaria | 2020 |
Le choix thérapeutique : médicaments du psoriasis et grossesse avant, pendant et après la grossesse.
Topics: Acitretin; Biological Factors; Breast Feeding; Contraindications, Drug; Cyclosporine; Dermatologic Agents; Female; Humans; Immunosuppressive Agents; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Psoriasis; Risk Factors; Ultraviolet Therapy | 2020 |
Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Combined Modality Therapy; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Retrospective Studies; Ultraviolet Therapy | 2021 |
Refractory systemic juvenile idiopathic arthritis successfully treated with rapamycin.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Juvenile; Child; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; NF-KappaB Inhibitor alpha; Piperidines; Pyrimidines; Severity of Illness Index; Sirolimus; Treatment Failure; Tumor Necrosis Factor Inhibitors | 2021 |
Novel agents for atopic dermatitis in patients over 50 years of age: A case series.
Topics: Aged; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Infant; Methotrexate; Treatment Outcome | 2021 |
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cladribine; Comorbidity; COVID-19; Crotonates; Cyclophosphamide; Cyclosporine; Databases, Factual; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Incidence; Interferon-beta; Logistic Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid; Natalizumab; Nitriles; Obesity; Risk Factors; Rituximab; SARS-CoV-2; Toluidines; United States; White People; Young Adult | 2021 |
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Transplantation Conditioning; Unrelated Donors | 2022 |
Combined Methotrexate and Alitretinoin for the treatment of difficult-to-treat generalized prurigo nodularis: a case series.
Topics: Alitretinoin; Cyclosporine; Humans; Methotrexate; Prurigo; Pruritus | 2021 |
Large granular lymphocytic leukemia - A retrospective study of 319 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cyclophosphamide; Cyclosporine; Disease Management; Female; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2021 |
Drug survival rates and reasons for drug discontinuation in patients with atopic dermatitis: a retrospective study of adult outpatients.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Female; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Medication Adherence; Methotrexate; Middle Aged; Mycophenolic Acid; Outpatients; Patient Satisfaction; Probability; Proportional Hazards Models; Retrospective Studies; Young Adult | 2021 |
The potential impact of systemic anti-inflammatory therapies in psoriasis on major adverse cardiovascular events: a Korean nationwide cohort study.
Topics: Acitretin; Adult; Aged; Anti-Inflammatory Agents; Cardiovascular Diseases; Cyclosporine; Female; Humans; Incidence; Male; Methotrexate; Middle Aged; Phototherapy; Proportional Hazards Models; Psoriasis; Republic of Korea; Severity of Illness Index; Young Adult | 2021 |
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience.
Topics: Adult; Allografts; Antilymphocyte Serum; Cyclosporine; Disease-Free Survival; Dose-Response Relationship, Immunologic; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Incidence; Infections; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Recurrence; Retrospective Studies; T-Lymphocytes; Unrelated Donors | 2021 |
A case of psoriasis successfully treated by extracorporeal photopheresis during COVID-19 pandemic.
Topics: Acitretin; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Contraindications, Drug; COVID-19; Cyclosporine; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Nails; Pandemics; Photopheresis; Psoriasis; Quality of Life; SARS-CoV-2; Severity of Illness Index; Ultraviolet Therapy | 2021 |
Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis.
Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Argentina; Arthritis, Psoriatic; Biological Products; Body Mass Index; Cyclosporine; Electronic Health Records; Etanercept; Female; Humans; Incidence; Infliximab; Male; Methotrexate; Middle Aged; Nail Diseases; Phototherapy; Psoriasis; Retrospective Studies; Risk Factors; Sex Factors; Ustekinumab; Young Adult | 2022 |
Immunosuppressants as steroid-sparing agents for chronic DRESS: four cases.
Topics: Adrenal Cortex Hormones; Cyclosporine; Drug Hypersensitivity Syndrome; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Methotrexate; Treatment Outcome | 2021 |
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation.
Topics: Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Methotrexate; Prospective Studies; Recurrence; Siblings; Transplantation Conditioning; United States | 2022 |
Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD).
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Severity of Illness Index; Treatment Outcome | 2022 |
Predictors and outcomes of dose reduction of methotrexate and cyclosporin graft-versus-host disease prophylaxis following allogeneic haemopoietic cell transplantation.
Topics: Cyclosporine; Drug Tapering; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Retrospective Studies | 2023 |
Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe.
Topics: Adolescent; Azathioprine; Biological Products; Child; Child, Preschool; Cyclosporine; Delphi Technique; Dermatitis, Atopic; Expert Testimony; Humans; Janus Kinase Inhibitors; Janus Kinases; Methotrexate; Mycophenolic Acid; Quality of Life | 2022 |
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records.
Topics: Acute Disease; Adult; Chronic Disease; Cohort Studies; Cyclosporine; Electronic Health Records; Female; Humans; Methotrexate; Middle Aged; Psoriasis; Retrospective Studies; Skin Diseases, Vesiculobullous; Tacrolimus | 2022 |
Risk of malignancy in patients with psoriasis receiving systemic medications: A nested case-control study.
Topics: Adalimumab; Biological Products; Case-Control Studies; Cyclosporine; Dermatologic Agents; Etanercept; Humans; Methotrexate; Neoplasms; Psoriasis; Ustekinumab | 2022 |
Annual Trends in Medicare Part D Prescription Claims for Dupilumab 2017 to 2019.
Topics: Aged; Antibodies, Monoclonal, Humanized; Cyclosporine; Dermatitis, Atopic; Humans; Medicare Part D; Methotrexate; Prescriptions; Severity of Illness Index; Treatment Outcome; United States | 2022 |
Trends in prescriptions of oral medications for psoriasis: A single-center retrospective study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Etretinate; Humans; Methotrexate; Phosphodiesterase 4 Inhibitors; Psoriasis; Retrospective Studies; Severity of Illness Index | 2023 |
Systemic treatment for severe atopic dermatitis in children: a case series.
Topics: Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Mycophenolic Acid; Prednisone; Thalidomide | 2022 |
Conventional therapy in psoriasis. Lost in translation?
Topics: Acitretin; Cohort Studies; Cyclosporine; Fumarates; Humans; Methotrexate; Psoriasis | 2023 |
Effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for patients with moderate-to-severe psoriasis: a cohort study from BADBIR.
Topics: Acitretin; Adjuvants, Immunologic; Biological Factors; Cohort Studies; Cyclosporine; Dermatologic Agents; Fumarates; Humans; Immunologic Factors; Male; Methotrexate; Prospective Studies; Psoriasis; Treatment Outcome | 2023 |
Adverse impact of a high CD4/CD8 ratio in the allograft may be overcome by methotrexate- but not mycophenolate- or post-transplant cyclophosphamide-based graft versus host disease prophylaxis.
Topics: Allografts; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Retrospective Studies | 2023 |
The real-world effectiveness and persistence of acitretin, ciclosporin, fumaric acid esters and methotrexate for treating moderate-to-severe psoriasis.
Topics: Acitretin; Cohort Studies; Cyclosporine; Fumarates; Humans; Methotrexate; Psoriasis | 2023 |
Post-transplantation Cyclophosphamide-based Graft-versus-host-disease Prophylaxis Compared to Methotrexate-cyclosporine a in Matched-related Allogeneic Hematopoietic Stem Cell Transplantation.
Topics: Adult; Cyclophosphamide; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Neoplasm Recurrence, Local; Retrospective Studies | 2023 |
Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality.
Topics: Adalimumab; Alkylating Agents; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Cohort Studies; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infliximab; Methotrexate; Mycophenolic Acid; Neoplasms; Retrospective Studies; Tumor Necrosis Factor Inhibitors | 2023 |
Cyclosporin A-mediated translocation of HuR improves MTX-induced cognitive impairment in a mouse model via NCOA4-mediated ferritinophagy.
Topics: Animals; Apoptosis; Cyclosporine; Cytoplasm; Methotrexate; Mice; Transcription Factors | 2023 |
A clinical trial in children and young people with severe eczema comparing methotrexate with ciclosporin.
Topics: Adolescent; Child; Cyclosporine; Dermatitis, Atopic; Eczema; Humans; Immunosuppressive Agents; Methotrexate | 2023 |